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Abstract 
Introduction: Oesophageal adenocarcinoma has increased dramatically in 
incidence over the past three decades with a particularly high burden of disease 
at the gastro-oesophageal junction. Many cases occur in individuals without 
known gastro-oesophageal reflux disease and in the absence of Barrett’s 
oesophagus suggesting that mechanisms other than traditional reflux may be 
important. 
Distal squamous mucosa may be prone to acid damage even in the absence of 
traditional reflux by the mechanism of distal opening of the lower oesophageal 
sphincter. This is splaying of the distal segment of lower oesophageal sphincter 
allowing acid ingress without traditional reflux. 
It has been suggested that the cardiac mucosa at the gastro-oesophageal 
junction, separating oesophageal squamous mucosa and acid secreting columnar 
mucosa of the stomach may be an abnormal mucosa arising as a consequence of 
acid damage. By this theory the cardiac mucosa is metaplastic and akin to ultra-
short Barrett’s oesophagus. 
Obesity is a known risk factor for adenocarcinoma at the gastro-oesophageal 
junction and its rise has paralleled that of oesophageal cancer. Some of this 
excess risk undoubtedly operates through stress on the gastro-oesophageal 
junction and a predisposition to reflux. However we sought to explore the 
impact of obesity on the gastro-oesophageal junction in healthy volunteers 
without reflux and in particular to determine the characteristics of the cardiac 
mucosa and mechanisms of reflux in this group. 
Methods: 61 healthy volunteers with normal and increased waist circumference 
were recruited. 15 were found to have a hiatus hernia during the study protocol 
and were analysed separately. Volunteers had comprehensive pathological, 
physiological and anatomical assessments of the gastro-oesophageal junction 
including endoscopy with biopsies, MRI scanning before and after a standardised 
meal, prolonged recording of pH and manometry before and after a meal and 
screening by fluoroscopy to identify the squamo-columnar junction.  
17 
 
In the course of the early manometric assessments a potential error associated 
with the manometry system recordings was identified. We therefore also sought 
to document and address this on the benchtop and in vivo.    
Key Findings 
 In documenting the behaviour of the manoscan we described an 
immediate effect of temperature change on the pressure recorded by the 
sensors; ‘thermal effect’ and an ongoing drift of the recorded pressure 
with time; ‘baseline drift’. Thermal effect was well compensated within 
the standard operation of the system but baseline drift not addressed. 
Applying a linear correction to recorded data substantially reduced the 
error associated with baseline drift.  
 In asymptomatic healthy volunteers there was lengthening of the cardiac 
mucosa in association with central obesity and age. Furthermore, the 
cardiac mucosa in healthy volunteers demonstrated an almost identical 
immunophenotype to non-IM Barrett’s mucosa, which is considered to 
arise by metaplasia of oesophageal squamous mucosa. These findings 
support the hypothesis that the cardia is metaplastic in origin. 
 We have demonstrated a plausible mechanism of damage to distal 
squamous mucosa in association with obesity. In those with a large waist 
circumference we observed increased ingress of acid within but not across 
the lower oesophageal sphincter; ‘intrasphincteric reflux’ 
 The 15 healthy volunteers with a hiatus hernia were compared to 15 
controls matched for age, gender and waist circumference. Those with a 
hiatus hernia had a longer cardiac mucosa and although they did not have 
excess traditional reflux they had excess distal acid exposure by short 
segment acid reflux and intrasphincteric acid reflux. 
Conclusions: These findings are likely to be relevant to adenocarcinoma of the 
gastro-oesophageal junction 
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1 An Introduction to Gastro-oesophageal 
Reflux Disease 
1.1 Background 
Gastro-oesophageal reflux disease (GORD) occurs when reflux of gastric contents 
causes troublesome symptoms and or complications (Montreal definition)1. The 
cardinal associated symptoms are heartburn and regurgitation.  It is one of the 
commonest chronic diseases in Western world affecting up to 28% of the 
population in North America and up to 26% in Europe and the prevalence 
continues to increase. 2  
The importance of GORD lies in its associated complications. Complications arise 
as a result of mucosal damage and encompass erosive oesophagitis with or 
without associated strictures, Barrett’s oesophagus and oesophageal 
adenocarcinoma (Table 1.1) 
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TABLE 1.1: THE CLINICAL SPECTRUM OF GASTRO-OESOPHAGEAL REFLUX DISEASE 
Clinical Entity Definition 
Non-Erosive Reflux 
Disease 
Reflux of gastric contents causing troublesome 
symptoms in the absence of endoscopically visible 
mucosal damage 
 
Erosive Oesophagitis Oesophageal mucosal damage caused by the reflux 
of gastric contents and graded by severity 
according to the Los Angeles classification.3 
 Grade A: One (or more) mucosal break no 
longer than 5mm, that does not extend 
between the tops of two mucosal folds 
Grade B: One (or more) mucosal break 
more than 5mm long that does not extend 
between the tops of two mucosal folds 
Grade C: One (or more) mucosal break that 
is continuous between the tops of two or 
more mucosal folds, but which involves less 
than 75% of the circumference 
Grade D: One (or more) mucosal break that 
involves more than 75% of the oesophageal 
circumference. 
 
Barrett’s Oesophagus The presence of columnar lined oesophagus with 
or without intestinal metaplasia.  
 
In 1952 the occurrence of oesophageal adenocarcinoma in Barrett’s oesophagus 
merited a case report 4 . Over the last three decades incidence has increased 
markedly. In the UK the cumulative risk between the ages of 15 and 74 increased 
tenfold in men and fivefold in women in little more than a single generation. 5 
Oesophageal adenocarcinoma is now the 5th leading cause of cancer related 
death in the world in men6 and Scotland has the highest incidence worldwide.  7   
1.2 The Gastro-oesophageal Junction and Anti-reflux Mechanisms 
The environment of the gastro-oesophageal junction is unique in that acid 
producing parietal cells of the proximal stomach are in close proximity to the 
squamous mucosa of the distal oesophagus. Indeed the mucosal subtypes may be 
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separated by only a few mm8. The columnar mucosa of the stomach is adapted 
to withstand the challenge of a highly acidic environment whilst the stratified 
squamous mucosa of the distal oesophagus is vulnerable.   
The gastro-oesophageal junction incorporates a number of protective 
mechanisms acting in concert to prevent retrograde flow of acid and pepsin and 
protect vulnerable squamous mucosa (Figure 1.1)9 
1. Intrinsic and extrinsic components of the lower oesophageal sphincter.  
2. The intra-abdominal oesophagus. 
3. The mucosal flap valve. 
4. The location of the SCJ within the LOS  
5. Mechanisms to limit oesophageal acid exposure 
 
 
 
FIGURE 1.1: THE NORMAL GASTRO-OESOPHAGEAL JUNCTION AND ANTI-REFLUX MECHANISMS 
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1.2.1 Intrinsic and Extrinsic Components of the Lower Oesophageal Sphincter  
The LOS comprises both intrinsic and extrinsic components. The intrinsic 
sphincter is formed as a length of circular smooth muscle measuring 3-4 cm in 
length. It maintains a tone of 10-15mmHg above intra-gastric pressure to 
prevent reflux of intra-gastric contents9. The extrinsic sphincter is formed by the 
crural diaphragm which overlaps and reinforces the intrinsic component.  The 
relationship between the sphincter components is maintained by the integrity of 
the phreno-oesophageal ligament which is formed by the fused endothoracic and 
endoabdominal fascia of the diaphragm and inserts circumferentially into the 
oesophageal musculature close to the squamo-columnar junction.  
This overlapping arrangement of sphincter components provides additional 
protection against an array of pressure challenges for the GOJ. For example 
during inspiration when the gastro-oesophageal pressure gradient increases, the 
contraction of the crural diaphragm increases the pressure exerted by the 
extrinsic sphincter. There is also reflex contraction of the diaphragm with 
sudden increases in intra-abdominal pressure. 
1.2.2 The Intra-Abdominal Oesophagus. 
The normal location of the GOJ in the intra-abdominal compartment is a further 
protective mechanism against reflux. Increased intra-abdominal pressure can act 
to provoke reflux by increasing intragastric pressure and the gradient between 
stomach and oesophagus (gastro-oesophageal pressure gradient).  However a rise 
in intra-abdominal pressure and therefore intra-gastric pressure is offset by an 
equal rise in the pressure in the intra-abdominal oesophagus.  
1.2.3 The Gastro-oesophageal Flap Valve 
The gastro-oesophageal flap valve is a mucosal fold in the proximal stomach 
formed by gastric sling fibres. It is passively closed when intragastric pressure 
increases preventing retrograde acid flow. 
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1.2.4 The Location of the SCJ within the Lower Oesophageal Sphincter 
In healthy individuals the SCJ is distally located within the high pressure zone of 
the lower oesophageal sphincter with the peak sphincter pressure more 
proximally. The local pressure gradient therefore acts to promote flow towards 
stomach rather than oesophagus. 
1.2.5 Mechanisms to Limit Oesophageal Acid Exposure 
Following a reflux episode oesophageal acid clearance begins by empting the 
refluxed fluid by peristalsis. Residual acidic refluxate is neutralized by 
swallowed salivary bicarbonate.10  
1.3 Mechanisms of Reflux 
The anti-reflux barrier is structurally and functionally complex and therefore 
vulnerable to dysfunction. The three dominant mechanisms of reflux are: 
1. Transient lower oesophageal sphincter relaxations (TLOSRs) 
2. A hypotensive lower oesophageal sphincter 
3. Disruption of sphincter integrity most commonly associated with a hiatus 
hernia. 
The relative importance of each is debated but is likely that the dominant 
mechanism varies with disease severity11. In mild reflux disease, acid reflux 
during transient lower oesophageal sphincter relaxation predominates12. At the 
more severe end of the spectrum hiatus hernia and a hypotensive LOS become 
more important.12-14 
1.3.1 Transient Lower Oesophageal Sphincter Relaxations 
During a transient lower oesophageal sphincter relaxation there is complete 
vagally-mediated relaxation of both intrinsic and extrinsic sphincter 
components15. This differs from swallow induced relaxation of the lower 
oesophageal sphincter in duration (>10secs) and by the absence of oesophageal 
peristalsis or a preceding pharyngeal contraction16. Oesophageal shortening 
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occurs resulting in the formation of a temporary hiatus hernia and effacement of 
the gastro-oesophageal flap valve17. 
TLOSRs occur in both healthy individuals and those with reflux disease and are 
thought to allow venting of air by belching. It is therefore not the occurrence of 
TLOSRS per se that causes reflux disease but rather a dysregulation of this 
complex process with an increased proportion of TLOSRs associated with acid 
reflux in those with GORD18. The reason for this progression is incompletely 
understood although one hypothesis is an increased compliance of the gastro-
oesophageal junction associated with enlargement of the diaphragmatic hiatus 
in those with reflux disease. 19 The associated increase in the cross sectional 
area of the GOJ during opening may limit the ability of the system to protect 
against reflux and to discriminate between air and liquid refluxate. 
1.3.2 Hypotensive Lower Oesophageal Sphincter 
Only a minority of patients with gastro-oesophageal reflux disease have a grossly 
hypotensive lower oesophageal sphincter (<10mmHg) during fasting conditions. 
20. However many have periods of sphincter hypotension associated with factors 
that further reduce LOS tone such as gastric distension, certain foods, drugs or 
smoking. There are two main mechanism by which reflux can occur in 
association with a hypotensive sphincter.  
1. Strain induced reflux: the hypotensive sphincter is overcome by an 
increase in the gastro-oesophageal pressure gradient. Experimental data 
suggests a prerequisite basal LOS pressure of below 4mmHg.21 
2. Free reflux: reflux occurs without an increase in gastro-oesophageal 
pressure gradient in the context of significant sphincter hypotension 
(<4mmHg) 
1.3.3 Hiatus Hernia 
Hiatus hernia is characterised by the proximal displacement of the gastro-
oesophageal junction relative to the diaphragmatic hiatus. This is associated 
with mechanical disruption to the anti-reflux barrier and is a well-recognised 
risk factor for GORD. Almost all patients with severe GORD have an associated 
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hiatus hernia and hiatus hernia is seen in up to 77% of patients with Barrett’s 
oesophagus.22, 23 
Hiatus hernia causes gastro-oesophageal reflux by a number of different 
mechanisms 9 19, 24-27 
 Loss of the gastro-oesophageal flap valve 
 Reduced LOS pressure 
 Excess acid reflux during transient lower oesophageal sphincter 
relaxations 
 Increased diameter of the diaphragmatic hiatus promoting retrograde flow 
 Impaired oesophageal acid clearance.  
 Acid trapping within hiatal sac forming a reservoir for refluxate. 
 Re-reflux following a peristaltic wave.  
In combination these abnormalities render the lower oesophageal sphincter a 
less effective barrier to reflux of acid and gastric contents. 
A hiatus hernia has historically been considered an ‘all or none’ phenomenon but 
it is more likely that there is a spectrum of severity with progressive mechanical 
degradation of the GOJ. At one end of the continuum subtle functional 
alterations may dominate with increased GOJ compliance19, loss of LOS-CD 
synergy28 and weakening of the phreno-oesophageal ligament and at the other 
frank separation of the sphincter components as overt hiatus hernia. In keeping 
with this concept several investigators have now demonstrated the intermittent 
nature of small hiatus hernias in longitudinal and interventional studies.29, 30 
Developing this further Bredenoord et al demonstrated that the double peaked 
profile was associated with acidic and weakly acidic reflux suggesting that 
intermittent hiatus hernia may be an important mechanism of mild reflux30. 
1.4 Impaired Oesophageal Acid Clearance 
When the reflux barrier is breached, an important determinant of damage to 
squamous mucosa is the acid exposure time, defined as the length of time the 
oesophageal pH is below 4. Impaired oesophageal acid clearance occurs by two 
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broad mechanisms; Defective peristalsis, such as occurs with connective tissue 
disorders, oesophageal fibrosis or in association with a hiatus hernia and reduced 
salivation eg in cigarette smokers. The latter also helps to explain the damaging 
effect of nocturnal reflux since salivation is reduced during sleep and acid 
contact time in this situation is prolonged.  
1.5 Factors Predisposing to GORD 
Many factors have been described which promote or aggravate GORD acting 
through one or more of the mechanisms described above. Obesity for example is 
thought to contribute to GORD by progressive mechanical disruption leading to 
hiatus hernia. The rate of TLOSRs is also increased in obesity and an elevated 
gastro-oesophageal pressure gradient will exploit any impairment of barrier 
function. 
Another well recognised association is pregnancy which acts both via a 
hormonally mediated reduction in smooth muscle sphincter tone and an increase 
in mechanical stress on the sphincter. Further associations include increasing 
age, trauma, oesophageal dysmotility and cigarette smoking. The interplay of 
these factors is summarised in figure 2.  It is likely that Helicobacter Pylori 
confers a protective effect through impaired gastric acid production. 
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FIGURE 1.2: THE PATHOPHYSIOLOGY OF GASTRO-OESOPHAGEAL REFLUX 
1.6 Summary 
Gastro-oesophageal reflux disease is a common clinical problem, important both 
in terms of significant associated morbidity but also due to the devastating 
complication of oesophageal adenocarcinoma. The pathogenesis is complex and 
it is likely that the dominant mechanism varies with progressively more severe 
disease. At the mild end of the spectrum, reflux during transient lower 
oesophageal sphincter relaxations predominates.  With progressive failure of 
barrier function there is more significant reflux during TLOSRs and increasing 
non-TLOSR associated reflux. At the severe end of the spectrum lies the overt 
hiatus hernia with its myriad mechanical failings. 
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2 The Luminal Environment at the Gastro-
oesophageal Junction 
2.1 Background 
The gastro-oesophageal junction is disproportionately affected by pathology and 
whilst we have seen an increase in oesophageal adenocarcinoma we have seen a 
much greater increase in the incidence of junctional adenocarcinoma31-33. 
Adenocarcinoma is recognised to be a consequence of chronic acid damage and 
columnar metaplasia of distal squamous mucosa. Over time increasing genetic 
mutations predispose to neoplasia. However the association between gastro-
oesophageal reflux disease and junctional adenocarcinoma is weak. Only 28% 
have a history of frequent reflux symptoms34 and in one study Barrett’s 
oesophagus was found in only 12% at the time of cancer diagnosis.35 These 
observations suggest that mechanisms other than traditional reflux may be 
important. 
2.2 The Acid Pocket 
A paradox in the pathophysiology of reflux disease is the occurrence of reflux 
episodes predominantly after a meal when the buffering effect of a meal acts to 
reduce gastric acidity. This was resolved in 2001 by the description of the acid 
pocket. 36 Using the technique of gastric pull-though, withdrawing a pH catheter 
in small increments, Fletcher et al demonstrated a region of acidity persisting at 
the gastro-oesophageal junction after a meal with a pH of 1.6 compared with 
the intra-gastric pH of 4.7. Oesophageal refluxate after the meal was more 
acidic than the pH in the body of the stomach establishing this ‘acid pocket’ as a 
potential source of post-prandial acidic refluxate. Differences in regional acidity 
have since been confirmed by numerous investigators using a variety of 
techniques. 25, 27, 36-42. Figure 2.1 shows the changes in regional acidity after a 
meal measured using high resolution pHmetry. Immediately after the meal 
buffering of intragastric contents is demonstrated, depicted by a neutral pH.  
With increasing time from the meal a region of acidity emerges close to the 
squamocolumar junction.  
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FIGURE 2.1: COLOUR CONTOUR PLOTS DEPICTING THE OCCURRENCE OF THE ACID POCKET AFTER 
THE MEAL. (A) THE FASTING STATE WITH MARKED INTRAGASTRIC ACIDITY. (B) AT 3 MIN AFTER 
COMPLETION OF THE MEAL, INTRAGASTRIC BUFFERING BY THE INGESTED MEAL IS SEEN. (C) AT 17 
MIN AFTER THE MEAL THE EMERGENCE OF THE ACID POCKET AT THE GASTRO-OESOPHAGEAL 
JUNCTION IS SEEN. (D) AT 43.5 MIN AFTER THE MEAL THE ENLARGING ACID POCKET IS 
DEMONSTRATED. (E) AT 47.5 MIN AFTER THE MEAL AN ACIDIC REFLUX EPISODE (CIRCLED) FROM 
THE ACID POCKET IS SEEN WITH SIMULTANEOUS DISTAL INTRAGASTRIC BUFFERING. (F) AT 73.5 
MIN AFTER THE MEAL BOTH THE PROXIMAL ACID POCKET AND DISTAL ACIDITY ARE RECORDED 
SIMULTANEOUSLY. SCJ: SQUAMOCOLUMNAR JUNCTION. (REPRODUCED WITH PERMISSION, BMJ 
PUBLISHING GROUP, LICENSE NUMBER 3742681210338)  
Although this has advanced our current concept of reflux disease as Mitchell et 
al state in a recent review it is more likely a rediscovery of an old concept. 43 In 
a paper published in 1898, Cannon states:  “In the fundus food near the 
periphery was acid; food 2cm from the gastric wall showed the original 
alkalinity”. Another paper published in the UK by Hurst in 1911 observes “As no 
peristalsis and consequently no churning of the contents occurs high in the 
fundus, the outer layer of chyme remains constantly very acidic” 
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2.2.1 Acid as ‘Pocket’,’ Film’ or ‘Coat’ 
In the original description by Fletcher et al the concept was of a pocket or pool 
of acid in the proximal stomach with in vitro studies confirming the formation of 
a layer of acid atop gastric contents which will disperse by mixing. 36 In vivo the 
fundus of the stomach relaxes after a meal and there is relatively little motility 
and mixing allowing persistence of acid in this region. 44 Studies using MRI have 
shown the formation of a secretion layer accumulating after a meal at the meal-
air interface (Figure 2.2).41  
 
FIGURE 2.2: MRI SHOWING A SECRETION LAYER FORMING ATOP GASTRIC CONTENTS AFTER THE 
MEAL. THIS LAYER ENLARGES AND ULTIMATELY DISPERSES BY MIXING WITH GASTRIC CONTENTS 
FROM PROXIMAL TO DISTAL. (REPRODUCED WITH PERMISSION FROM JOHN WILEY AND SONS, 
LICENSE NUMBER: 374269138312) 
Studies using scintigraphy have also been able to locate a pocket of fluid 
persisting in the proximal stomach after the meal. By aspirating the fluid 
identified by scintigraphy the authors confirmed that the finding represented an 
actual volume of fluid with an acidic pH of 1.8. 25 
An alternative explanation for differences in regional acidity is the ‘acid coat’. 
Acid is secreted from the gastric wall in response to a meal. Post-prandially this 
region will be most acidic since the lumen is buffered by the presence of food. 
When the acid pocket was first described and investigated it was by stationary 
pH pull-through giving a one dimensional view of regional acidity. Interestingly 
as well as a proximal drop in pH, an acid environment has also been 
demonstrated in the distal stomach which likely corresponds to where the probe 
contacts the wall of the greater curvature (Figure 2.3). 37, 38 In this description 
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therefore the peripheries of the stomach including the cardia region remain 
acidic after a meal with a progressive increase in pH towards the middle due to 
mixing of gastric contents.  
 
FIGURE 2.3: DEPICTION OF THE ‘ACID COAT’, A PERIPHERAL ZONE OF ACIDITY SURROUNDING THE 
CENTRAL FOOD BOLUS AND RELATIVELY UNBUFFERED COMPARED WITH THE GASTRIC LUMEN. 
The final model of regional variation in acidity is the ‘acid film’. Pandolfino et al 
described proximal displacement of acid within a closed sphincter in patients 
with GORD after a meal40. The acid was seen to traverse the squamo-columnar 
junction. They argued that a volume of acid would not traverse a closed LOS but 
proposed that a ‘film’ of acid may be the explanation. 
Regardless of the terminology, differences in regional acidity after a meal have 
now been confirmed by numerous investigators and by various modalities. It is 
likely that these theories are not mutually exclusive but rather overlap with 
variability attributable to different predispositions to reflux in the populations 
studied. 
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2.2.2 Acid Pocket Length 
In healthy volunteers the length of the acid pocket has been measured as 
between 1cm and 3.3cm.25, 36, 40 The variability may stem from differences in the 
techniques employed or the populations studied. There is likely also some 
variation with time after the meal with Beaumont et al demonstrating a 
maximum length of 3.3 cm at sixty minutes after the meal with multiple 
measurements.25 
In patients with known gastro-oesophageal reflux disease the acid pocket is 
lengthened, ranging from 3.0 to 6.5cm in length.25, 27, 40 This lengthening 
represents proximal extension of acid toward or even across the squamo-columar 
junction. 
2.2.3 Acid Pocket and Association with Hiatus Hernia 
Hiatus hernia is a key mediator in the pathogenesis of gastroesophageal reflux 
through impaired function of the barrier mechanism of the gastro-oesophageal 
junction and delayed oesophageal acid clearance.  Studies suggest hiatus hernia 
may also contribute to reflux disease through effects on the size and position of 
the acid pocket. 
Two principal studies have described the characteristics of the acid pocket in 
association with hiatus hernia. Clarke et al demonstrated lengthening of the acid 
pocket in reflux patients compared with healthy volunteers attributable to the 
presence of a hiatus hernia27.  Beaumont et al studied the acid pocket in those 
with small and large hiatus hernias and controls25. Consistent with the 
observations of Clarke et al they demonstrated lengthening of the acid pocket in 
association with hiatus hernia but they argued it was the position of the acid 
pocket relative to the diaphragm that was the important determinant of reflux. 
In 40% of those with a large hiatus hernia, the acid pocket was consistently 
located above the diaphragm whereas in controls and those with a small hiatus 
hernia it was consistently below the diaphragm.  The location of the acid pocket 
above the diaphragm was a risk factor for acid reflux during transient lower 
oesophageal sphincter relaxations.  
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There are likely a number of mechanisms at play causing lengthening of the acid 
pocket in sliding hiatus hernia. The presence of a hernial sac above the 
diaphragm will act as a reservoir for acid secreted by the gastric mucosa within 
the sac. Thus contained, the acid may be protected from the buffering effect of 
intragastric food and from the dispersing and mixing effect of the proximal 
stomach. The intrinsic sphincter, deprived of reinforcement from the crural 
diaphragm, will be more easily breached allowing proximal extension of acid 
into the distal oesophagus 
2.3 Short Segment Reflux 
Reflux episodes are conventionally measured 5 cm above the lower oesophageal 
sphincter. Acid exposure adjacent to the SCJ is less likely than conventionally 
measured reflux to be symptomatic; 45-47 however, it is potentially of great 
pathophysiological significance. Recent interest has therefore focussed on acid 
exposure in this important region. 
Oesophageal acid exposure is significantly more frequent close to the squamo-
columnar junction. Fletcher et al. first described this concept of ‘short segment 
reflux’ noting that oesophageal acid exposure was significantly greater at 0.5cm 
above the squamo-columnar junction compared with 5.5cm (11.7 vs. 1.8%; 
P<0.001). 48 This difference was even more pronounced for the post-prandial 
period. In 2008 Merkapti et al extended this observation with a pH profile across 
the sphincter detailing increased acid exposure for sensors located 1.5 cm above 
the sphincter compared to 5cm above and progressively increasing acid exposure 
for sensors traversing the sphincter.49 This finding of distal oesophageal acid 
exposure or ‘short segment reflux’ has been widely replicated and also 
implicated in distal oesophageal pathology50-52. 
2.4 The Concept of Intrasphincteric Reflux 
Retrograde flow of acid into the oesophagus requires complete breach of the 
integrity of the protective gastro-oesophageal junction. However it is plausible 
that distal squamous mucosa be exposed to acid without complete failure of the 
lower oesophageal sphincter. 
38 
 
This mechanism was first proposed by and developed by Chandrasoma and 
deMeester based on post mortem studies53. Our own group in living human 
subjects has demonstrated shortening of the lower oesophageal sphincter after a 
meal due to loss of the distal component (Figure 2.4). 37, 54  
 
FIGURE 2.4: SIGNIFICANT SHORTENING OF THE HIGH PRESSURE ZONE AFTER THE MEAL DUE TO 
LOSS OF THE DISTAL COMPONENT OF THE LOWER OESOPHAGEAL SPHINCTER. THE POST-PRANDIAL 
ACID POCKET HAS MOVED PROXIMALLY TO OCCUPY THE FASTING LOCATION OF THE DISTAL HIGH 
PRESSURE ZONE THAT OPENED DURING THE MEAL. (REPRODUCED WITH PERMISSION, BMJ 
LICENSING GROUP, LICENSE: 3742701398297) 
This ‘distal opening’ was associated with acid ingress within the sphincter in the 
absence of detectable acid measured at the traditional site 5cm above the lower 
oesophageal sphincter. This mechanism is distinct from transsphincteric reflux in 
that the proximal sphincter remains closed and only the most distal squamous 
mucosa is exposed to acid. Acid exposure by the mechanism may be more 
prolonged in the absence of secondary protective mechanisms such as 
oesophageal clearance. 
2.5 Summary 
There is a rising incidence of adenocarcinoma at the gastro-oesophageal 
junction. The relationship with reflux disease is weak suggesting mechanisms 
other than traditional reflux may be important. After a meal a region of acidity 
termed the ‘acid pocket’ persists at the cardia escaping the buffering effect of 
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food. There is also loss of the distal component of the lower oesophageal 
sphincter allowing acid ingress within the sphincter, ‘intrasphincteric acid’.  
This distal acid exposure may explain how metaplasia of the distal oesophagus is 
most prevalent at, and immediately proximal to, the SCJ and can occur in 
subjects without conventional evidence of reflux disease.  
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3 The Histology of the Gastro-oesophageal 
Junction 
3.1 Epithelial Types in the Oesophagus and Proximal Stomach 
There are five epithelial subtypes found to varying degrees at the gastro-
oesophageal junction (Table 3.1) 
TABLE 3.1: EPITHILIAL TYPES THAT OCCUR IN THE OESOPHAGUS AND PROXIMAL STOMACH 
Epithelial Type Location Description 
Squamous Only oesophagus Stratified squamous 
epithelium 
Oxyntic Only stomach Columnar epithelium glands 
composed only of parietal 
and chief cells 
Cardiac Oesophagus and within 3cm 
distal to the endoscopically 
defined gastro-oesophageal 
junction 
Columnar epithelium 
composed only of mucous 
cells 
Oxyntocardiac  Oesophagus and within 3cm 
distal to the endoscopically 
defined gastro-oesophageal 
junction 
Columnar epithelium with 
glands composed of a 
mixture of mucous and 
parietal cells 
Intestinal 
Metaplasia 
  
Oesophageal 
Type 
Oesophagus and within 3cm 
distal to the endoscopically 
defined gastro-oesophageal 
junction 
Goblet cells in cardiac 
mucosa 
Gastric Type Only stomach Goblet cells in oxyntic 
(usually atrophic) mucosa 
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3.1.1 Squamous Mucosa 
The tubular oesophagus is lined by stratified squamous non-keratinised 
epithelium. (Figure 3.1) Since the principal function of the oesophagus is as a 
conduit for foodstuff the epithelium is highly adapted, with a capacity to resist 
shear stress. The multi-layered epithelium gradually changes from the basal 
cuboidal cells that divide and replenish superficial layers to the flattened 
surface layers that eventually slough off. 
Beneath the epithelium there is a thin layer of connective tissue, the lamina 
propria containing small lymphatics and blood vessels and scattered mucous 
glands, and a smooth muscle layer, the muscularis mucosae, a thin layer of 
longitudinal irregularly arranged muscle fibres. 
 
FIGURE 3.1: STRATIFIED SQUAMOUS EPITHELIUM OF THE OESOPHAGUS (REPRODUCED WITH 
PERMISSION LICENSE NUMBER 3767650624116)8 
3.1.2 Gastric Oxyntic Mucosa 
This is the normal lining of the body and fundus of the stomach (Figure 3.2). 
Oxyntic gastric mucosa is characterised by:  
 A surface layer of mucous cells with small basally located nuclei and 
uniform apical cytoplasm producing a thick protective coating of mucous 
 A foveolar region that extends vertically down from the surface as a pit 
which is usually very short and lined with mucous cells 
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 A straight tubular gland that is lined by parietal and chief cells and 
scattered neuroendocrine cells. There are a few mucous cells in the neck 
region of the gland but the deeper part is normally devoid of mucous 
cells. 
 
FIGURE 3.2: NORMAL GASTRIC OXYNTIC MUCOSA SHOWING A SHORT FOVEOLAR PIT FROM WHICH 
ARISES A STRAIGHT TUBULAR GLAND CONTAINING PARIETAL AND CHIEF CELLS WITHOUT MUCOUS 
CELLS (REPRODUCED WITH PERMISSION. LICENSE NUMBER 3767651282535) 
The parietal cell or oxyntic cell is responsible for acid production whilst the 
chief cells secrete pepsinogen. The glands are tightly packed so there is minimal 
lamina propria. Normal gastric mucosa is a dynamic epithelium continually 
renewing from progenitor cells in the deep region of the foveolar pit and isthmus 
of the gastric gland. 
3.1.3 Cardiac Mucosa 
Cardiac mucosa is defined as a mucosa composed entirely of mucous cells and 
devoid of parietal or goblet cells. (Figure 3.3) Cardiac mucosa can have Paneth 
cells, pancreatic cells and neuroendocrine cells but never parietal or goblet 
cells. 
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FIGURE 3.3: CARDIAC MUCOSA AT THE SQUAMO‐COLUMNAR JUNCTION (LICENSE 3767641501944)8 
3.1.4 Oxynto-cardiac Mucosa 
Oxynto-cardiac mucosa is defined by the presence of glands that are composed 
of a mixture of mucous cells and parietal cells. The presence of even a single 
parietal cell in a single glandular unit excludes cardiac mucosa. Paneth cells, 
pancreatic cells and neuroendocrine cells may be present in oxynto-cardiac 
mucosa. 
 
FIGURE 3.4: OXYNTO‐CARDIAC MUCOSA SHOWING MILD CHRONIC INFLAMMATION AND SHORT, 
SLIGHTLY DISTORTED GLANDS CONTAINING A MIXTURE OF MUCOUS AND PARIETAL CELLS 
(REPRODUCED WITH PERMISSION: 3767670067402) 
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3.1.5 Intestinal Metaplastic Epithelium 
The hallmark of intestinal metaplasia is the presence of well-formed goblet 
cells, which may be present in the surface epithelium or the foveolar region.  
 
FIGURE 3.5: INTESTINAL METAPLASIA SHOWING TYPICAL GOBLET CELLS. (REPRODUCED WITH 
PERMISSION 3767670410775) 
Intestinal metaplasia may occur in the oesophagus or the stomach. Histologically 
intestinal metaplasia of the oesophagus is defined by the presence of goblet 
cells in cardiac type mucosa and is the result of the effect of gastro-oesophageal 
reflux on the mucosa. Gastric intestinal metaplasia occurs on a background of 
gastric oxyntic mucosa and is mainly seen with atrophic gastritis due to 
Helicobacter pylori, autoimmune gastritis and in the healing phase of erosive 
lesions. 
3.2 Defining the Cardia 
Whilst the histological description of epithelial subtypes is clear what constitutes 
a normal gastro-oesophageal junction is controversial even amongst experienced 
pathologists. Until recently it was commonly believed that the distal 1-2 cm of 
the oesophagus was lined with a transitional zone of columnar epithelium 
extending for a variable extent into the stomach as the gastric cardia55. This 
concept persisted until 1994 when Spechler et al demonstrated the presence of 
intestinal metaplasia in the distal 2cm of columnar lined oesophagus redefining 
this mucosa as short segment Barrett’s oesophagus.56  
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The accepted endoscopic criterion for the transition from oesophagus to 
stomach is the proximal limit of the gastric folds.57-59 In normal individuals this 
coincides with the squamo-columnar junction, ‘Z line’, and histological 
transition from squamous to columnar type mucosa. Many investigators therefore 
define the cardia as the most proximal region of the stomach. Thus any biopsy 
from this region would be ‘cardiac mucosa’ and accordingly a mix of phenotypes 
and characteristics have been reported.60, 61 
Chandrasoma proposed stricter definitions based purely on the histological 
classification as outlined above and therefore easily reproducible.8, 53 Defined in 
this way cardiac mucosa is simply columnar mucosa devoid of parietal cells. 
3.2.1 Is Cardiac Mucosa Universally Present? 
As the definition of the cardia has evolved so too has a debate over its origins. 
The original description of ‘normal’ columnar epithelium in the distal 
oesophagus, although now disproven, introduced the concept of a transitional 
zone of columnar tissue devoid of acid producing cells. Such a zone would have a 
protective function separating vulnerable squamous mucosa from the gastric 
body mucosa densely packed with parietal cells. This idea of an innate 
transitional zone measuring 2-3cm has been perpetuated in medical teaching.  
In an autopsy study published in 2000, Chandrasoma examined the entire 
circumference of the gastro-oesophageal junction including the vertical extent 
of the various epithelial types.62 The cardiac mucosa was completely absent in 
10 of 18 subjects with direct transition from squamous to parietal cell-containing 
mucosa, either oxyntic or oxynto-cardiac. The maximum cardiac mucosal length 
ranged between 0 and 2.75mm.  
Studies in children and adults are now numerous61, 63-67 and yet disagreement 
persists over whether the cardia is an innate or abnormal epithelium. In a study 
of a paediatric population, Glickman et al reported the presence of cardiac 
mucosa in 81% of 74 patients and oxynto-cardiac in the remainder with no 
patients in this study group transitioning directly from squamous to oxyntic 
mucosa64. The authors concluded that their findings supported a congenital 
origin for the cardia. Similarly Zhou and colleagues and Kilgore and colleagues 
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support the concept of the gastric cardia as an innate structure describing its 
universal presence in paediatric populations.67, 68 These studies have been 
criticized for imprecise definitions and in fact when the strict definition of 
cardiac mucosa is applied to the former study by Zhou et al its presence was 
demonstrated in only 22 of the 45 post-natal patients.  
In endoscopy samples in adult populations the cardiac mucosa has been deemed 
to be absent in 26 to 39% with direct transition from squamous to oxynto-cardiac 
or pure oxyntic mucosa. 63, 65, 66. Autopsy studies allow for more detailed 
mapping and in one study of 36 patients, cardiac mucosa was present in the 
entire circumference of the squamo-columnar junction in 20, in part of the 
circumference in 15 and entirely absent in one case.69 
Variations in estimates may arise through populations studied, methodology and 
definitions. However when these studies are taken together it is reasonable to 
conclude that cardiac mucosa is not universally present. 
3.2.2 What is the Significance of Cardiac Mucosa? 
Cardiac mucosa where present is minimal in paediatric populations and increases 
in length with age62. Characteristics of the cardia are also influenced by 
measures of gastro-oesophageal reflux disease. Oberg et al associated the 
presence of cardiac mucosa and carditis with several indicators of reflux disease 
including an abnormal 24 hour pH score and the presence of hiatal hernia or 
erosive oesophagitis.66. Glickman and colleagues described lengthening of the 
cardiac mucosa in association with active oesophagitis. 64 
In a study of the characteristics of the cardia in 141 patients, Der and colleagues 
demonstrated that the cardia was universally chronically inflamed whilst most 
patients had no inflammation in body or antral biopsies70. Furthermore the 
extent of inflammation was correlated with higher acid exposure by 24 hour pH 
monitoring. 
In contrast studies on subjects with a lower propensity towards reflux for 
example normal autopsy populations62 and biopsies obtained from patients more 
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likely to have a normal gastro-oesophageal junction at endoscopy (REF Jain) 
demonstrate a lower prevalence of cardiac mucosa. 
Thus where present the characteristics of the cardia are influenced by the 
clinical characteristics of the subjects studied. 
3.2.3 What is the Significance of Cardiac Mucosal length? 
There is a relationship between cardiac mucosa length and measures of reflux in 
those without endoscopic evidence of columnar lined oesophagus. In the study 
by Glickman et al the presence of more than 1mm of cardiac mucosa had a 
significantly greater association with reflux than those with less than 1mm of 
cardiac mucosa.64 Oberg and colleagues, as well as demonstrating inflammation 
in the cardiac mucosa demonstrated a progressive increase in acid exposure as 
the length of cardiac plus oxyntocardiac mucosa increased.66 In a more recent 
study in an Eastern population the presence of cardiac mucosa at the gastro-
oesophageal junction was associated with endoscopically apparent oesophagitis. 
71 
Barret’s oesophagus arises from columnar metaplasia of oesophageal squamous 
mucosa. Histologically there are three main epithelial components; cardiac 
mucosa, oxyntocardiac mucosa, and intestinal metaplasia (cardiac mucosa with 
goblet cells). There is a well described relationship between the length of 
Barrett’s oesophagus and severity of reflux 72 which continues as the length of 
columnar lined oesophagus increases.73  
These parallel observations have led some to propose that cardiac mucosa is an 
abnormal epithelium arising from squamous to columnar metaplasia in the same 
way as Barrett’s oesophagus.74 
3.3 Summary: The Acquired Cardia Hypothesis 
Cardiac mucosa, defined as columnar epithelium devoid of parietal cells is not 
universally present. Where present it increases in length with age and with 
markers of gastro-oesophageal reflux disease. Histologically it is 
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indistinguishable from endoscopically apparent columnar lined oesophagus and 
may represent an early stage of squamous to columnar metaplasia. 
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4 Obesity and Adenocarcinoma of the Cardia 
4.1 Epidemiology 
Whilst the incidence of many solid tumours has been in decline over the past 
thirty years, there has been a dramatic and continued rise in the incidence of 
oesophageal adenocarcinoma and adenocarcinoma of the gastro-oesophageal 
junction75. Data from the USA has shown that the overall incidence of 
adenocarcinoma of the oesophagus and gastric cardia increased from 13.4 per 
million in 1973 to 51.4 per million in 2009 and continues to rise76. For gastric 
cardia adenocarcinoma incidence has risen from ten cases per million population 
in 1973 to over 20 cases per million population in 2010. Data from other Western 
countries has shown similar trends. 
The rise in oesophageal adenocarcinoma and adenocarcinoma of the gastric 
cardia has been paralleled by a worldwide obesity epidemic leading to 
speculation of a causative relationship. Recent data from the USA show that 68% 
of the population over twenty years old are defined as overweight and 32% as 
obese77. In Scotland in 2014 figures were remarkably similar with 65% of adults 
aged 16 and over defined as overweight, including 28% who were obese.78 These 
trends are echoed throughout the Western world.79 
4.2 Obesity and Gastric Cardia Adenocarcinoma: Is there a link? 
Obesity comes with a myriad of health consequences including an association 
with cancers of the colon and rectum, renal cell carcinoma, malignant 
melanoma and liver cancer80. One of the most strongly associated cancers is 
oesophageal adenocarcinoma with a recent meta-analysis giving an odds ratio of 
2.73 for a BMI of 30kg/m2 or more81.  
There is also an accumulating literature on the relationship between obesity and 
adenocarcinoma of the gastric cardia with most studies demonstrating a positive 
association between increasing BMI and cancer risk and many showing evidence 
of a dose response relationship.75  The earliest report of a positive relationship 
was a case control study in a Chinese population by Ji et al in 1997 where men in 
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the fourth quartile (highest) BMI group were found to have an odds ratio of 3.0 
for gastric cardia cancer compared with those in the first quartile.82 Similarly 
Chow et al the following year, this time in a Western population demonstrated 
an increasing risk of gastric cardia cancer with increasing body mass index.83 
Several studies have since confirmed this trend in populations from the USA and 
Europe with odds ratios ranging from 1.46 to 4.3 84-90  
There have been two negative studies published. The first by Tran and 
colleagues in a Chinese population was a large prospective cohort study of 1089 
cases.91 The study was in a population at generally lower risk of oesophageal and 
gastric adenocarcinoma but has also been criticised for a complex design 
including dietary intervention.75 In another large study examining the influence 
of obesity on multiple cancer types Semanic and colleagues found an elevated 
risk for oesophageal adenocarcinoma but did not demonstrate a relationship for 
the 229 cases of cardia cancer80. 
Studies are heterogeneous in design and plagued by inconsistencies in definitions 
but nonetheless 9 of 11 studies summarised in a recent review demonstrated a 
positive association between obesity and gastric cardia adenocarcinoma.75 This 
was confirmed in a meta-analysis where obesity was associated with gastric 
cardia adenocarcinoma with a relative risk of 1.93 (95 % CI 1.52–2.45).81 
4.3 Is All Fat Equal? 
There is increasing recognition of the importance of body fat distribution in 
cancer risk and central or visceral obesity has attracted particular interest. 
Rates of obesity have been rising in men and women and across ethnic groups. 
However the incidence of oesophageal adenocarcinoma and gastric cardia 
adenocarcinoma varies by race and gender.92, 93 
This apparent discord may be explained by variations in the distribution of body 
fat by race and gender. For example body fat is characteristically more visceral 
than truncal in men and Caucasians, two groups at higher risk of adenocarcinoma 
of the oesophagus. Several studies have now documented an excess risk of 
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oesophageal adenocarcinoma in association with measures of central obesity.85, 
94, 95 
For adenocarcinoma of the gastric cardia three recent studies have examined 
the risk associated with the central pattern of fat distribution.85, 94, 95 O’Doherty 
and colleagues found an association for both waist circumference and BMI with 
gastric cardia adenocarcinoma 95 whilst Corley et al failed to demonstrate an 
association using abdominal diameter as an index of central obesity. 85 Most 
recently, using data from almost 400,000 individuals from the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study, investigators 
demonstrated an association between gastric cardia adenocarcinoma and waist 
circumference only after adjustment for BMI.94 
4.4 Obesity and Gastric Cardia Adenocarcinoma: What is the link? 
4.4.1 Gastro-oesophageal reflux disease 
Obesity is a recognised risk factor for gastro-oesophageal reflux disease and 
there is, in turn, a well-documented relationship between gastro-oesophageal 
reflux disease and oesophageal adenocarcinoma. 60, 96 However the data linking 
reflux symptoms with adenocarcinoma at the cardia are either more modest or 
conflicting. Derakhshan and colleagues reported on 53 cases of adenocarcinoma 
of the gastric cardia finding an odds ratio of 10.0 (95% CI 2.29-44.36) for 
frequent symptoms of gastro-oesophageal reflux disease compared with age 
matched controls.97 However a larger case-control study including 261 cases of 
adenocarcinoma of the cardia failed to find a link with symptoms of gastro-
oesophageal reflux. 98 Lagergren and colleagues in 1999 reported a relatively 
weak association between symptoms of reflux and cardia cancer with an odds 
ratio of 2.0 (95% CI 1.4-2.9) but a much higher odds ratio of 7.7 (95% CI 5.3-11.4) 
for oesophageal adenocarcinoma and in 2003 Wu et al reported similar 
findings.96 
Therefore despite the epidemiological evidence indicating that adenocarcinoma 
of the gastro-oesophageal junction in the Western world is the result of acid 
reflux, there is only a weak association between these cancers and reflux 
symptoms. This raises the question as to whether the most distal oesophagus 
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may be subject to damage by gastric acid in the absence of reflux symptoms or 
traditional reflux disease. 
4.4.2 The Use of Acid Suppressing Medications 
There is a theory linking the use of acid suppressing medications to the rising 
incidence of oesophageal cancer and therefore also potentially to gastric cardia 
adenocarcinoma. The use of these medications became widespread in the 1970s 
coincident with the start of the rise of oesophageal and gastric cardia 
adenocarcinoma. Although there are some supportive data 99, 100 and a plausible 
mechanism in elevated gastrin levels, this theory has not gained general support. 
4.4.3 Diabetes mellitus 
There is a slight excess risk of gastric cancer associated with a diagnosis of 
diabetes mellitus with an odds ratio of the order of 1.1 to 1.2. 101 Whether this 
extends to adenocarcinoma of the gastric cardia is less clear. This has been 
specifically examined in three studies, two of which failed to demonstrate an 
independent relationship between diabetes mellitus and gastric cardia 
adenocarcinoma.102, 103 In the third an association was seen between obesity and 
gastric cardia adenocarcinoma but not with oesophageal adenocarcinoma, 
directly contradicting the findings of the other studies.104 This suggests that the 
observed relationship between gastric cardia adenocarcinoma and obesity is 
unlikely to operate entirely through a comorbid diagnosis of diabetes mellitus. 
4.4.4 Diet 
Diet is an important potential confounder in a relationship between obesity and 
gastric cardia adenocarcinoma. Although there are some conflicting studies the 
literature is generally supportive of a beneficial effect of fruit and vegetable 
intake and a deleterious effect of starchy foods, meat and fats.105 Studies of diet 
are difficult to interpret due to recall and reporting bias. 
4.4.5 Helicobacter Pylori 
There is a well-established positive association between distal gastric cancer and 
infection with Helicobacter pylori. On the other hand gastric cardia 
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adenocarcinoma, like oesophageal adenocarcinoma has been negatively 
associated with H. Pylori with an odds ratio of 0.5-1.0, thought due to increased 
acid production by a healthy (non-atrophic) stomach.97, 106, 107 Is it possible that 
the association between obesity and gastric cardia adenocarcinoma is operating 
through the influence of H. pylori on both variables? 
There are some data suggesting that H. pylori infection impacts on appetite 
through effects on gastric atrophy and grehlin production, a hormone involved in 
appetite stimulation.108 In support of this, one study showed significant weight 
gain after successful eradication of H. pylori in dyspeptic patients.109 The 
authors attributed this finding to the improvement in dyspeptic symptoms but 
others have speculated that eradicating H. pylori may impact appetite 
regulation.75 Other studies have failed to show an association between BMI and 
H. Pylori status.110 There is therefore weak but inconclusive evidence that 
eradicating H. pylori may promote obesity and this area requires further study. 
4.5 Potential Mechanisms 
For oesophageal adenocarcinoma there are two competing models of 
carcinogenesis associated with obesity; the humoral model and the mechanistic 
model and it is likely that the same principles apply to gastric cardia 
adenocarcinoma. 
4.5.1 Metabolic Model 
Adipose tissue is metabolically active secreting various biologically active 
products that promote inflammation and insulin resistance. The proposed 
mechanisms linking obesity to cancer include hyperinsulinaemia and altered 
insulin growth factor 1 (IGF 1) signalling, growth factors produced by adipocytes 
(adipokines) and the pro-inflammatory effects of obesity.111 
Insulin and IGF-1 Signalling 
Obesity is associated with insulin resistance and increased circulating levels of 
insulin and IGF 1.112 This is at least partly driven by secretions from 
metabolically active visceral fat. Both insulin and IGF-1 can bind to the IGF 
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receptor complex, stimulating pathways that promote cellular proliferation.112 
Insulin resistance has been associated with an increased risk of progression to 
adenocarcinoma in patients with Barrett’s oesophagus.113 In resection specimens 
from patients with oesophageal adenocarcinoma IGF-1 receptor expression was 
increased in viscerally obese patients and associated with higher circulating 
levels IGF-1.114 However in a longitudinal study of patients with Barrett’s 
oesophagus no association was seen between levels of IGF-1 or of the principal 
binding protein (IGFBP3) and risk of oesophageal adenocarcinoma.115   
Adipokines 
Adipose tissues synthesise and secrete polypeptide growth factors and cytokines 
known as adipokines. Of these, adiponectin and leptin are the best studied in 
relation to carcinogenesis in the GI tract. Adiponectin normally opposes 
proliferation and angiogenesis and has anti-inflammatory properties. Its level is 
reduced in association with obesity and also with oesophageal adenocarcinoma 
and gastric cardia adenocarcinoma.111, 116 Leptin on the other hand, which 
stimulates cell growth and proliferation and angiogenesis, has been associated 
with the risk of progression from Barrett’s oesophagus to oesophageal 
adenocarcinoma.113 Its level is elevated in gastric cardia adenocarcinoma and 
levels have been shown to correlate with histological stage and outcome111. 
Meta-inflammation  
Obesity is associated with chronic low grade inflammation, also called meta-
inflammation.111 This is related to the secretion of a variety of pro-inflammatory 
mediators by the adipose tissue including tumour necrosis factor-α (TNF-α), IL-1, 
IL-6, IL-8, interferon-β and monocyte chemoattractant protein 1 (MCP-1). It is 
not completely understood how the associated systemic inflammatory response 
promotes cancer but simplistically many of these mediators promote cell 
proliferation, inhibit apoptosis and stimulate angiogenesis 112. How this systemic 
inflammatory process might translate into an increased risk of cancer in the 
oesophagus or gastric cardia is not clear but faecal calprotectin is also elevated 
in association with obesity indicating chronic low grade inflammation in the 
gastrointestinal tract.117 
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4.5.2 Mechanistic Model 
Although the humoral model is attractive is does not explain why the effects of 
obesity should be so marked in the distal oesophagus and gastro-oesophageal 
junction. Obesity is associated with an array of assaults on the gastro-
oesophageal junction and consequent mechanical stress. 
Obesity, particularly visceral obesity has been associated with increased intra-
gastric pressure.118-120 Although there is a concomitant rise in intra-oesophageal 
pressure this does not offset the rise in intra-gastric pressure and there is an 
overall increase in the gastro-oesophageal pressure gradient. This enhances the 
likelihood of reflux of gastric contents in the setting where the barrier function 
of the lower oesophageal sphincter is compromised.  
Obesity simultaneously impacts on gastro-oesophageal junction integrity in a 
more complex manner than simple pressure changes121. Where the intra-
abdominal pressure is artificially elevated for example by extrinsic compression 
or straight leg raising the pressure of the intrinsic lower oesophageal sphincter is 
either preserved or increased.122, 123 This is thought due either to reflex crural 
contraction and reinforcement123 or passive external compression of the intra-
abdominal segment of the distal oesophagus122. In the setting of chronic obesity 
however the pressure of the intrinsic lower oesophageal sphincter is reduced.119, 
120 What is the explanation for this discrepancy? This may represent a process of 
adaptation to chronically elevated intra-abdominal pressure associated with 
obesity as distinct from an acute pressure challenge. Alternatively it could be an 
early manifestation of a hiatus hernia121. 
 Obesity is associated with the presence of hiatus hernia which in turn is a well-
recognised determinant of reflux disease. In a recent meta-analysis involving 
3597 patients increased BMI was associated with a hiatus hernia with a pooled 
odds ratio of 1.93.124 Smaller hiatus hernias are likely to be more common but 
less readily detected. Pandolfino and colleagues have demonstrated an 
increased likelihood of separation of intrinsic and extrinsic components of the 
lower oesophageal sphincter in association with obesity.119 Integrating these 
observations De Vries et al suggested that elevated intra-abdominal pressure 
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acting through chronic stress on the gastro-oesophageal junction predisposes to 
hiatus hernia formation, a well-documented determinant of reflux118.  
Furthering this observation work from Lee and colleagues has shown a proximally 
positioned squamo-columnar junction within the diaphragmatic hiatus in obese 
versus non-obese asymptomatic subjects.125 In obese subjects the squamo-
columnar junction was consistently 2–3 cm above the crural diaphragm but not 
beyond the upper border of the GOJ. This was observed without obvious 
evidence of separation of gastro-oesophageal junction pressure components 
manometrically, considered the hallmark of overt hiatus hernia. The authors 
interpreted these findings as the presence of ‘partial hiatus hernia’, an early, 
minimal but discernible hiatus herniation that occurs in asymptomatic subjects 
with obesity.125 
Another potential mechanism by which obesity could predispose to gastro-
oesophageal reflux is through transient lower oesophageal sphincter relaxations. 
In one study, obese subjects had increased frequency of transient lower 
oesophageal sphincter relaxations and an increased proportion associated with 
acid reflux126.  Although further studies have failed to confirm the former 
observation there is more consistent evidence of the latter.121, 125 This may 
relate to the presence of an elevated gastro-oesophageal pressure gradient in 
the obese exploiting deficiencies of the anti-reflux barrier or indeed the 
presence of a partial hiatus hernia with earlier opening of the lower oesophageal 
sphincter.121 
The effects of obesity on the acid pocket are unknown. However obesity is 
associated with hiatus hernia which in turn is associated with lengthening of the 
acid pocket.27 It is likely that this will also hold true for obesity. 
These mechanistic analyses assume that the lower oesophageal sphincter has to 
fail completely for acid reflux and damage to occur. However as discussed in 
Chapter 2 there is accumulating evidence that distal squamous mucosa can be 
exposed to acid in the absence of complete breach of the lower oesophageal 
sphincter termed ‘intrasphincteric reflux’.  This mechanism may help reconcile 
the poor correlation between symptoms of reflux and gastric cardia 
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adenocarcinoma. How obesity may contribute to this process has not been well 
studied. Conceivably obesity, through increasing the intra-gastric pressure could 
contribute to opening of the distal sphincter promoting acid influx.  
4.6 An integrated model of carcinogenesis of the gastro-oesophageal 
junction 
Given the wealth of accumulating literature and associated controversies how 
can we integrate these observations into a model of obesity related 
carcinogenesis at the gastro-oesophageal junction? Central to the pathway is the 
progression from normal squamous mucosa to columnar metaplasia and 
eventually adenocarcinoma. It is likely that the mechanism of acid exposure 
varies. At one end of the spectrum lies the mechanically dysfunctional gastro-
oesophageal junction with a myriad of impairments the result of chronic stress 
caused and perpetuated by obesity. At the other end more subtle and 
presumably more common abnormalities allowing distal acid damage through 
distal opening of the sphincter and intrasphincteric reflux, likely with a 
contribution from a partial hiatus hernia.  
By either pathway damage to squamous mucosa could over time cause 
progression to columnar metaplasia with the attendant risk of adenocarcinoma 
promoted perhaps by the metabolic disturbances associated with obesity. 
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5 Aims and Methods 
5.1 Aims 
The aim of these studies was to investigate the anatomy, physiology and 
histology of the gastro-oesophageal junction in healthy volunteers without 
known gastro-oesophageal reflux disease. In particular: 
1. To determine the influence of obesity on the cardiac mucosal length 
2. To examine acid exposure at the gastro-oesophageal junction in relation 
to measures of obesity 
3. To investigate the barrier function of the gastro-oesophageal junction in 
obese and non-obese volunteers 
4. To study the pathophysiology of acid reflux in those healthy volunteers 
found incidentally to have a hiatus hernia but without known reflux 
disease. 
In the course of the study it was observed that there was a progressive alteration 
in the pressure recordings taken using the high resolution manometry system. 
Thus a secondary aim was to investigate and document this potential error and 
to develop and assess a correction method. 
5.2 Methods 
5.2.1 Recruitment 
Volunteers were recruited by word of mouth and by advertisement in the local 
newspaper. Potential volunteers were invited to attend for a urea breath test 
for Helicobacter pylori and were screened for eligibility. Those found positive 
for H. Pylori were excluded from participation in the study. Others were asked 
to complete a brief questionnaire to determine any history of reflux symptoms 
and current or past use of acid suppressing medications. Past medical history 
and drug history was documented as was history of smoking and alcohol use and 
past history of obesity. The symptom assessment was adapted from the Leeds 
dyspepsia questionnaire. 127, 128 A sample questionnaire is shown in appendix 2.  
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Those found to have a hiatus hernia during the study protocol were analysed 
separately 
5.2.2 Upper GI Endoscopy 
Subjects attended after an overnight fast. The procedure was undertaken with 
local anaesthetic throat spray (xylocaine 1%) or conscious sedation (intravenous 
midazolam 1-4mg) according to volunteer preference. The anatomy of the upper 
GI tract was examined and any abnormalities documented.  
 Hiatus hernia was defined as present where the indentation made by the 
crural diaphragm was separated by 2cm or more from the top of the 
gastric folds, recognised as the endoscopic landmark of the gastro-
oesophageal junction. 
 Barrett’s oesophagus was diagnosed where columnar mucosa was seen 
endoscopically proximal to the top of the gastric folds. 
Biopsies were taken across the squamo-columnar junction using large capacity 
radial jaw forceps 4 (Boston Scientific, Hemel Hempstead, Herts, UK). Biopsies 
were taken perpendicular to the Z line and targeted to include just enough 
squamous mucosa to confirm positioning with an emphasis on capturing a full 
span of cardiac mucosa (Figure 5.1).  
 
FIGURE 5.1: ENDOSCOPIC TARGETTING OF BIOPSIES ACROSS THE SQUAMOCOLUMNAR JUNCTION 
INDICATING OPTIMAL POSITIONING  
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To maximise the chances of successfully capturing the cardia intra-procedure 
pathological feedback was available. Biopsies obtained were immediately 
examined by simple light microscopy to determine that squamous mucosa and 
glandular mucosa were present within the same biopsy and in continuity. Up to 
three biopsies were taken to maximise the chances of obtaining a full span of 
cardiac mucosa within at least one biopsy allowing accurate length 
measurement. 
Further biopsies were taken from the antrum and body of the stomach for 
comparison. Finally two endoclips were applied to the squamo-columnar 
junction as markers for subsequent fluoroscopic visualisation ((HX-610-135; 
Olympus, Southend-on-Sea, UK). See also appendix 1. 
5.2.3 Biopsy Orientation and Processing 
Biopsy specimens were placed immediately on dental wax, which has a non-
adherent surface, and oriented flat. An isotonic solution of Hyoscine N butyl 
bromide (1 mg/mL) was applied to minimize sample contraction and preserve 
the length. Biopsy specimens were transferred to filter paper using a non-touch 
technique and re-oriented where necessary (Figure 5.2). Samples were 
transported in formalin and embedded in agar on the filter paper without 
further manipulation.  
 
FIGURE 5.2: SAMPLE BIOPSY OBTAINED FROM SQUAMOCOLUMNAR JUNCTION AND CAREFULLY 
ORIENTATED ON FILTER PAPER. 
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5.2.4 Staining and Immunophenotyping of Biopsies 
All biopsies were stained with H&E for initial assessment. Further staining was 
carried out using a panel of antibodies selected to evaluate the immune-
histochemical staining pattern of the gastro-oesophageal junction: 
 CDX-2 (caudal type homeobox 2) —a marker of epithelial intestinal 
differentiation; 129 
 Villin—essential for brush border formation in normal intestinal epithelial 
cells130 and with differential expression in cardiac type mucosa versus 
Barrett's mucosa with intestinal metaplasia;131  
 Liver–intestine (LI)-cadherin—a sensitive marker of intestinal metaplasia 
in the upper GI tract;132  
 Trefoil factor family 3 (TFF-3)—a marker of intestinal differentiation, 
strongly expressed in Barrett's mucosa  with intestinal metaplasia 133  
 MUC1, a membrane—associated mucin apoprotein 
 MUC2; a marker of mucin cell differentiation associated with intestinal 
type mucosa 
 MUC5AC—a marker of mucin cell differentiation associated with normal 
gastric mucosa   
To assess the extent of cell replication, we used MIB-1 antibodies against Ki-67 
antigens.134 97 
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TABLE 5.1: ANTIBODIES USED FOR IMMUNOHISTOCHEMISTRY 
Antibody Manufacturer Product Type Specificity Dilution 
CDX-2 Leica 
Biosystems 
NCL-CDX2 Mouse 
monoclonal 
Human 1:100 
Villin Abcam ab133510 Rabbit 
Monoclonal 
Human 1:1000 
TFF-3 Abcam ab109104 Rabbit 
monoclonal 
Human 1:1000 
LI-cadherin Abcam ab109220 Rabbit 
monoclonal 
Human 1:1000 
Ki-67  
(MIB-1) 
DAKO IR62661 Mouse 
monoclonal 
Human 1:500 
MUC-1 Leica 
Biosystems 
NCL-MUC-
1core 
Mouse 
monoclonal 
Human 1:500 
MUC-2 Leica 
Biosystems 
NCL-MUC-2 Mouse 
monoclonal 
Human 1:1000 
MUC-5ac Leica 
Biosystems 
NCL-MUC-
5ac 
Mouse 
monoclonal 
Human 1:1000 
CDX-2,caudal type homeobox 2; LI, liver–intestine; MUC, mucin; TFF-3,trefoil 
factor family 3. 
Formalin-fixed paraffin-embedded (FFPE) sections cut at 3 µm floated out on a 
water bath at 56°C were collected on silane-coated glass slides, put in a metal 
rack and dried at 60°C in a fan-assisted oven for 1 h. Slides were then 
transferred to plastic slide racks for use with the DAKO autostainer with reagents 
from the DAKO EnVIsion FLEX+ Mouse High pH kit (DAKO K8002). 
Deparaffinisation and rehydration were followed by heat-induced epitope 
retrieval with DAKO High pH EnVision FLEX Target Retrieval Solution (1:50 in 
deionised water). The slides were placed in a retrieval bath heated to 85°C, 
then 100°C for 20 min, then 70°C for 15 min before transfer to phosphate-
buffered saline (PBS) at room temperature for 5 min. All staining was carried out 
in the DAKO autostainer. Endogenous peroxidase was blocked using DAKO 
EnVIsion FLEX peroxidise blocking reagent for 5 min. The sections were then 
washed in PBS for 5 min. After titration and optimisation, the primary 
monoclonal antibodies were diluted in DAKO diluent. Antibodies were incubated 
for 30 min then washed in PBS for 5 min. A negative control was diluent alone 
63 
 
for each run. A polymer-based detection system was used: EnVIsion FLEX/HRP. 
Sections were incubated for 30 min then washed for 5 min in PBS.  
Visualisation used diaminobenzidine (DAB) (20 drops concentrate/20 mL of DAB 
substrate buffer) applied twice×5 min. After washing in PBS (5 min), DAB 
staining was enhanced in 0.5% copper sulfate/0.9% saline solution for 5 min. 
Sections were counterstained with haematoxylin, then coverslipped. 
5.2.5 MRI Studies 
Scans were performed before and after a standardised meal consisting of 
battered fish and chips using the Phillips T1.5 scanner. For fat quantification, 
images were taken in three axial planes at the levels of the third, fourth and 
fifth lumbar vertebrae and examined independently by two GI radiologists. Fat 
quantification was performed using commercially available software (Tomovision 
Slice-o-matic, Magog, Quebec, Canada).  This software allows segmentation of 
different tissue types, in this case visceral and subcutaneous fat and accurate 
volume measurement. An example axial scan is shown in Figure 5.3 with the 
subcutaneous and visceral fat compartments highlighted in green and blue 
respectively.  
 
FIGURE 5.3: SAMPLE SCAN USED FOR QUANTIFICATION OF VISCERAL AND SUBCUTANEOUS FAT, 
COMMERCIALLY AVAILABLE SOFTWARE ALLOWS SEGMENTATION OF THE FAT COMPARTMENTS WITH 
VISCERAL SHOWN IN BLUE AND SUBCUTAENOUS IN GREEN. THE VOLUME OF FAT PRESENT CAN 
THEN BE ACCURATELY DETERMINED. 
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Note was made of the presence of absence of a hiatus hernia defined as the 
gastro-oesophageal junction visible above the diaphragmatic hiatus.  
5.2.6 pH Monitoring 
pH data were captured using a custom made high resolution pH probe (Synectics 
Medical Ltd, Ensfeld, UK) with 12 antimony pH sensors designed to maximise 
resolution at the gastro-oesophageal junction. The flexible catheter was 2.1 mm 
in diameter. The most distal sensor was located at the tip of the catheter with 
the other 11 sensors positioned 30, 50, 61, 72, 83, 94, 105, 116, 127, 138 and 
172 mm proximally (Figure 5.4). Prior to each study the probe was calibrated by 
immersion in buffer solutions at pH 1.07 and 7.01.  
 
FIGURE 5.4: SCHEMATIC SHOWING THE SPACING OF THE PH SENSORS ON THE CUSTOM MADE HIGH 
RESOLUTION PH PROBE 
Data was recorded using Polygram Net software (Medtronic Inc., Fridley, 
Minnesota, USA). Raw data were exported for detailed analysis our own custom-
designed software.  
5.2.7 Manometry Set Up and Pressure Calibration 
Manometry data were captured using the commercially available Manoscan 360 
system model A100. (Sierra Scientific Instruments) The probe was 4.2mm in 
diameter and had 36 circumferential solid state manometry sensors spaced 
10mm apart. Each sensor in turns comprised 12 radially orientated sensors 
(TactArray TM) such that the pressure reading represented an average of the 
circumferentially recorded pressures.  
Before each study the probe was calibrated for pressure according to 
manufacturer’s recommendations. This process involves application of known 
externally applied pressure from 0-300mmHg within a pressure chamber. All 
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experiments were performed with a protective sheath (Manoshield, Sierra 
Scientific). 
Manoview acquisition software was used to display recorded pressures and 
capture data. After each study the raw data was exported as a text file. pH and 
manometry text files were combined and analysed using our own custom made 
software. 
5.2.8 Combining pH and Manometry Probes 
Once calibrated, pH and manometry probes were attached with adhesive tape 
placed to avoid interference with sensors. Probes were consistently combined so 
that pH sensor 7 corresponded to manometry sensor 29 (Figure 5.5). This 
allowed correlation of pH and pressure data. (Appendix 1) 
 
FIGURE 5.5: COMBINED PH AND MANOMETRY APPARATUS WITH MANOMETRY SENSOR 29 
CORRESPONDING TO PH SENSOR 7. 
5.2.9 Thermal Calibration of the Manometry Probe 
To address the thermal drift of the manoscan system two calibration processes 
were applied. It is widely recognised that there is an immediate response of the 
manoview system to temperature change. We have also gone on to describe an 
ongoing linear drift of the recorded pressures with time and have employed and 
tested a corrective process to minimise the error associated with the drift. 
These were developed and validated as part of developing the methods of the 
study and this process is detailed in the results chapters. 
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At the beginning of a recording the combined pH and manometry apparatus was 
placed in a water bath at 2cm depth and 37oC and left for three minutes to 
reach a steady state. At the end of this period the probe was removed from the 
water bath and held aloft. At this point the probe was considered to be at body 
temperature but without external pressure influence and the pressure readings 
were zeroed.   
At the end of each study the probes were removed from the volunteer and held 
aloft. Again the probes were considered to be recording conditions of zero 
pressure and to be at body temperature. A linear interpolation process was used 
to correct the pressures assuming a linear drift of the pressure recorded by each 
sensor.  
The manufacturer also recommends an additional weekly ‘in vivo’ calibration of 
the system for temperature. For this process the catheter is placed in water at 
thirty-seven degrees Celsius (37oC) and 2cm depth. The software records the 
change in detected pressure for each sensor with the change in temperature. 
The pressure effect of the water is assumed to be negligible. These recorded 
values are then subtracted from the pressures collected in the in vivo 
environment to reset the baseline. 
5.2.10 Data Capture and Handling 
Recordings were synchronised electronically by starting both recordings 
simultaneously. At the end of the recording period the recordings were also 
stopped simultaneously. The raw data were exported separately as text files 
from each programme of origin; Polygram Net for pH data and Manoview analysis 
software for manometry data. A custom made programme was used to combine 
the files for further analysis. The pH sampling rate was 8Hz whilst the 
manometry was 40Hz. To allow correlation of the data the manometry data was 
compressed into 8 readings per second by calculating the mean of the 
manometry recordings taken over each 0.125s from the raw data.  
Since characteristics of the lower oesophageal sphincter vary by respiration, 
analysis was performed by inspiration and by expiration separately. To assist this 
process a programme was designed to allow manual selection of data points for 
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detailed analysis. First the manoview analysis software was used to identify the 
index time of recording for detailed analysis for example a period with 
concurrent fluoroscopy. This time was entered into the custom designed 
software ‘ManpH’ which also allowed the user to select from 1-36 manometry 
channels to display pressure output as line tracings. Inspiration and expiration 
could be clearly identified. The user could then select six consecutive 
inspirations and six consecutive expirations.  The raw data from these manually 
selected time points were output into an excel file for further analysis. 
5.2.11 Fluoroscopy 
During the recording of pH and manometry fluoroscopic images were obtained 
using the portable Phillips BV Pulsera C arm. Volunteers were asked to breathe 
normally and minimise swallowing to allow capture of a period of stable lower 
oesophageal sphincter tone. Recordings were taken over thirty seconds and were 
synchronised with the pH and manometry recording using an event marker 
simultaneously on both traces to mark the start and end of recording. 
Fluoroscopy was carried out before and after the meal and in upright and supine 
postures.  
Images were uploaded onto the picture archiving and communication system 
(PACS) used by the National Health Service for viewing and reporting images. 
The endoscopically placed clip previously placed to mark the position of the 
squamo-columnar junction was identified and its position from the nares 
calculated using the manometer as reference and internal scale. Thus data were 
available for the position of the squamo-columnar junction relative to the nares 
and to the pH and manometry data. 
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6 Addressing the Thermal Drift of the 
Manoscan System 
6.1 Introduction:  
The solid state high resolution manometry (HRM) system (Manoscan, Sierra 
Scientific Instruments, CA) is a sophisticated and widely used technology 
allowing detailed examination of oesophageal function. A recognised limitation 
of the system is a propensity to ‘thermal drift’ where the pressure recorded by 
the manometry catheter is affected by temperature. In our own practice we 
have observed marked increases in pressure at the end of prolonged studies, in 
the range 40-60mmHg for some sensors. (Figure 6.1)  
 
FIGURE 6.1: THE HRM CATHETER HAS BEEN REMOVED FROM THE PATIENT AND HELD ALOFT. AT 
THIS STAGE PRESSURES SHOULD BE EQUAL TO ATMOSPHERIC PRESSURE REPRESENTED BY THE 
BLUE COLOUR IN THE COLOUR CONTOUR SCALE. IN SOME SENSORS THE PRESSURE IS IN THE 
RANGE OF 40 TO 60MMHG REPRESENTED BY THE GREEN/YELLOW COLOUR IN THE PRESSURE 
SCALE. THESE VALUES REPRESENT THE MAGNITUDE OF BASELINE OR THERMAL DRIFT IN A 
PROLONGED STUDY. 
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This effect is less striking with shorter studies, suggesting an ongoing pressure 
change with time rather than a simple temperature effect. The standard thermal 
correction does not appear to adequately correct the elevated pressures in 
prolonged studies. There has been a lack of clarity on the availability and 
application of alternative corrections. 
Given the potential impact of this pressure change on measured physiological 
values, the aims of this study were: 
1. To characterise the behaviour of the manoscan system with temperature 
and time 
2. To test the currently available corrections.  
6.2 Methods 
6.2.1 High Resolution Manometry 
The manoscan A100 system was used for all experiments (Sierra Scientific 
Instruments, Los Angeles, CA) Equipment was calibrated for pressure and 
temperature according to manufacturers’ instructions.  
The in vitro studies were performed using a catheter with only one prior clinical 
use (EAN 00119). For the in vivo studies results were available from two 
additional probes used within the unit (EAN 00762 and EAS 0010). Experiments 
were performed with a sheath. (Manoshield, Sierra Scientific, CA) 
6.2.2 Characterising ‘Thermal Drift’ in Vitro 
6.2.2.1 Immediate Effect of Temperature Change 
A water bath was prepared with water at 37oC and 2cm depth. Atmospheric 
pressure was recorded at room temperature by holding the catheter in mid-air 
and at body temperature by immersing the catheter in the water bath. The 
calculated pressure of 2cm water (1.47mmHg) was subtracted from readings 
taken in the water bath.  
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Difference in recorded pressure between the two temperatures tested was 
calculated. This process was repeated six times. Results were summarised as 
median and inter-quartile range. Comparison was made between sensors using 
the Kruskal-Wallis test.  
6.2.2.2 Measurement of a Constant Pressure at 37oC 
Six further experiments were performed with the HRM catheter placed in a 
water bath at a constant depth of 10cm and temperature of 37oC. Pressure 
readings for the 36 sensors were plotted against time at 5 minute intervals for 2 
hours. Pressure change for each sensor was calculated as the difference between 
the last recorded pressure and the pressure recorded at 60 seconds into the 
study, expressed as median and interquartile range. Kruskal-Wallis test was used 
to assess variability between sensors.  
6.2.3 Correction Processes 
6.2.3.1 Thermal Compensation Method 
In the standard correction for thermal drift, the pressure in each sensor is 
measured immediately after extubation with the catheter still at body 
temperature. These values are used to correct recorded pressures. To replicate 
this, measured pressures at the end of each two hour study were subtracted 
from the pressure readings taken at five minute intervals. Difference from zero 
was considered an error. 
6.2.3.2 Interpolated Correction 
For prolonged studies a separate correction process ‘interpolated thermal 
compensation’ can be enabled. This assumes a linear drift of measured pressures 
and corrects the data accordingly. To replicate this, the equation for the best-fit 
line was calculated for each of 216 pressure-time lines produced. Each measured 
pressure was corrected by subtracting the drift predicted by the best fit line. 
Difference from zero in either direction was considered the magnitude of the 
error. 
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6.2.4 Probe Behaviour ‘in Vivo’ 
For each of the three probes used within our unit six ‘in vivo’ studies were 
selected at random. For each study the time point immediately after extubation 
was selected such that the probe was free of external pressure but still at body 
temperature. Actual pressure values were documented for each sensor. As part 
of our protocol for prolonged studies we record pressures at conditions of 37oC 
and no applied pressure at the start of each study prior to intubation. These 
values were used to calculate a line gradient for each sensor within each study. 
Using line gradient corrects for study duration and allows comparison between 
studies of different length and with the bench top data. 
Comparison was made between the probe tested on the bench top, ‘probe A’ 
and the same probe tested in vivo. Probe ‘A’ was also compared to each of the 
other two probes ‘B’ and ‘C’. Results were summarised as median and inter 
quartile range and compared using Mann-Whitney U test 
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6.3 Results 
6.3.1 The Immediate Effect of Temperature Change 
The median immediate pressure change for all 36 sensors was 7.0mmHg (IQR 
3.8mmHg). Considerable variability was observed between sensors (P <0.0001). 
Some sensors demonstrated a drop in detected pressure associated with change 
in temperature whilst most demonstrated a rise with a range of -3.3 to 
+9.9mmHg. (Figure 6.2) We termed this immediate pressure response to 
temperature ‘thermal effect’ 
 
FIGURE 6.2: THE IMMEDIATE EFFECT OF TEMPERATURE ON PRESSURE RECORDED BY THE 
MANOMETRY CATHETER. SENSORS 1TO 36 ARE SHOWN ON THE X AXIS AND FOR EACH SENSOR THE 
BOX PLOT DEPICTS THE MEDIAN, RANGE AND INTERQUARTILE RANGE OF SIX EXPERIMENTS. 
CONSIDERABLE VARIATION IN RECORDED PRESSURES WAS OBSERVED BETWEEN SENSORS. (P<0.001) 
6.3.2 Measurement of a Constant Pressure at 37oC 
For a 2 hour study at 37oC the median pressure change was 11.1mmHg (IQR 
9.9mmHg). The magnitude of the effect varied between sensors with a range of 
3.0mmHg to 33.2mmHg. (P <0.0001)  
For a given sensor within a given experiment, change in measured pressure with 
time was linear with R2 values above 0.85 in all cases. Thirty-six example 
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pressure time graphs are shown (Figure 6.3). Median line gradient for all sensors 
was 0.1mmHg/minute equating to a pressure change of 1.5mmHg in 15 minutes, 
3mmHg in 30 minutes and 6mmHg in 60 minutes. Maximum line gradient was 
0.39mmHg/min which corresponds to a pressure change of 5.85mmHg in 15 
minutes. We termed this ongoing linear drift of the measured pressure with time 
‘baseline drift’. 
 
FIGURE 6.3: SAMPLE PRESSURE-TIME GRAPHS SHOWING THE CHANGE IN RECORDED PRESSURE 
WITH TIME FOR 36 SENSORS IN A SINGLE TWO HOUR EXPERIMENT. FOR A SINGLE SENSOR WITHIN A 
GIVEN STUDY THE MEASURED DRIFT WAS LINEAR. 
The results from six experiments on each sensor are presented in Table 1.  
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TABLE 6.1: SUMMARY OF SIX EXPERIMENTS EXAMINING THERMAL EFFECT AND BASELINE DRIFT IN A 
SINGLE HIGH RESOLUTION MANOMETRY CATHETER.  
Sensor 
Number 
Thermal Effect Baseline Drift 
Median Maximum Minimum Median  Maximum Minimum 
1 8.5  9.6  8.1  12.4  14.8  6.5  
2 8.5 9.6 9.1 13.1 15.9 9.8 
3 9.9 10.6 8.7 9.0 11.7 6.8 
4 4.1 5.0 3.1 12.6 13.8 8.6 
5 8.1 8.9 7.3 5.1 13.0 2.6 
6 3.4 4.0 3.2 11.2 12.2 5.0 
7 8.9 9.5 7.2 12.4 40.9 4.1 
8 9.3 10.9 8.7 18.8 23.5 14.5 
9 6.7 8.8 5.7 16.0 17.3 11.8 
10 7.2 7.7 6.4 19.9 23.3 14.0 
11 7.3 8.7 6.3 33.2 40.4 20.6 
12 7.4 8.1 6.1 18.7 25.2 11.1 
13 6.2  7.8  5.1  16.4  20.4  8.5 
14 5.8 7.7 4.9 8.7 12.3 4.8 
15 7.5 9.8 6.5 16.7 26.0 11.1 
16 9.0 12.3 7.9 5.8 20.0 3 
17 5.9 8.0 5.6 5.6 10.1 2.8 
18 2.8 3.2 2.0 26.3 41.8 16.5 
19 5.9 7.3 5.5 6.9 11.8 3.9 
20 2.9 4.4 1.9 9.3 10.6 7.6 
21 4.7 5.7 3.8 18.2 44.7 7.9 
22 -3.0 -2.0 -3.6 8.3 19.2. 3.1 
23 -0.3 0.5 -0.9 9.2 10.8 8.7 
24 8.2 10.4 7.6 8.0 17.8 5.3 
25 6.8 8.7 6.5 8.8 9.8 4.9 
26 2.2 2.9 1.7 17.9 35 12.5 
27 -1.8 -0.3 -2.1 12.8 15.7 8.1 
28 6.2 7.8 5.3 16.1 19.2 10.3 
29 8.6 10.5 8.1 6.6 7.8 5.3 
30 8.3 9.5 7.2 18.9 27.3 14.8 
31 4.9 5.9 4.7 5.4 6.2 2.8 
32 5 6.4 4.5 25.7 38.7 13.9 
33 8.7 10.4 7.8 6.7 10.9 3.2 
34 8.5 9.3 7.6 2.9 6.5 1.9 
35 7.5 9.8 7.2 8 13.5 2.7 
36 9.2 11.4 8.5 4.8 6.8 3.1 
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6.3.3 The Thermal Compensation Correction 
For data corrected by the thermal compensation method the error was least for 
data collected at the end of the study and greatest for early data. For data 
collected 15 minutes before study end the median error for all 36 sensors was 
1.2mmHg (IQR 1.2mmHg). Corresponding values for 30 and 60 minutes were 
2.9mmHg (IQR 2.5mmHg) and 5.4mmHg (IQR 5.2mmHg) respectively.  
6.3.4 Linear Correction 
After application of a linear correction, the median error was independent of 
study duration at 0.3mmHg (IQR 0.2mmHg) overall.  
6.3.5 Probe Behaviour ‘In Vivo’ 
The median line gradient for probe A in vivo was 0.10mmHg/min (IQR 0.08) 
which would equate to a baseline drift of 12.0mmHg in two hours. For probes B 
and C gradients were 0.05mmHg/min (IQR 0.05) and 0.10mmHg/min (IQR 0.06) 
respectively. The median line gradient for probe A on the bench top was 
0.10mmHg/min (IQR 0.09) which was not significantly different from the in vivo 
gradient. (p=0.91)  
For individual sensors in vivo there was considerable variability in the extent of 
baseline drift indicated by variation in line gradients.  (P=<0.0001) This did not 
appear exaggerated in sensors exposed to the high pressures of upper and lower 
oesophageal sphincters. 
In vivo probe behaviour was similar between probe A and probe C. (P=0.71) 
Probe B showed significantly less drift than either of the other two probes. 
(P=0.0001)  
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Discussion 
The problem of thermal drift has long been recognised but we believe this 
represents the first attempt to characterise the phenomenon and assess the 
potential associated error.135 Rather than a ‘once and for all’ type phenomenon, 
we have demonstrated two components to thermal drift, an initial change in 
pressure associated with change in temperature and an ongoing pressure drift 
with time. We have employed the terms thermal effect and baseline drift 
respectively to differentiate these concepts. 
Thermal effect therefore is the discrepancy between measurements of the same 
pressure taken at two different temperatures. From body temperature to room 
temperature there was a median pressure step up of 7mmHg. The magnitude of 
the thermal effect varied between sensors but the important clinical implication 
is the ability of the system to compensate.  
In vivo calibration is a process carried out weekly in the normal operation of the 
manoscan system. The catheter is placed in a shallow water bath at 37oC. The 
software records the change in pressure for each sensor with change in 
temperature, assuming negligible pressure effect of water and uses these values 
to reset the baseline. In essence the system is measuring the thermal effect for 
each sensor and correcting recorded pressures accordingly.  
Baseline drift is best understood as a progressive upward change of the zero 
pressure with time. This effect varies markedly between sensors but for a given 
sensor within an experiment the effect is linear. The potential impact of this 
effect depends on study duration. For prolonged studies a pressure change of up 
to 33.2mmHg as demonstrated on the bench top would render interpretation of 
the data impossible. For short clinical studies, lasting less than fifteen minutes 
baseline drift will have less impact but may still affect sensitive measurements 
such as sphincter length. 
‘Thermal compensation’ subtracts measured pressures from the end of a clinical 
study after extubation from the in vivo pressures. Correcting the data in this way 
simply shifts the maximum error from the end to the start of the study 
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underestimating early pressures. Since it does not address the gradient of the 
line, the magnitude of the error is unchanged. 
We have tested a linear correction on our bench top data with an overall error 
of 0.3mmHg independent of study duration. This mirrors the interpolated 
compensation process recommended by the manufacturer for prolonged studies 
and extrapolating from our bench top data will dramatically reduce the error 
associated with baseline drift. Whilst a linear correction can be applied within 
current software, it has to be enabled discretely in the program files in 
conjunction with the manufacturer and as it is not referenced in the standard 
operating instructions it requires awareness of the problem on the part of the 
user.  
Of course it is not possible to entirely replicate the complex and dynamic in vivo 
environment on the bench top. To address this we examined six in vivo studies 
from each of three probes used within our unit. The magnitude of the baseline 
drift was comparable for the probe tested on the bench-top and used for 
extended in vivo studies. There was also no clear exaggeration of the baseline 
drift in sensors exposed to the upper and lower oesophageal sphincters. This 
suggests that the baseline drift is predominantly a temperature rather than a 
pressure phenomenon.  
Comparison between the three probes from the in vivo data suggests a variation 
in propensity to baseline drift. From both the bench top and in vivo data it is 
clear that there is marked variability in the extent of baseline drift between 
sensors. Since a probe is a collection of thirty-six sensors with independent 
baseline drift characteristics it follows that the baseline drift profile will vary 
from probe to probe. This poses a quality control issue for manufacturers.  
Based on these results we would suggest that the current correction process be 
replaced by a linear correction already within the capability of current software. 
This could be done by interpolating between stored in vivo compensation values 
collected weekly and the set thermal compensation values specific to each 
study. This would markedly improve the accuracy of the system, would allow its 
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use for prolonged studies without additional modification and would not impact 
on ease of use. 
In conclusion we have described the behaviour of the HRM system with 
temperature and time. There is an immediate thermal effect which is well 
compensated and an ongoing baseline drift which is not well recognised or 
addressed. The error associated with this phenomenon could be reduced by 
applying a linear correction. Ultimately this would be best incorporated into 
standard software so that ease of use is maintained. This observation represents 
a quality control issue for the manufacturer as well as setting a challenge to all 
manufacturers of similar technologies. Thermal effect and baseline drift must be 
considered, documented and addressed. 
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7 Central Obesity in Asymptomatic Volunteers 
is Associated with Expansion of the Cardia by 
Columnar Metaplasia  
7.1 Introduction 
The gastro-oesophageal junction carries a high burden of disease and 
adenocarcinoma at this site has shown an alarming increase in incidence over 
the past thirty years.75, 76 This cancer shared epidemiological features with 
oesophageal adenocarcinoma.97, 136 However, its association with traditional 
reflux is particularly weak, with only 29% having a history of reflux symptoms60 
and Barrett’s mucosa being detected in only 12% at the time of cancer 
diagnosis.35 
An observation that may provide a clue to the aetiology of adenocarcinoma of 
the gastric cardia and gastro-oesophageal junction (GOJ) in subjects with no 
reflux history is the frequent finding of pathologic changes at the cardia and GOJ 
in asymptomatic volunteers. Inflammation of the gastric cardia has been 
reported in a high proportion of asymptomatic subjects.56, 66, 70  This ‘carditis’ 
has been attributed to either Helicobacter pylori infection or acid reflux66, 137  
but is also present in most people without H. pylori infection or symptoms or 
signs of reflux138. Intestinal metaplasia at the cardia has also been described in 
the absence of H. pylori infection or GORD.139 In one study, intestinal metaplasia 
at the cardia was observed in 16% of Caucasians having screening colonoscopy. 
139 
Cardiac mucosa is non–acid-secreting columnar mucosa lying between the 
squamous mucosa of the oesophagus and the acid-secreting mucosa of the 
stomach. The origin and even universal existence of cardiac mucosa has been 
hotly debated. In neonates, the cardiac mucosa is less than 1mm in length64 but 
increases in length with age.62 Previous investigators have also shown 
lengthening of the cardiac mucosa in association with acid reflux.64, 66 These 
observations have led some to suggest that the cardiac mucosa is a pathologic 
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phenomenon arising through a process of metaplasia of the most distal 
oesophageal squamous mucosa akin to the development of Barrett’s oesophagus. 
8 
Obesity is a risk factor for both oesophageal adenocarcinoma and 
adenocarcinoma of the gastro-oesophageal junction.75, 81 There is a documented 
association between obesity and Barrett’s oesophagus.140 The influence of 
obesity on the development of cardiac mucosa or on pathological changes at the 
gastro-oesophageal junction is not known. 
The aims of this study therefore were: 
1. To examine the association between measures of obesity and cardiac 
mucosa length 
2. To test the hypothesis that the cardiac mucosa arises from columnar 
metaplasia of distal squamous mucosa 
To avoid confusion related to H pylori–induced histologic changes in the proximal 
stomach we limited our study to subjects without the infection. In addition, 
because we were interested in subjects without traditional reflux, we also 
excluded subjects with hiatus hernia. 
7.2 Methods 
7.2.1 Subjects 
7.2.1.1 Healthy Volunteers 
Healthy volunteers were recruited by word of mouth and newspaper 
advertisement. Those who had ever taken proton pump inhibitors or ever 
attended primary or secondary care with reflux symptoms were excluded. All 
subjects were screened for H pylori by urea breath test and those testing 
positive or who had a past history of the infection were excluded. Subjects who 
were found to have hiatus hernia during the study protocol were excluded from 
the current analysis. 
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Subjects were recruited to the study to achieve 2 groups defined by small or 
large waist circumference (WC) and matched with respect to age and sex. Large 
WC was defined on entry as greater than 102 cm in males and greater than 88 
cm in females. Small WC was defined as less than 94 cm in males and less than 
80 cm in females. Waist circumference has been validated as a non-invasive 
assessment of visceral fat mass.141 
7.2.1.2 Barrett's oesophagus patients 
Archived endoscopic biopsies from 15 patients with long-segment Barrett's 
oesophagus were included in the analysis to compare immunophenotypes with 
GOJ, gastric body and antral biopsies taken from healthy volunteers. All Barrett's 
specimens had columnar metaplasia, with or without intestinal metaplasia, but 
no dysplastic changes. Biopsies were confirmed to be of oesophageal origin by 
endoscopic and histological indicators consistent with guidelines of the British 
Society of Gastroenterology.142 
7.2.2 Study Design 
7.2.2.1 Study day 1: Clinical and magnetic resonance imaging assessment of fat 
distribution 
Demographic details and waist circumference were recorded and magnetic 
resonance imaging (MRI) scans of the abdomen were performed using the Philips 
T1.5 MRI scanner (Philips Healthcare, Surrey, UK) before and 45 minutes after a 
standardized meal. 
7.2.2.2 Study day 2: Upper gastrointestinal endoscopy with biopsies  
An upper gastrointestinal (GI) endoscopy was performed after a 12-hour fast. 
Biopsy specimens were taken across the squamo-columnar junction using a large-
capacity radial jaw 4 forceps (Boston Scientific, Hemel Hempstead, Herts, UK) 
with a jaw span of 8 mm. Junctional biopsy specimens were taken perpendicular 
to the squamo-columnar junction and targeted to include just enough squamous 
mucosa at the proximal end to confirm positioning. Biopsy specimens were 
examined during the endoscopy procedure for the presence of glandular and 
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squamous mucosa and intra-procedure feedback was given for biopsy accuracy. 
Up to 3 junctional biopsy specimens were taken to optimize the chances of 
capturing the full span of the cardiac mucosa in a single biopsy sample, allowing 
accurate length measurement. Biopsy specimens also were taken of the body 
and antrum of the stomach.  
7.2.3 Biopsy specimen processing 
Biopsy specimens were placed immediately on dental wax, which has a 
nonadherent surface, and oriented flat. An isotonic solution of Hyoscine N butyl 
bromide (1 mg/mL) was applied to minimize sample contraction and preserve 
the length. Biopsy specimens were transferred to filter paper using a no touch 
technique and re-oriented where necessary. Samples were transported in 
conventional formalin and embedded in agar on the filter paper without further 
manipulation.  
7.2.4 H&E and Immunohistochemistry Staining of Biopsies 
All biopsies were stained with H&E for initial assessment. Further staining was 
carried out using a panel of antibodies selected to evaluate the immune-
histochemical staining pattern of the gastro-oesophageal junction: 
 CDX-2 (caudal type homeobox 2) —a marker of epithelial intestinal 
differentiation; 129 
 Villin—essential for brush border formation in normal intestinal epithelial 
cells130 and with differential expression in cardiac type mucosa versus 
Barrett's mucosa with intestinal metaplasia;131  
 Liver–intestine (LI)-cadherin—a sensitive marker of intestinal metaplasia 
in the upper GI tract;132  
 Trefoil factor family 3 (TFF-3)—a marker of intestinal differentiation, 
strongly expressed in Barrett's mucosa  with intestinal metaplasia 133  
 MUC1, a membrane—associated mucin apoprotein 
 MUC2; a marker of mucin cell differentiation associated with intestinal 
type mucosa 
 MUC5AC—a marker of mucin cell differentiation associated with normal 
gastric mucosa   
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To assess the extent of cell replication, we used MIB-1 antibodies against Ki-67 
antigens.134 97 
7.2.5 Data Analysis 
7.2.5.1 MRI scans.  
Images were taken in 3 axial planes at the level of the second, third, and fourth 
lumbar vertebrae and assessed by 2 independent GI radiologists. Fat 
quantification was performed with commercially available software (Tomovision 
Slice-o-matic, Magog, Quebec, Canada). The presence or absence of a hiatus 
hernia on MRI was defined as the identification of the gastro-oesophageal 
junction proximal to the diaphragmatic hiatus. 
7.2.5.2 Cardiac mucosal length.  
The cardiac mucosa was considered fully measurable when consecutive 
squamous, cardiac, and cardio-oxyntic mucosal types were present in the same 
biopsy specimen. The cardiac mucosa was defined as epithelium devoid of 
parietal cells and consisting of mucous-secreting cells. The demarcation 
between squamous and cardiac epithelium was clear and the distal limit of 
cardiac mucosa was taken as the appearance of parietal cells. Biopsy specimens 
were assessed by 2 independent gastrointestinal pathology experts blinded to 
the clinical characteristics of the volunteers. Length was assessed by ocular 
micrometre. Inter-observer agreement of length measurement was examined 
(kappa test, 0.78) (P < 0.01). 
7.2.5.3 Inflammatory Scoring of Biopsy specimens.  
Biopsy specimens were scored quantitatively for the presence and degree of 
inflammation. Scores of 0–3 were given for inflammation, as follows: 0, none; 1, 
mild; 2, moderate; and 3, marked inflammation. This was performed for acute 
inflammation, chronic inflammation, and reactive atypia, and for each different 
mucosal type. This was performed by 2 independent GI pathologists blinded to 
the details. Inter-observer agreements were examined using kappa tests, which 
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ranged between 0.74 and 0.89 (P values for each < .01) for different parameters 
in the 3 parts of squamous, cardiac, and oxyntocardiac mucosae. 
7.2.5.4 Assessment of Immunohistochemical Pattern 
In sections of gastric antrum, body and gastro-oesophageal junction (cardiac, 
oxyntocardiac mucosa and Barrett’s), the percentage of glandular cells having 
positive immunostaining was estimated by eye, with all mucosal epithelial cells 
(surface, foveolar and glandular) being the relevant denominator. In 
oesophageal squamous epithelium, the only positive differentiation markers 
were TFF-3 and LI-cadherin. As their expression was entirely restricted to the 
basal and suprabasal layers, these cells (i.e., those cells not yet showing obvious 
squamous differentiation) were taken as the relevant denominator. Positive 
immunostaining was represented by unequivocal brown DAB signal. In any one 
biopsy, all the mucosae of a particular phenotype were assessed using medium 
(×10, ×20) and high-power (×40) objectives. In the case of Ki-67, where there 
was >2 mm of squamous mucosa, separate scores were assigned for proximal and 
squamous epithelium. 
7.2.6 Statistical Analysis 
Results are presented as either mean (+SD) or median (+IQR), based on symmetry 
of data distribution. Comparisons between groups were made using Mann–
Whitney U test or independent groups T test, if appropriate. To compare two 
paired groups, we used related samples T test or related samples Wilcoxon 
signed-rank test, where appropriate. For correlations between continuous 
variables, Spearman’s rho bivariate correlations were used with significance 
taken at p<0.05. 
If any correlations had to be adjusted to other variables, partial correlations 
were used with a condition of normal distribution of variables to be correlated. 
For the determinants of cardiac mucosal length, multivariable analysis was 
performed using stepwise linear regression. The variables incorporated in the 
model were age, WC, and MRI total fat. 
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7.2.7 Ethics 
The study protocol was approved by the West of Scotland ethics committee and 
all volunteers provided written informed consent. 
7.3 Results: 
Sixty-one volunteers completed the study protocol. However, 10 were found to 
have a hiatus hernia on MRI scanning and were excluded from this analysis. Thus, 
the study groups had 24 volunteers (12 females) in the small WC group and 27 
volunteers (13 females) in the large WC group. 
The median age in the group with the small WC was 45 years (21y–73 y) and in 
the large WC group the median age was 46 years (21y–71 y) (P= 0.610). The 
median BMI was 23.6 kg/m2 in the small WC group (16.7–26.7 kg/m2) and 30.5 
kg/m2 in the large WC group (25.3–43.3 kg/m2) (P < 0.001). 
The Barrett’s oesophagus comparison patients (12 men, 3 women) had a mean 
(SD) age of 58 (14) years. 
7.3.1 Obesity and Cardiac Mucosal Length 
Thirty-five volunteers without hiatus hernia had at least one biopsy of the 
gastro-oesophageal junction incorporating squamous, cardiac, and oxyntic 
mucosa (median length, 6.5 mm) (17 in the large WC group and 18 in the small 
WC group). Results presented for cardiac mucosal length refer to these 35 
volunteers with a fully measurable cardiac mucosa whereas associations with 
physiological parameters refer to the whole group. 
In the group with a large WC, the cardiac mucosal length was 2.5 mm (IQR 0.8 
mm) compared with 1.75mm (IQR 1.1 mm) in the small WC group (p= 0.008). In 
both groups the transition from cardiac to cardio-oxyntic mucosa was identified 
easily by the abrupt appearance of parietal cells. (Figure 7.1) 
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FIGURE 7.1: SAMPLE BIOPSY ACROSS GASTRO-OESOPHAGEAL JUNCTION SHOWING SQUAMOUS, 
CARDIAC AND CARDIO-OXYNTIC MUCOSAL TYPES. 
By bivariate analysis, cardiac mucosal length was correlated positively with age 
(R = 0.455; p=0 .006), with intra-abdominal fat (R = 0.351; p =0.045), and with 
total fat (R =0.369; p =0.034). No significant associations were seen for BMI 
(p=0.125) or for subcutaneous fat (p=0.133). 
No difference was seen in cardiac mucosal length by sex (p =0.722) or by height 
(p=0.434). On correcting for age, the association for intra-abdominal fat was lost 
(R = 0.276; p=0.126). The association with total fat remained significant (R= 
0.357; p=0.045). 
On regression analysis the independent predictors of cardiac mucosal length 
were WC (standardized coefficient, 0.342; p=0.035) and age (standardized 
coefficient, 0.322; p=0.046). 
7.3.2 Inflammation and Intestinal Metaplasia at Cardia and SCJ 
In this group of healthy volunteers, the cardiac mucosa was universally inflamed. 
As shown in Figure 7.2 inflammation defined by the density of neutrophils was 
significantly higher in cardiac mucosa than in the adjacent oxyntocardiac or 
distant gastric body and antral mucosa (all p values < 0.001). Again, 
inflammation measured by the density of mononuclear cells was evident in all 3 
mucosal subtypes and was in its maximum density in cardiac mucosa (all p values 
< 0.001 for cardia vs others). Reactive atypia, an indicator of mucosa stress, was 
seen in all 3 types of SCJ mucosa, but the maximum activity was evident in the 
most distal squamous mucosa followed by cardiac mucosa (Figure 7.2).  All 
biopsy specimens from the gastric body and antral mucosa were virtually normal. 
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Intestinal metaplasia at the cardia defined by the presence of goblet cells was 
seen in only 1 volunteer. 
 
FIGURE 7.2: INFLAMMATION AND MUCOSAL STRESS (REACTIVE ATYPIA) AT SQUAMO-COLUMNAR 
JUNCTION COMPARED TO GASTRIC BODY AND ANTRAL MUCOSAE. PMN: POLYMORPHONUCLEAR 
CELLS, MN: MONONUCLEAR CELLS, RA: REACTIVE ATYPIA. ALL COMPARISONS ARE BETWEEN 
SCORES OF CARDIA AND OTHER LOCATIONS, AND TESTED BY WILCOXON SIGNED RANK TEST. 
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When biopsies from the gastro-oesophageal junction in healthy volunteers were 
compared with the biopsies from patients with Barrett’s oesophagus, 
Inflammation in the cardiac mucosa was equivalent to that in Barrett’s mucosa 
with or without intestinal metaplasia (Table 7.1). Reactive atypia was also 
similar to that in Barrett’s with or without intestinal metaplasia (Table 7.1) 
TABLE 7.1: INFLAMMATION IN SQUAMOCOLUMNAR JUNCTION BIOPSIES COMPARED WITH OTHER 
PARTS OF GASTRIC MUCOSA 
 Squamous Cardiac Oxynto-
cardiac 
Body Antrum Barrett’s 
(IM) 
Barrett’s 
(Non-IM 
PMN Infiltration        
  Mean 0.06 0.48 0.04 0.04 0.05 0.61 0.46 
  SD 0.24 0.58 0.21 0.27 0.30 0.61 0.66 
  p Value 
(cardia vs other) 
<0.001  <0.001 <0.001 <0.001 0.405 0.807 
 
MN Infiltration        
  Mean 1.17 1.88 1.02 0.27 0.22 2.06 2.15 
  SD 0.55 0.58 0.45 0.56 0.42 0.54 0.69 
  p Value 
(cardia vs other) 
<0.001  <0.001 <0.001 <0.001 0.270 0.163 
 
Reactive Atypia        
  Mean 1.79 1.50 0.65 0.07 0.36 1.78 1.77 
  SD 0.70 0.73 0.48 0.33 0.59 0.65 0.83 
  p Value 
(cardia vs other) 
0.014  <0.001 <0.001 <0.001 0.184 0.388 
  p Value  
     (squamous vs 
other) 
 
 <0.001 <0.001 <0.001 <0.001 n/a n/a 
IM, intestinal metaplasia; MN, mononuclear cells; PMN, polymorphonuclear cells. 
 
 
7.3.3 Immunohistochemistry of the GOJ 
7.3.3.1 CDX-2 
There was no CDX-2 immunostaining of oesophageal squamous mucosa, gastric 
oxyntic or oxyntocardiac mucosa. A small number of glandular cells (1%, IQR 0–
3%) showed positive staining in cardiac and antral mucosa. In biopsies from 
Barrett’s mucosa, CDX-2 was strongly expressed (90%, IQR 50–90%) in glandular 
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areas with intestinal metaplasia but was much less evident in the absence of 
intestinal metaplasia. (5%, IQR 1–5%, p=0.022) (Table 7.2) 
7.3.3.2 Villin 
There was no immunostaining for villin in squamous mucosa. There was 
substantial expression in cardiac mucosa (30%, IQR 10–70%) with a sharp 
decrease in oxyntocardiac (5%, IQR 0–10%) and oxyntic (1%, IQR 0–1%) mucosae. 
Antral mucosa (90%, IQR 81–90%) and Barrett’s mucosa with intestinal metaplasia 
(90%, IQR 86–95%) both expressed villin even more strongly than cardia (p<0.001 
for both). Villin expression in Barrett’s mucosa without intestinal metaplasia was 
lower at 25% (IQR 10–40%), similar to cardiac mucosa (p=0.425). (Table 7.2) 
7.3.3.3 TFF-3 
In oesophageal squamous mucosa, a minority, mean 4% (SD 6%), of basal layer 
cell were distinctly positive for TFF-3 (Figure 7.3) This was significantly lower 
than its expression in cardiac mucosa (54%, SD 37%, p<0.001). TFF-3 expression 
decreased to 26% (SD 20%, p<0.001 vs cardia) in oxyntocardiac and to 12% (SD 
19%, p=0.003 vs cardia) in oxyntic mucosae. Again in antral mucosa, a high 
proportion (47%, SD 25%) of cells expressed TFF-3 and similar to cardia 
(p=0.489). 
In Barrett’s mucosa, TFF-3 expression was maximal in IM (89%, SD 3%), which was 
significantly higher than cardia (p=0.001). Non-IM Barrett’s mucosa expresses 
TFF-3 at levels similar to cardia (69%, SD 9, p=0.352). 
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TABLE 7.2: THE EXTENT (%) OF IMMUNOSTAINING WITH DIFFERENT ANTIBODIES IN BIOPSIES FROM 
SQUAMOCOLUMNAR JUNCTION COMPARED WITH GASTRIC BODY, ANTRUM AND BARRETT’S 
Antibody Squamous Cardiac Oxynto-
cardiac 
Body Antrum Barrett’s 
(IM) 
Barrett’s 
(Non-IM 
CDX2        
Median 0 1 0 0 1 90 5 
IQR 0-0 0-3 0-0 0-0 0-1.0 50-90 1-5 
P Value (cardia 
vs other) 
<0.001  <0.001 <0.001 0.384 <0.001 0.022 
Villin        
Median 0 30 5 1 90 90 25 
IQR 0-0 10-70 0-10 0-1 81-90 86-95 10-40 
P Value (cardia 
vs other) 
<0.001  <0.001 0.069 0.001 <0.001 0.425 
TFF-3        
Mean 4 54 26 12 47 89 69 
SD 6 (37) 20 (19) (25) (3) (9) 
P Value (Cardia 
vs other) 
<0.001  <0.001 0.003 0.489 0.001 0.352 
LI-Cadherin        
Mean 7 14 10 5 18 65 13 
SD (6) (11) (7) (4) (7) (37) (10) 
P Value (cardia 
vs other) 
<0.001  <0.001 <0.001 0.594 <0.001 0.465 
MUC1        
Median 1 5 15 40 10 0 3 
IQR 0-1 1-8 9-22 8-65 5-50 0-0 0-5 
P Value (cardia 
vs other) 
<0.001  <0.001 0.028 0.035 <0.001 0.063 
MUC2        
Median 0 0 0 0 0 90 0 
IQR 0-0 0-1 0-0 0-0 0-0 80-90 0-1 
P Value (cardia 
vs other) 
0.0014  0.011 0.317 0.157 <0.001 0.074 
MUC5ac        
Median 0 50 40 30 55 90 60 
IQR 0-0 50-70 30-40 25-60 40-70 90-90 50-70 
P Value (cardia 
vs other) 
<0.001  <0.001 0.013 0.270 <0.001 0.927 
Marker expression is given as the percentage of positive cells for all mucosal epithelial cells, 
except for TFF-3 and LI-cadherin, which were only expressed by basal cells (and suprabasal cells 
for LI-cadherin) and are expressed as the percentage of the cells in that specific compartment. 
CDX-2, caudal type homeobox 2; IM, intestinal metaplasia; LI, liver–intestine; MUC, mucin; TFF-
3,trefoil factor family 3. 
91 
 
7.3.3.4 LI-cadherin 
The distal oesophageal squamous mucosa showed strong LI-cadherin 
immunostaining in 7% (SD 6%) of basal and suprabasal layer cells (Figure 7.3). 
There was greater staining in cardiac mucosa (14%, SD 11%), which gradually 
decreased to 10% (SD 7%) (p<0.001 vs cardia) in oxyntocardiac and then to 5% (SD 
4%) (p<0.001 vs cardia) in oxyntic mucosa. Expression of LI-cadherin in antral 
mucosa was 18% (SD 7%), similar to cardia (p=0.594). (Table 7.2) 
In Barrett’s biopsies, while sections with IM expressed LI-cadherin strongly (65%, 
SD 37%) (p<0.001 vs cardia) non-IM sections expressed lower levels (13%, SD 10%) 
similar to cardia (p=0.465). 
7.3.3.5 MUC-1, MUC-2 and MUC-5ac 
Except weak and superficial expression of MUC1, extending to a median of 1% 
(IQR 0–1%), none of the other antibodies were detectably expressed in squamous 
mucosa of the SCJ. MUC1 was expressed in 5% (IQR 1–8%) of cells in cardiac 
mucosa, and the expression increased distally to 15% (IQR 9–22%) in 
oxyntocardiac (p=0.001) and 40% (IQR 8–65%) (p=0.028 vs cardia) in oxyntic 
mucosae. Antral mucosa showed 10% (IQR 5–50%) expression, slightly higher than 
cardia (p=0.035). There was no reactivity in Barrett’s mucosa with IM, but non-
IM Barrett’s showed 3% (IQR 0–5%) expression, similar to cardia (p=0.063).(Table 
7.2) 
MUC-2 was strongly expressed only in Barrett’s mucosa with IM (90%, IQR 80–90), 
which was significantly higher than that of cardiac mucosa (p<0.001). MUC-5ac-
positive cells were present in 50% (IQR 50–70%) of cardia and decreased in 
oxyntocardiac to 40% (IQR 30–40%) (p<0.001) and in oxyntic mucosae to 30% (IQR 
25–60%) (p<0.001 vs cardia). In antrum, MUC-5ac was expressed in 55% (IQR 40–
70%), which was similar to cardia. MUC-5ac was highly expressed in Barrett’s 
with IM (90%, IQR 90–90%, p<0.001), but its expression in non-IM Barrett’s was 
similar to cardia (60%, IQR 50–70%, p=0.927) (Table 7.2) 
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FIGURE 7.3: SAMPLE BIOPSIES OF SQUAMOCOLUMNAR JUNCTION SHOWING INFLAMMATION AND 
IMMUNOHISTOCHEMICAL STAINING. 
TOP ROW: (A) LOW-POWER VIEW OF A BIOPSY FROM THE SQUAMOCOLUMNAR JUNCTION OF A 
VOLUNTEER SHOWING BIOPSY LENGTH AND ORIENTATION. (B) HIGHER-POWER VIEW OF 
SQUAMOCOLUMNAR JUNCTION OF ANOTHER VOLUNTEER SHOWING INFLAMMATION AND REACTIVE 
CHANGES TO SQUAMOUS AND GLANDULAR MUCOSA.  
MIDDLE ROW: LIVER–INTESTINE (LI)-CADHERIN, IMMUNOHISTOCHEMISTRY. (C) STRONG EXPRESSION 
BY BARRETT'S MUCOSA WITH INTESTINAL METAPLASIA (IM). (D) OCCASIONAL POSITIVE CELLS IN 
NON-IM BARRETT'S MUCOSA. (E) OCCASIONAL POSITIVE CELLS IN CARDIA MUCOSA IN A 
VOLUNTEER. (F) BASAL LI-CADHERIN-POSITIVE CELLS IN SQUAMOUS MUCOSA IN A VOLUNTEER. 
BOTTOM ROW: TREFOIL FACTOR FAMILY (TFF)-3. (G) STRONG EXPRESSION BY BARRETT'S MUCOSA 
WITH IM. (H) INTERFACE BETWEEN BARRETT'S MUCOSA WITH IM AND NON-IM BARRETT'S MUCOSA. 
(I) CARDIAC MUCOSA FROM A VOLUNTEER. (J) BASAL TFF-3 POSITIVITY IN SQUAMOUS EPITHELIUM 
NEXT TO CARDIA IN A VOLUNTEER. 
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7.3.3.6 Immunostaining of cardiac versus other mucosae 
Cardiac mucosa immunostaining was statistically indistinguishable from that of 
non-IM Barrett’s mucosa with respect to six of the seven antibodies employed. 
CDX-2 was expressed by a slightly but significantly higher number of cells in non-
IM Barrett’s mucosa (1%, 0–3 vs 5%, 1–5). Cardiac mucosa differed from all the 
other upper GI epithelia by showing different characteristics with respect to at 
least two of the immunostains. 
7.3.3.7 Proliferation marker Ki-67 and inflammation 
As expression of Ki-67 appeared to vary across squamous mucosa of GOJ 
biopsies, we measured the variation of expression in 20 biopsies with >2 mm of 
squamous mucosa. In SCJ biopsies, expression of Ki-67 was maximum at the most 
distal squamous epithelium (39%), and decreased moving proximally (25%) and 
distally (20% in cardia) (p for trend <0.01) (Table 7.3) 
Decreasing Ki-67 expression in the small distance between distal to proximal 
squamous epithelium within single biopsies was parallel to a decreasing median 
inflammatory score (mononuclear cells + polymorphonuclear cells) over the same 
distance (4.0 (IQR 3.5–5.0) vs 2.5 (IQR 2.0–3.0), p value <0.01). Correlation 
between proliferation (indicated by Ki-67) and inflammation at the SCJ was 
positive (Spearman’s coefficient 0.510) and statistically significant (p=0.022) in 
the 20 samples with sufficient length of squamous mucosa in specimen. 
Ki-67 expression was highest in Barrett’s mucosa with IM (75%, IQR 70–80) and 
lower in non-IM Barrett’s at 40% (IQR 35–45) (p<0.01 for cardia vs Barrett’s with 
IM and p<0.05 for cardia vs non-IM Barrett’s). 
  
94 
 
TABLE 7.3: THE EXTENT (%) OF KI-67 IMMUNOREACTIVITY IN BIOPSIES FROM SQUAMOCOLUMNAR 
JUNCTION COMPARED WITH TISSUES FROM GASTRIC BODY, ANTRUM AND BARRETT’S 
 Squamo-columnar Junction     
 Squamous 
(proximal) 
Squamous 
(distal) 
Cardiac Oxynto-
cardiac 
Body Antrum Barrett’s 
(IM) 
Barrett’s 
(Non-IM 
N 20 20 39 18 11 10 15 15 
Median 25.0 39.0 20.0 10.00 10.00 30.00 75.00 40 
Centiles         
25 15.00 31.50 20.00 10.00 5.00 25.00 70.00 35 
75 30.75 47.00 30.00 15,00 10.00 30.00 80.00 45 
IM, intestinal metaplasia 
 
7.3.4 Obesity and markers of glandular differentiation 
In squamous mucosa of the distal oesophagus, expression of TFF-3 and LI-
cadherin was correlated with obesity (Table 7.4). The TFF-3 expression was 
correlated strongly to WC (correlation coefficient (CC) =0.54, p=0.001), BMI 
(CC=0.58, p=0.001), subcutaneous fat thickness at lower abdomen (CC=0.39, 
p=0.020), average subcutaneous fat (CC=0.44, p=0.005) and intra-abdominal fat 
at a similar area (CC=0.48, p=0.002). These correlations remained significant or 
became stronger when adjusted for age and gender or age, gender and cardiac 
mucosa length (Table 7.4).  
Expression of LI-cadherin also was correlated to WC (CC=0.51, p=0.001), BMI 
(CC=0.37, p=0.015) and subcutaneous fat thickness at lower abdomen (CC=0.34, 
p=0.039), and these correlations also became stronger when correcting for age, 
gender and cardia length. 
Expression of CDX-2, villin and Ki-67 in distal squamous mucosa was not 
correlated with obesity. None of the tested antibodies in cardiac mucosa 
correlated with obesity parameters (Table 7.5). 
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TABLE 7.4: CORRELATION BETWEEN OBESITY AND EXPRESSION OF TREFOIL FACTOR FAMILY 3 (TFF-
3) AND LIVER–INTESTINE (LI)-CADHERIN IN GASTRO-OESOPHAGEAL JUNCTIONAL BIOPSIES, 
SQUAMOUS MUCOSA (PARTIAL CORRELATION) 
 TFF-3 
 
LI-Cadherin 
Adjustment None Age and 
Gender 
Age, gender 
and cardia 
length 
 
None Age and 
Gender 
Age, gender 
and cardia 
length 
WC    
 
   
CC  0.540 0.542 0.604 
 
0.512 0.462 0.462 
P Value 0.001 0.001 0.001 
 
0.001 0.002 0.002 
N 41 37 30 
 
43 39 39 
BMI    
 
   
CC  0.582 0.573 0.617 
 
0.369 0.366 0.366 
P Value 0.001 0.001 0.001 
 
0.015 0.019 0.019 
N 41 37 30 
 
43 39 39 
SCF Thickness, upper 
abdomen 
  
 
   
CC  0.238 0.210 0.239 
 
0.355 0.372 0.372 
P Value 0.156 0.226 0.188 
 
0.188 0.023 0.023 
N 37 33 30 
 
39 35 35 
SCF Thickness, lower 
abdomen 
  
 
   
CC  0.391 0.518 0.536 
 
0.341 0.447 0.447 
P Value 0.020 0.002 0.002 
 
0.039 0.007 0.007 
N 35 31 30 
 
37 33 33 
SCF (L2, L3, L4 average)   
 
   
CC  0.445 0.441 0.505 
 
0.243 0.325 0.325 
P Value 0.005 0.007 0.003 
 
0.130 0.047 0.047 
N 38 34 30 
 
40 36 36 
IAF (L2, L3, L4 average)   
 
   
CC  0.482 0.602 0.638 
 
0.302 0.060 0.060 
P Value 0.002 0.001 0.001 
 
0.058 0.721 0.721 
N 38 34 30 
 
40 36 36 
Total Fat (L2, L3, L4 average)  
 
   
CC  0.586 0.593 0.668 
 
0.307 0.249 0.249 
P Value 0.001 0.001 0.001 
 
0.054 0.132 0.132 
N 
 
38 34 30 
 
40 36 36 
BMI, body mass index; CC, correlation coefficient; IAF, intra-abdominal fat; SCF, subcutaneous 
fat; WC, waist circumference 
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TABLE 7.5: CORRELATION BETWEEN OBESITY AND EXPRESSION OF VARIOUS ANTIBODIES IN 
GASTRO-OESOPHAGEAL JUNCTIONAL BIOPSIES, CARDIAC MUCOSA 
 CDX-2  Villin  TFF-3  LI-cadherin  Ki-67 
WC      
CC  -0.066 -0.055 0.097 0.284 0.176 
P Value 0.676 0.733 0.523 0.058 0.272 
N 43 41 46 45 41 
BMI      
CC  -0.163 0.064 0.060 0.262 0.154 
P Value 0.295 0.692 0.692 0.082 0.336 
N 43 41 46 45 41 
SCF Thickness, upper abdomen    
CC  0.120 0.004 0.098 0.017 0.283 
P Value 0.462 0.982 0.531 0.918 0.085 
N 40 38 43 41 38 
SCF Thickness, lower abdomen    
CC  0.164 -0.035 0.141 0.144 0.265 
P Value 0.332 0.842 0.386 0.381 0.123 
N 37 35 40 39 35 
SCF (L2, L3, L4 average)     
CC  0.003 -0.073 0.221 0.026 0.206 
P Value 0.985 0.657 0.149 0.870 0.209 
N 41 39 44 42 39 
IAF (L2, L3, L4 average)     
CC  0.094 -0.043 0.104 0.069 0.263 
P Value 0.561 0.794 0.502 0.664 0.106 
N 41 39 44 42 39 
Total Fat (L2, L3, L4 average)    
CC  0.077 -0.062 0.221 0.114 0.290 
P Value 0.630 0.707 0.150 0.470 0.073 
N 
 
41 39 44 42 39 
BMI, body mass index; CC, correlation coefficient; CDX-2, caudal type homeobox 2; IAF, 
intra-abdominal fat; LI, liver–intestine; SCF, subcutaneous fat; TFF-3, trefoil factor family 3; 
WC,waist circumference. 
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7.4 Discussion 
The main finding of this study was that in asymptomatic volunteers without a 
hiatus hernia, the length of cardiac mucosa lying between oesophageal 
squamous mucosa and gastric oxyntic mucosa increases with waist circumference 
and age.  There is debate regarding the origin of cardiac mucosa in apparently 
normal individuals, and whether its expansion with age may be a result of 
columnar (glandular) metaplasia of distal oesophageal squamous mucosa. The 
findings of our current study support the cardia arising in this way as it shows an 
almost identical immunophenotype to non-IM Barrett’s mucosa, which is 
considered to arise by metaplasia of the oesophageal squamous mucosa, induced 
by gastro-oesophageal acid reflux. 
To accurately measure the length of the cardiac mucosa we used biopsy forceps 
with an 8-mm jaw span and took a biopsy specimen perpendicular to the 
squamo-columnar junction, carefully oriented the sample, and then cut on edge. 
In some cases, the mucosa included the distal squamous mucosa but did not 
include oxyntic mucosa, and therefore we may have underestimated the mean 
length of non-oxyntic cardia mucosa. However, this should not affect the 
association with waist circumference, which we limited to those with accurately 
measured full-length non-oxyntic cardia mucosa. 
In our group of asymptomatic volunteers, we found that the cardiac mucosa was 
inflamed, showing infiltration with both acute and chronic inflammatory cells. In 
contrast, the oxyntic mucosa distal to the cardiac mucosa was not inflamed. 
Reactive atypia, an indicator of epithelial damage and repair, was most marked 
in squamous mucosa. Only 1 subject had evidence of intestinal metaplasia. 
Previous studies have reported inflammation of cardiac mucosa and attributed it 
to H pylori infection or gastro-oesophageal reflux disease138. However our 
subjects were H pylori negative and had no symptoms of reflux. We are not 
aware of either the length or inflammatory status of the cardiac mucosa having 
been studied in this subject group previously. 
We were able to assess the correlation of the cardiac mucosa length with a 
range of parameters of body size and fat distribution. There was no correlation 
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with body height, indicating it was not merely a reflection of skeletal size. 
There was a significant correlation with intra-abdominal fat, but not with 
subcutaneous fat, and after correcting for age only total abdominal fat remained 
significant. We recognize that intra-abdominal fat on its own explains only a 
relatively small part of the variance in cardiac mucosa length.  
The increasing length of the cardiac mucosa with age and waist circumference 
suggests that some or all of this mucosa is acquired throughout life. This 
possibility was suggested originally by Chandrasoma,8 who proposed that cardiac 
mucosa developed by gastro-oesophageal reflux, inducing squamo-columnar 
metaplasia of the distal oesophagus. Two features of the histologic appearance 
of the gastroesophageal junction in our current study are consistent with the 
lengthening of the cardiac mucosa being caused by changes affecting its 
proximal end where it abuts the oesophageal squamous mucosa. First, the 
subjects did not have H pylori infection, which might cause atrophy of adjacent 
oxyntic mucosa with loss of parietal cells. This atrophic mucosa, with loss of 
specialized parietal cells, would resemble cardiac mucosa producing apparent 
distal lengthening. Second, the inflammation was focused at the squamo-
columnar junction, suggesting local damage, which could result in proximal 
extension as a result of replacement of squamous mucosa by columnar mucosa. 
The mucosal changes we have observed at the gastro-oesophageal junction in 
our asymptomatic subjects with central obesity may be relevant to the aetiology 
of adenocarcinoma of the cardia and gastro-oesophageal junction. As mentioned 
earlier in the text, these cancers are associated with obesity and frequently 
present in subjects without evidence of traditional reflux. We found that cardiac 
mucosa showed identical staining to non-IM Barrett’s mucosa for six of the seven 
immunohistological markers of differentiation of GI epithelium. The only marker 
showing a slight difference was CDX-2, which had a slightly lower median value 
for cardia versus non-IM Barrett’s. In contrast, in IM Barrett’s CDX-2 expression 
was much higher than either with a median of 90% (IQR 50–90). The slightly 
higher value in the non-IM Barrett’s mucosa versus cardia might indicate some of 
the former starting to show evidence of progression to IM-type Barrett’s. 
Vallbohmer et al 143 have previously reported that Cdx-2 gene expression in 
cardiac mucosa lies between that of squamous mucosa and Barrett’s mucosa. 
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Unlike cardiac mucosa, the other gastric epithelia, that is, phenotypes, 
oxyntocardiac, oxyntic and antral, all differed from non-IM or IM Barrett’s with 
respect to at least three of the immunostains. Both non-IM Barrett’s and cardiac 
epithelium are known to develop and/or expand with increasing age, and the 
close similarity of cardiac and non-IM Barrett’s with respect to markers of 
differentiation is consistent with them being acquired by a similar process. 
In long-segment Barrett’s oesophagus, the mucosa is a patchwork of regions with 
intestinal and non-intestinal columnar metaplasia.144 Proximally, IM is most 
prevalent, whereas at the distal end, non-IM is more prevalent.144 Cardiac 
mucosa is at the most distal end of the oesophagus and therefore columnar 
metaplasia in this region would most typically be similar to non-IM rather than IM 
metaplasia. Glandular metaplasia of the oesophagus is regarded as an adaptation 
to the changing environment of the adjacent lumen. Predominance of IM at the 
proximal end of long-segment Barrett’s oesophagus is consistent with this region 
being exposed to less acidic reflux and thus developing mucosa more typical of 
the small or large intestine where the environment is much less acidic than that 
of the stomach. In contrast, the distal end of the oesophagus in patients with 
Barrett’s mucosa is exposed to levels of acidity similar to the stomach and 
therefore metaplasia similar to the antrum of the stomach may have an adaptive 
advantage. 
Only one of our subjects had evidence of intestinal metaplasia of the cardia, 
which traditionally has been regarded as a marker of malignant potential in 
patients with columnar-lined oesophagus. The carcinogenic potential of 
intestinal metaplasia vs non–goblet cell columnar (cardiac-type) metaplasia 
recently was challenged. A recent study of 141 patients who had endoscopic 
resection of early carcinoma at the gastro-oesophageal junction reported that 
70% had cardiac-type epithelium rather than intestinal metaplasia adjacent to 
the cancer.145 In addition, a retrospective study of 712 patients who had 
undergone previous biopsy studies of their distal oesophagus found a similar rate 
of adenocarcinoma over the subsequent 12 years in those with (45%) vs those 
without (36%) goblet cells in their oesophageal columnar epithelium.146 The 
changes we have observed in the cardia are occurring in the asymptomatic 
population and thus are many times more prevalent than traditional Barrett’s. 
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Even a small risk of malignant transformation therefore could result in a high 
burden of cancer cases. 
Previous studies have reported similarity between cardiac mucosa and non-IM 
Barrett’s mucosa. However, our current study differs from those studies in two 
respects. First, our study included healthy volunteers without gastro-
oesophageal acid reflux, whereas previous studies have involved patients with 
typical reflux symptoms,147 reflux oesophagitis,148 Barrett’s oesophagus 149 or 
oesophageal adenocarcinoma.150 Second, our current study has employed a more 
comprehensive panel of immunostains than the previous studies. Pereira et al 
used a panel of four immunostains (villin, sucrose isomaltae CK7 and CK20) and 
only the villin showed similarity of both mucosae.148 Chaves and colleagues used 
only antibodies against mucins (Muc-2, Muc-5ac and Muc-6).149 Lord et al used 
CK7, CK20 and DAS-1 as markers of Barrett’s plus other antibodies to assess 
dysplasia, which was not our interest.150 Theisen et al 151 used only Alcian blue to 
assess the presence of goblet cells in both mucosae. We believe our 
comprehensive panel of immunostains covered full ranges of cellular and 
histological changes in the cardiac and Barrett’s mucosae and also in other types 
of interest in the upper GI tract. 
Cardiac mucosa also resembled Barrett’s mucosa with respect to pattern and 
severity of inflammatory infiltrate. Acute and chronic inflammatory cell 
infiltrates in cardiac mucosa, IM and non-IM Barrett’s mucosa were similar and 
substantially greater than in any other upper GI mucosae in our H. pylori-
negative healthy volunteers. Likewise, reactive atypia, a marker of stress, was 
similar in cardiac mucosa, IM and non-IM Barrett’s mucosa and greater than in 
any other upper GI columnar mucosae. The similarity with respect to 
inflammation, reactive atypia and markers of differentiation all support the two 
mucosae being acquired by a similar mechanism. 
If the expansion of the cardia is arising by gastric acid damaging the most distal 
oesophageal squamous mucosa and resulting in metaplastic change, then one 
would expect to see evidence of damage and possibly early metaplasia of the 
oesophageal squamous mucosa at the SCJ. We found that the inflammatory cell 
infiltrate and rate of epithelial proliferation were most marked near to the SCJ. 
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We also observed evidence of expression of TFF-3 and LI-cadherin within the 
distal oesophageal squamous mucosa consistent with early columnar metaplasia 
or at least a wavering commitment to glandular differentiation. TFF-3 and LI-
cadherin especially were expressed by a small number of basal and immediately 
suprabasal cells. This could indicate transient expression by stem cells or early 
daughter cells, not maintained in later generations of transit-amplifying cells. If 
such glandular differentiation was maintained, rather than being switched off, it 
would represent a possible pathway to glandular metaplasia potentiated by 
obesity. 
In addition to the association seen between obesity and cardiac mucosal length 
we also observed associations between central obesity and the immunohistology 
of the GOJ. In the distal oesophageal squamous mucosa, the expression of the 
markers of glandular columnar differentiation (TFF-3 and LI-cadherin) correlated 
with WC and this was strongest when corrected for age, gender and cardia 
length. This is consistent with central obesity promoting squamo-columnar 
metaplasia close to the SCJ by mechanically inducing acid reflux within the 
region of the LOS and possibly also aggravated by humeral factors related to 
central obesity. 
In conclusion, we have shown that in the asymptomatic, moderately overweight 
population there is evidence of lengthening of the gastric cardiac mucosa. The 
immunohistological changes observed at the GOJ provide further support for 
gastric acid causing damage and columnar metaplasia of the distal oesophageal 
mucosa. This inflammation and metaplasia occurring at the SCJ in apparently 
healthy volunteers may be relevant to the high proportion of junctional 
adenocarcinoma that present in subjects without a history of reflux disease. 
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8 Central Obesity in Asymptomatic Volunteers 
is associated with Intrasphincteric Acid 
Reflux without Traditional Reflux 
8.1 Introduction 
Oesophageal adenocarcinoma is believed to develop from columnar metaplasia 
of oesophageal squamous epithelium (Barrett’s oesophagus), resulting from 
gastro-oesophageal reflux of acid and possibly bile. Reflux occurs when there is 
complete loss of lower oesophageal sphincter (LOS) tone, allowing gastric juice 
to flow up into the body of the oesophagus. This transsphincteric reflux occurs 
most commonly during transient lower oesophageal sphincter relaxations 
(TLOSRs). 
There is a strong association between oesophageal adenocarcinoma and both 
body mass index (BMI) and waist circumference.81, 84 This may be explained 
partly by these morphometric characteristics being associated with impaired 
function of the lower oesophageal sphincter.118-120 In addition, increased visceral 
fat might promote the carcinogenic pathway by humoral mechanisms. 112 
Most cases of adenocarcinoma at the gastro-oesophageal junction are in 
individuals without a prior history of gastro-oesophageal reflux disease or 
Barrett’s oesophagus34, 35, 60 suggesting that mechanisms other than traditional 
reflux may be important. We previously suggested that pathology occurring at 
the gastro-oesophageal junction might be related to opening of the distal 
segment of the lower oesophageal sphincter, allowing ingress of gastric juice, 
while the more proximal segment of the sphincter retains tone, preventing 
transsphincteric reflux.27, 152 
We have described lengthening of the cardiac mucosa at the gastro-oesophageal 
junction in healthy volunteers in association with age and obesity.153 We have 
also demonstrated similarities between cardiac mucosa and non-IM Barrett’s 
oesophagus suggesting that the cardiac mucosa may be a pathological 
phenomenon acquired over time by a process of metaplasia of distal squamous 
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mucosa.154 The short length of cardiac mucosa and its circumferential pattern 
also would fit with it arising from the opening of the most distal segment of the 
lower oesophageal sphincter rather than by conventional reflux. 
The aim of this current study was therefore to determine whether central 
obesity disrupts the structure and functioning of the distal segment of the lower 
oesophageal sphincter, allowing acid ingress without transsphincteric reflux. To 
avoid confusion related to H pylori–induced histologic changes in the proximal 
stomach, we limited our study to subjects without the infection. In addition, 
because we were interested in subjects without traditional reflux, we also 
excluded subjects with hiatus hernia. 
8.2 Methods 
8.2.1 Study Subjects 
The study volunteers were recruited and allocated to 2 groups defined by normal 
or increased waist circumference as previously outlined. (7.2.1.1) 
8.2.2 Study Protocol 
8.2.2.1 Study Days 1 and 2 
As part of the full study protocol study volunteers attended on two initial study 
days as outlined in chapter 7. On the first visit anthropometric assessment was 
carried out and MRI scans performed for assessment of fat volume and 
distribution. On the second, upper GI endoscopy with biopsies was performed. At 
the time of endoscopy the squamo-columnar junction was marked by 2 endoclips 
(HX-610-135; Olympus, Southend-on-Sea, UK) to allow subsequent fluoroscopic 
visualisation. 
8.2.2.2 Study Day 3: combined recording of pH and manometry. 
After a 12-hour fast, a combined high-resolution manometry catheter and high-
resolution pH catheter was passed nasally. Recordings were taken for 15 minutes 
fasting with subjects seated in an upright position and for a further 15 minutes 
supine. Subjects then consumed a standardized meal over a 20-minute period 
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and were asked to eat until full. The meal consisted of battered fish and chips 
with 150 mL of water. After the meal, combined recording of pH and pressure 
was continued for 45 minutes with patients in an upright position and for 30 
minutes supine. In each of the 4 periods of recording (fasting upright, fasting 
supine, post-prandial upright, and postprandial supine), fluoroscopic screening 
was performed for 30 seconds to visualize the endoscopically placed clips. 
8.2.2.3 Equipment 
High-resolution pH-metry: pH recordings were taken using a high-resolution 
custom-made pH probe, composed of 12 antimony pH electrodes (Synectics 
Medical, Ltd, Enfield, UK). The most distal pH electrode was placed at the tip of 
the catheter and the other 11 electrodes were 30, 50, 61, 72, 83, 94, 105, 116, 
127, 138, and 172 mm proximal to it. Recordings were captured using polygram 
net software (Synectics Medical). 
High-resolution manometry:  Manometry was performed using a solid-state high-
resolution manometry system with 36 circumferential sensors spaced at 10-mm 
intervals (Manoscan A100; Sierra Scientific Instruments, Los Angeles, CA). To 
compensate for thermal drift, calibration was performed weekly and an 
additional tailored linear correction was applied to collected data.135 
The Combined Probe and its Positioning: The manometry and pH probes were 
combined so that pH sensor 7 corresponded to manometer sensor 29. The 
combined probe was positioned so that the 9 closely spaced (11-mm apart) pH 
sensors straddled the lower oesophageal sphincter and the most proximal pH 
sensor was 5 cm proximal to the upper border of the lower oesophageal 
sphincter. 
Fluoroscopy: Fluoroscopic images were obtained using the Siemens portable C 
arm (Siemens, Surrey, UK). Images were uploaded onto our in-house picture 
archiving and communication system (PACS) for further analysis. 
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8.2.3 Data Analysis 
8.2.3.1 MRI Scans: 
Images were taken in 3 axial planes at the level of the second, third, and fourth 
lumbar vertebrae and assessed by 2 independent GI radiologists. Fat 
quantification was performed with commercially available software (Tomovision 
Slice-o-matic, Magog, Quebec, Canada). The presence or absence of a hiatus 
hernia on MRI was defined as the identification of the gastro-oesophageal 
junction proximal to the diaphragmatic hiatus.  
The positions of the diaphragmatic hiatus and the dome of the left hemi-
diaphragm were measured relative to the lumbar vertebrae. 
8.2.3.2 Acid exposure  
The mean pH was calculated for each of the 12 pH sensors for each phase of the 
study. For the postprandial data the recording period from 30 to 45 minutes was 
used to represent the post-prandial upright position and the period from 45 to 60 
minutes was used to represent the post-prandial supine position. The pH 
transition point within the gastro-oesophageal junction was defined by the index 
sensor recording a decrease in mean pH of at least 1 unit from proximal to distal 
and corrected for 1.1-cm spacing between sensors.  
Acid exposure was examined at the pH transition point as the mean percentage 
of time the pH was less than 4. The location of the pH transition point was 
determined relative to the upper border of the LOS. Acid exposure also was 
determined at the following points:  
1. The traditional site 5 cm above the upper border of the LOS,  
2. The sensor 1.1 cm proximal to the pH transition point, and 
3. The sensors distal to the pH transition point.  
Traditional acid reflux was considered present where the sensor 5 cm proximal 
to the LOS recorded a mean percentage of time the pH was less than 4 of at 
least 4%. Short-segment acid reflux was considered present if the sensor 1.1 cm 
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proximal to the pH transition point recorded a mean percentage of time the pH 
was less than 4 of at least 4%. 
8.2.3.3 Manometry  
For each of the 4 phases of the study the period during fluoroscopic recording 
was analysed in detail. Six inspiratory and 6 end-expiratory points were selected 
using a custom-made computer program.  
 The lower border of the LOS was defined as the first sensor moving 
proximally from the stomach where the pressure increased to more than 
2mmHg above gastric baseline.  
 The upper border of the LOS was defined by a decrease in pressure to 
within 2 mm Hg of intra-gastric pressure. 
 Intragastric pressure (IGP) (mm Hg) was calculated on expiration and 
defined as the median pressure of the first 3 sensors immediately distal to 
the lower oesophageal sphincter. 
 The pressure inversion point (PIP) was defined as the first sensor moving 
from the lower oesophageal sphincter proximally toward the oesophageal 
sensors showing a pressure fall with inspiration. 
 Proximal and distal LOS lengths were determined using the PIP as 
reference point. 
 Transient Lower Oesophageal Relaxations (TLOSRs) were identified by 
visual inspection of the manometry trace and defined by Holloways 
criteria16:  
o absence of swallowing for 4 seconds before to 2 seconds after the 
onset of LOS relaxation 
o relaxation rate of at least 1mmHg/s 
o Time from onset to complete relaxation of at least 10 seconds 
o Nadir pressure of less than or equal to 2mmHg 
For distances measured from the nares, the midpoint between inspiration and 
expiration was used and 0.5 cm was added to correct for the error associated 
with the 1-cm spacing of the sensors. 
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8.2.3.4 Fluoroscopy.  
The position of the squamo-columnar junction (SCJ) was derived from 
fluoroscopic images using the manometric sensors as reference and internal 
scale. This was calculated for the midpoint between inspiration and expiration 
and was expressed both relative to the nares and to the upper border of the 
LOS. 
8.2.4 Statistical Analysis 
Results are presented as mean and standard error or median and interquartile 
range according to normal or non-normal distribution respectively. Comparison 
of variables between groups was made using the Mann–Whitney U test. For all 
correlations between 2 continuous variables, the Spearman Rho bivariate 
correlations were used.  
8.2.5 Ethics 
The study protocol was approved by the West of Scotland ethics committee and 
all volunteers provided written informed consent. 
8.3 Results 
Fifty one volunteers without hiatus hernia completed the study protocol: 24 
volunteers (12 females) in the small WC group and 27 volunteers (13 females) in 
the large WC group. 
The median age in the group with the small WC was 45 years (21y–73 y) and in 
the large WC group the median age was 46 years (21y–71 y) (P=0.610). The 
median BMI was 23.6 kg/m2 in the small WC group (16.7–26.7 kg/m2) and 30.5 
kg/m2 in the large WC group (25.3–43.3 kg/m2) (P < 0.001). 
8.3.1 Obesity and Acid Reflux 
The percentage of time the pH was less than 4 at 5 cm proximal to the LOS was 
0.1% (SE, 0.04) for fasting upright, 1.0% (SE, 0.06) for fasting supine, 1.3% (SE, 
0.44) for post-prandial upright, and 0.8% (SE, 0.63) for postprandial supine. 
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There was no significant excess of transsphincteric traditional reflux seen in the 
large WC group (Table 8.1, all P > 0.05).  When the relationship between cardiac 
mucosal length measured in these volunteers previously and transsphincteric 
reflux was assessed, no significant association was seen (fasting upright, P = 
0.386; fasting supine, P = 0.109; postprandial upright, P=0.464; post-prandial 
supine, P = 0.702). 
The pH transition point was determined by the position of the most proximal of 
the 12 pH sensors showing a mean pH decrease of 1 unit. As shown in Table 8.1, 
this sensor was the first showing an abrupt change from oesophageal to gastric 
pH. At the sensor located 1.1 cm proximal to the pH transition point there was 
some evidence of short-segment reflux in the post-prandial phase in the group as 
a whole (the percentage of time the pH < 4 was 4.2% [SE, 0.7] for postprandial 
upright, the percentage of time the pH < 4 was 5.6% [1.6] for post-prandial 
supine) (Table 8.1). Short segment reflux was similar in both groups (all P > 
0.05). 
8.3.2 Obesity and Manometric Measures 
8.3.2.1 IGP.  
IGP was significantly greater in the large WC group in the fasting state and post-
prandial supine (Table 8.2) 
8.3.2.2 LOS Length.  
The total LOS length was shortened in the large WC group for fasting upright and 
post-prandial supine postures (Table 8.2). There was no difference between the 
groups in the length of the intra-abdominal LOS or intrathoracic LOS measured 
with reference to the pressure inversion point (PIP). By using the position of 
peak pressure as a reference point, significant shortening of the distal LOS was 
seen in the post-prandial phase in the large WC group with a strong trend for 
distal shortening in the fasting upright phase (Table 8.2) 
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8.3.2.3 LOS Pressure.   
No differences were shown between the groups in LOS pressure measured 
relative to the IGP (Table 8.2). 
8.3.2.4 PIP position.  
The distance from the nares to the PIP was similar between the small and large 
WC groups (Table 8.2) 
8.3.2.5 TLOSRs.  
TLOSRs were infrequent in the fasting state with a median of 1 (IQR, 1) seen in 
the upright posture and 0 (IQR, 0) supine. In the first 45 minutes after the meal 
a median of 7 TLOSRs were observed (IQR, 4) and a further 1 (IQR, 1) in the 
supine posture. No significant differences were seen between the groups in 
frequency of TLOSRs (Table 8.2)  
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TABLE 8.1: MEAN ACID EXPOSURE TIME IN SENSORS LOCATED 5 CM ABOVE THE UPPER BORDER OF THE LES, SENSORS DETECTING PH TRANSITION POINT, AND THE 
SENSORS 1.1 CM PROXIMAL AND 1.1, 2.2, AND 3.3 CM DISTAL TO THE PH TRANSITION POINT 
Sensor Location 
Total Large WC Small WC 
FU FS PPU PPS FU FS PPU PPS FU FS PPU PPS 
Proximal 
5cm 0.1 (0.04) 0.1 (0.06) 1.4 (0.50) 0.9 (0.73) 0.1 (0.04) 0.1 (0.04) 0.9 (0.79) 0 (0) 0.2 (0.08) 0.1 (0.12) 1.7 (0.65) 1.6 (1.27) 
1.1cm 3.9  (0.8) 
 
4.0  (0.9) 4.7  (0.7) 6.1  (1.8) 4.2 (1.4) 4.4 (1.3) 4.5  (1.4) 6.7 (3.3) 3.6  (0.9) 3.5  (1.1) 4.8  (0.9) 5.6  (1.8) 
pH 
Transition 
Point 
0 37.9 (3.7) 
 
42.9 (4.2) 58.5 (5.3) 50.6 (4.8) 35.4 (4.9) 47.8 (6.0) 55.0 (8.2) 51.0 (7.2) 40.7 (5.7) 37.6 (5.6) 61.2 (7.0) 50.2 (6.5) 
Distal 
1.1cm 71.0 (4.2) 70.3 (4.5) 71.2 (5.3) 76.3 (5.0) 73.2 (5.7) 72.1 (5.8) 72.2 (8.1) 81.7 (7.4) 68.6 (6.2) 68.3 (7.0) 70.3 (7.3) 72.0 (6.8) 
2.2cm 81.1 (4.0) 87.5 (3.0) 65.3 (6.1) 76.4 (5.2) 79.9 (5.7) 92.2 (2.3) 65.5 (9.5) 75.2 (7.5) 83.4 (5.6) 82.6 (5.6) 65.2 (8.0) 77.3 (7.3) 
3.3cm 85.1 (3.9) 97.8 (0.7) 49.0 (7.1) 
 
64.9 (6.4) 87.5 (5.3) 98.1 (0.7) 56.8(10.7) 73.7 (8.1) 82.3 (5.9) 97.4 (1.3) 42.2 (9.3) 57.6 (9.6) 
NOTE. The mean acid exposure time is calculated as follows: percentage of time the pH value is less than 4. The SE is shown in parentheses. FS, fasting supine; FU, fasting 
upright; PPU, postprandial upright; and PPS, postprandial supine. 
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TABLE 8.2 SUMMARY OF DIFFERENCES BETWEEN LARGE AND SMALL WC GROUPS FOR MANOMETRIC 
MEASURES 
  Small WC Large WC Sig. 
     
IGP (mmHg) FU 9.0 (IQR 4.6) 11.1 (IQR 5.1) p=0.020 
FS 8.7(IQR 4.9) 10.3 (IQR 3.4) p=0.017 
PPU 10.7 (IQR 3.2) 11.6 (IQR 4.4) p=0.083 
PPS 8.9 (IQR 4.4) 11.1 (IQR 3.9) 
 
p=0.001 
LOS Length (cm) FU 6 (IQR 2) 4 (IQR 2) p=0.016 
FS 5 (IQR 2) 5 (IQR 1) p=0.254 
PPU 4 (IQR 3) 3 (IQR 2) P=0.298 
PPS 4.5 (IQR ) 3 (IQR 3) 
 
p=0.043 
Length Distal 
Component LOS 
(cm) 
 
FU 2.82 (2.27-3.38) 2.12 (1.63-2.61) p=0.066 
FS 2.72 (2.20-3.23) 2.34 (1.87-2.81) p=0.327 
PPU 2.36 (1.91-2.81) 1.69 (1.25-2.13) p=0.026 
PPS 2.17 (1.78-2.57) 1.52 (1.06-1.98) 
 
P=0.039 
LOS Pressure  
(mmHg vs IGP) 
FU 21.9 (IQR 15.9) 18.1 (IQR 16.6) p=0.165 
FS 24.4 (IQR 14.9) 17.9 (IQR 6.0) p=0.163 
PPU 9.1 (IQR 9.3) 11.2 (IQR 11.7) p=0.985 
PPS 16.5 (IQR 13.9) 15.7 (IQR 8.1) 
 
p=0.657 
Nares to PIP 
(cm) 
FU 45.5 (4.5) 44.5 (2.0) p=0.118 
FS 46.5 (4.25) 45.5 (3.5) p=0.319 
PPU 44.5 (4.25) 43.5 (3.0) p=0.382 
PPS 45.5 (4.25) 44.5 (4.0) 
 
P=0.333 
TLOSRs 
(Number) 
FU 1 (IQR 1) 0 (IQR 1) p=0.146 
FS 0 (IQR 0) 0 (IQR 0) p=0.279 
PPU 7 (IQR 3) 6 (IQR 4) p=0.157 
PPS 1 (IQR 1) 1 (IQR 1) 
 
p=0.901 
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8.3.3 Obesity and Diaphragm Position by MRI 
8.3.3.1 Obesity and the Position of the Dome of the Left Hemidiaphragm. 
 In the fasting state, the median diaphragm position in the large WC group was 
close to the upper margin of T9 (9.125; IQR, 1.19) whereas in the small WC 
group it was close to the upper margin of T10 (10.2; IQR, 0.75) (P =0.001), 
representing a difference of 26 mm155. A similar difference of 24 mm was 
observed postprandially. 
8.3.3.2 Obesity and the position of the diaphragmatic hiatus.  
The position of the diaphragmatic hiatus was similar between groups, being at 
the level of the 10th thoracic vertebrae for fasting and post-prandial states.  
8.3.4 Obesity and the location of the pH transition point 
The pH transition point was more proximal within the LOS in the group with a 
large WC compared with the small WC group (Table 8.3, Figure 8.1). In addition, 
gastric acid extended further up with respect to the location of the peak LOS 
pressure being distal to it in the small WC group, but at or above it in those with 
a large WC (Table 8.3, Figure 8.1). The positions of the upper border of the LOS 
and the peak LOS pressure relative to the nares were similar in large vs small WC 
groups (Table 8.3). 
Intra-abdominal fat and total fat were correlated strongly with a more proximal 
pH transition point (Table 8.4). BMI was associated with a shorter distance 
between the upper border of the LOS and acid in the postprandial setting. For 
subcutaneous fat this association was significant for the fasting upright phase 
only (Table 8.4). In the fasting supine state a negative correlation was seen 
between age and the position of the pH transition point, indicating more 
proximal acid ingress with increasing age (R = -0.286; P =0.044). No significant 
variation was seen by sex. 
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8.3.5 Obesity and location of the SCJ 
The SCJ was significantly closer to the upper border of the LOS and to the PIP in 
the large vs small WC subjects (Table 8.3, Figure 8.1). In addition, the SCJ was 
closer to the peak LOS pressure in the large WC subjects (Table 8.3, Figure 8.1). 
There was no difference between the groups with respect to the relative 
positions of the SCJ and pH transition point. 
 
 
FIGURE 8.1: ALTERATIONS IN THE GASTROINTESTINAL JUNCTION ASSOCIATED WITH INCREASED 
WAIST CIRCUMFERENCE. THE POSITION OF THE SCJ IS INDICATED BY A WHITE LINE. THE HIGH-
PRESSURE ZONE OF THE LOS IS REPRESENTED BY THE 2 VERTICAL SHADED COLUMNS AND THE 
POSITION OF THE PEAK LOS PRESSURE BY THE FACING APICES OF THE SHADED TRIANGLES. ACID, 
GASTRIC ACIDITY IS REPRESENTED BY THE SHADED AREA. THE SIGNIFICANCE VALUES FOR THE 
POSITION OF THE SCJ AND PH TRANSITION POINT ARE RELATIVE TO UPPER-BORDER LOS. DATA 
ARE BASED ON MEDIAN POSTPRANDIAL SUPINE VALUES. 
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TABLE 8.3: RELATIVE POSITIONS OF COMPONENTS OF THE LOS, PH TRANSITION POINT, AND SCJ 
  Small WC Large WC Sig. 
Nares to Upper Border LOS 
(cm) 
 
 
  
FU 44.0 (IQR 4.3) 44.0 (IQR 2.5) p=0.639 
FS 45.0 (IQR 4.8) 44.0 (IQR 3.0) p=0.699 
PPU 43.5 (IQR 4.0) 42.3 (IQR 3.9) p=0.063 
PPS 44.5 (IQR 4.0) 
 
43.5 (IQR 3.5) p=0.311 
Nares to Peak LOS Pressure 
(cm) 
FU 46.5 (IQR 4.5) 45.5 (IQR 2.5) p=0.373 
FS 47.0 (IQR 4.0) 46.0 (IQR 3.5) p=0.469 
PPU 45.5 (IQR 4.8) 44.0 (IQR 4.3) p=0.051 
PPS 46.5 (IQR 4.5) 
 
45.5(IQR 4.0) p=0.226 
Upper Border LOS to Peak 
LOSP (cm) 
FU 2.00 (IQR 0.50) 2.00 (IQR 1.00) p=0.435 
FS 2.00 (IQR 1.00) 2.00 (IQR 1.00) p=0.771 
PPU 2.00 (IQR 1.00) 1.50 (IQR 0.88) p=0.350 
PPS 2.00 (IQR 0.50) 
 
1.50 (IQR 0.50) p=0.133 
pH Transition Point from 
Upper Border LOS(cm) 
 
FU 4.1 (IQR 2.3) 2.65 (IQR 2.8) p=0.027 
FS 3.0 (IQR 3.3) 2.3 (IQR 2) p=0.051 
PPU 2.9 (IQR 1.4) 1.6 (IQR 2.3) p=0.011 
PPS 3.2 (IQR 1.9) 1.8 (IQR 1.5) 
 
p=0.002 
pH Transition Point from Peak 
LOSP (cm) 
FU 2.0 (IQR 2.30) 0.55 (IQR 2.83) p=0.058 
FS 1.4 (IQR 4.10) 0.4 (IQR 2.10) p=0.047 
PPU 0.9 (IQR 1.65) -0.1(IQR 2.30) p=0.042 
PPS 1.2 (IQR 1.90) 
 
-0.1 (IQR 1.62) p=0.007 
SCJ from Upper Border LOS 
(cm) 
FU 3.54 (IQR 1.49) 2.77 (IQR 1.04) p=0.023 
FS 3.42 (IQR 1.77) 2.89 (IQR 1.80) p=0.017 
PPU 3.02 (IQR 1.58) 2.85 (IQR 1.01), p=NS 
PPS 3.34 (IQR 1.73) 
 
2.20 (IQR 1.40), p=0.004 
SCJ from PIP(cm) FU 2.87 (1.15) 1.94 (0.88) p=0.003 
FS 2.31 (2.49) 1.47 (1.22) p=0.025 
PPU 2.59 (1.98) 2.20 (0.95) p=0.041 
PPS 3.1 (1.66) 
 
1.62 (1.51) p=0.005 
SCJ from peak LOSP(cm) FU 1.3 (1.5) 0.7(IQR 1.1) p=0.05 
FS 1.42 (1.8) 0.59 (IQR 1.46) p=0.011 
PPU 1.15 (1.90) 1.06 (0.76) p=0.395 
PPS 1.23 (1.58) 
 
0.58(1.24) P=0.017 
pH Transition Point from SCJ 
(cm) 
FU 0.56 (IQR 2.66) -0.36 (IQR 2.58) p=0.202 
FS 0.28 (IQR 2.32) 0.05 (IQR 2.80) p=0.297 
PPU -0.20 (IQR 2.25) -1.03 (IQR 2.29) p=0.250 
PPS -0.18 (IQR 1.46) 
 
-0.81 (IQR 2.11) p=0.276 
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TABLE 8.4: CORRELATIONS BETWEEN PARAMETERS OF OBESITY AND THE POSITION OF THE PH 
TRANSITION POINT RELATIVE TO THE UPPER BORDER OF THE LOS 
  Parameters of Obesity 
 
 
 
  BMI SCF IAF Total Fat 
P
o
si
ti
o
n
 o
f 
p
H
 T
ra
n
si
ti
o
n
 
P
o
in
t 
FU 
 
R 
P 
-0.243 
0.086 
 
-0.304  
0.034 
-0.271 
0.059 
-0.328 
0.021 
FS R 
P 
-0.196 
0.173 
 
-0.180 
0.220 
-0.378 
0.008 
-0.294 
0.042 
PPU R 
P 
-0.327 
0.019 
 
-0.212 
0.413 
-0.371 
0.009 
-0.325 
0.023 
PPS R 
P 
-0.345 
0.013 
 
-0.281 
0.051 
-0.473 
0.001 
-0.433 
0.002 
FS, fasting supine; FU, fasting upright; PPS, postprandial supine; PPU, post-prandial upright; 
SCF, subcutaneous fat. IAF, intra-abdominal fat; 
8.4 Discussion 
This study demonstrates a novel mechanism for acid damage at the gastro-
oesophageal junction associated with obesity in otherwise healthy asymptomatic 
volunteers.  In those with a large waist circumference, there was acid influx 
within the lower oesophageal sphincter (intrasphincteric reflux) without the 
complete loss of sphincter tone characteristic of traditional (transsphincteric) 
reflux. This mechanism may underlie the mucosal changes at the junction 
previously demonstrated in association with obesity in this group. 
Traditional reflux measured at 5cm above the gastro-oesophageal junction was 
not a feature in either group. However our subjects with a large waist 
circumference did have a number of abnormalities of the gastro-oesophageal 
junction and intrasphincteric acidity, which could explain the previously 
described lengthening of the cardiac mucosa. The LOS was shorter in those with 
a large WC and our data indicated that this was from loss of the distal 
component of the LOS, especially after a meal. In addition, in these subjects, 
gastric acid extended more proximally within the LOS relative to both the upper 
border of the LOS and peak LOS pressure.  In the small WC subjects, the leading 
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edge of gastric acidity only came to within 1–2 cm distal to the point of peak LOS 
pressure, whereas in those with a large WC it reached this point. This leading 
edge of gastric acidity represented a pH value of less than 4 for 40%–52% of 
recorded time. The association with intrasphincteric acid extension was 
strongest for MRI measurement of intra-abdominal fat and total abdominal fat. 
The SCJ also was positioned more proximally within the LOS with respect to the 
upper border of the LOS and peak LOS pressure in obese subjects. This more 
proximal positioning of the SCJ within the LOS could be due to 2 separate 
mechanisms, or more likely a combination of both. The first is proximal 
displacement of the gastro-oesophageal junction within the diaphragmatic hiatus 
similar to a very early or partial hiatus hernia. The second is proximal migration 
of the SCJ relative to the gastro-oesophageal junction as a result of proximal 
lengthening of the cardiac mucosa. 
The abnormalities observed at the gastro-oesophageal junction in the large WC 
group are likely to be explained by the increase in intra-abdominal pressure 
associated with central obesity and documented in our subjects by their 
increased intra-gastric pressure. Evidence of the effect of the increased intra-
abdominal pressure was the marked proximal displacement of the dome of the 
costal diaphragm being 2.6 cm higher in the obese group. In contrast, the 
position of the diaphragmatic hiatus was not displaced proximally, presumably 
because of the tethering of the crura to the nearby spinal column. It thus 
appears that the increased intra-abdominal pressure is compressing the GOJ into 
the undisplaced diaphragmatic hiatus, causing distortion and dysfunction. 
The mechanism of the proximal extension of gastric acid within the LOS is 
unclear but there are several possibilities. First, it could be due to increased 
intra-abdominal pressure prying open the distal segment of the LOS while the 
proximal segment remains closed, thus preventing full transsphincteric reflux. 
This is supported by the shortening of the LOS seen in those with large WC and 
caused by shortening of the distal component. Second, some of the 
intrasphincteric acid could be due to a proximal displacement of the GOJ within 
the diaphragmatic hiatus and thus the leading edge of acid-secreting gastric 
mucosa lying more proximally within the high-pressure zone. Finally, it is 
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possible that the deformity of the GOJ impairs the normal distal flow of acid 
secreted by mucosa within the sphincter and permits it to flow back up into the 
sphincter and toward the oesophageal squamous mucosa. This is supported by 
the altered juxtaposition of the intrasphincteric acid and peak LOS pressure seen 
in the group with large WC, with their pH transition point being at or above their 
peak sphincter pressure. 
The proximal extension of gastric acid within the LOS provides a plausible 
explanation for the lengthening of the cardiac mucosa153. Exposure of the most 
distal oesophageal squamous mucosa to gastric acid will damage it and with time 
cause it to be replaced with columnar mucosa suited to an acidic environment.  
Unlike Barrett’s oesophagus, the proximal extension of columnar mucosa 
associated with central obesity is confined to the intrasphincteric region of the 
distal oesophagus. Likewise, the proximal extension of acid in our asymptomatic 
subjects with central obesity is occurring within the LOS and is not traversing it 
as occurs with traditional reflux disease. This proximal extension of acidity 
within the LOS might be referred to as intrasphincteric reflux, as opposed to 
traditional (transsphincteric) reflux. 
The lack of heartburn in our healthy volunteers despite the intrasphincteric 
acidification is interesting. It has been shown previously that the severity of 
symptoms correlated positively with the extent that the reflux extends up the 
oesophagus46  This very short segment intrasphincteric reflux therefore may not 
activate sufficient nerve endings to reach consciousness. In addition, or 
alternatively, the extension of the cardiac mucosa with replacement of 
squamous mucosa by columnar mucosa may in itself provide some protection 
from symptom generation with short-segment acid reflux. 
In conclusion, we have shown that in the asymptomatic, moderately overweight 
population without evidence of traditional reflux there is proximal extension of 
gastric acid within the lower oesophageal sphincter without traditional acid 
reflux. This mechanism may underlie the observed lengthening of the cardiac 
mucosa in this group. These findings may be relevant to adenocarcinoma at the 
gastro-oesophageal junction which is associated with obesity and frequently 
presents in subjects without a history of reflux disease. 
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9 Hiatus Hernia in Healthy Volunteers is 
Associated with Intrasphincteric Reflux and 
Cardiac Mucosal Lengthening without 
Traditional Reflux  
9.1 Introduction 
Hiatus hernia is a key mediator of acid reflux. Although there is an extensive 
literature on the effect of hiatus hernia on lower oesophageal sphincter function 
in subjects presenting with reflux symptoms, 9, 24, 26 there is little on the effects 
of hiatus hernia detected in healthy volunteers.  
In our previous studies, 10 volunteers had a hiatus hernia on MRI scanning and 
were excluded from analysis153. If proximal extension of cardiac columnar 
mucosa and intrasphincteric acid exposure is indeed due to dysfunction of the 
lower oesophageal sphincter caused by age and/or central obesity, then similar 
changes may occur in subjects with lower oesophageal sphincter dysfunction due 
to hiatus hernia. 
In this current study we have examined the anatomy and physiology of the 
gastro-oesophageal junction in our healthy volunteers with hiatus hernia and 
compared them with healthy volunteers without hiatus hernia, matched for age, 
sex and central obesity.  
9.2 Methods 
As part of the previous study we recruited 61 healthy volunteers negative for 
Helicobacter Pylori and without known gastroesophageal reflux. Fifteen 
volunteers who completed the full study protocol were found to have a hiatus 
hernia; ten diagnosed by MRI, 12 by endoscopy and 7 by both modalities. The 
subgroup diagnosed by MRI was excluded from the original analysis. In this study 
we compared these volunteers who had a hiatus hernia with age and sex 
matched controls from the original study cohort.  
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9.2.1 Study Protocol 
9.2.1.1 Study Day 1: Clinical and MRI Assessment 
Clinical details were recorded including demographics and anthropometric 
measures. Volunteers completed a validated survey reporting reflux 
symptoms127. MRI scans of the abdomen were performed (Philips 1.5T MRI 
scanner, Surrey, UK) before and forty-five minutes after a standardised meal 
consisting of fried battered fish and chips. A hiatus hernia was identified when 
the gastro-oesophageal junction was proximal to the diaphragmatic hiatus. 
Where present on MRI, the length of the hiatus hernia was documented. In 
addition, the diameter of the gastro-oesophageal junction at the diaphragmatic 
hiatus was measured in all participants. 
9.2.1.2 Study Day 2: Endoscopy with Biopsies and Placement of Radio-opaque 
Clip 
Volunteers attended after an overnight fast. Upper GI endoscopy was carried out 
using standard equipment with throat spray or intravenous sedation according to 
volunteer preference. Anatomy of the upper GI tract was examined and hiatus 
hernia defined endoscopically as separation of the diaphragmatic indentation 
and the top of the gastric folds by at least 2cm. Where hiatus hernia was 
identified its length was measured and recorded. Biopsies were taken across the 
squamo-columnar junction (SCJ) in a cranio-caudal direction to include both 
squamous mucosa and glandular mucosa in the same sample. Intra-procedure 
pathology feedback of biopsy accuracy was available and up to three biopsies 
were taken to achieve an optimal sample allowing measurement of cardiac 
mucosal length. Finally the SCJ was marked by two endoclips (HX-610-135; 
Olympus, Southend-on-Sea, UK). Biopsies were carefully orientated for 
histological processing as previously described (5.2.3) 
9.2.1.3 Study Day 3: Combined pH and Manometry with Fluoroscopy 
Volunteers attended after an overnight fast. A combined high resolution 
manometry and pH probe was passed through the anaesthetised nostril. The pH 
probe used was customised for purpose and made up of 12 pH sensors (Synectics 
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Medical, Enfield, UK). Manometry recordings were taken using a high resolution 
probe comprising 36 solid state sensors. The probes were combined in a 
standardised way to allow correlation of pressure and pH findings. Recordings 
were taken for 15 minutes with volunteers seated in the upright posture and 15 
minutes supine. Volunteers then consumed the same standardised meal as on 
study day 1 and were asked to eat until full. After the meal, recordings were 
continued for 45 minutes seated upright and a further 30 minutes supine. 
Fluoroscopy was performed for thirty seconds during each phase to allow 
visualisation of the endoscopically placed clip. 
9.2.2 Data Analysis 
9.2.2.1 Cardiac Mucosal Length 
The cardiac mucosa was considered ‘fully measurable’ where consecutive 
squamous, cardiac and glandular mucosal types were present in continuity in the 
same biopsy. Specimens were considered ‘measurable’ if squamous mucosa and 
cardiac mucosa were present in continuity within the same biopsy. A third 
category of ‘not analysable’ was allowed where none of the samples taken had 
at least two mucosal subtypes in continuity within the same biopsy. Samples 
defined as ‘not analysable were not included in the measurement of cardiac 
mucosal length. 
The cardiac mucosa was defined as columnar epithelium devoid of parietal cells. 
The proximal demarcation of cardiac mucosa at the SCJ was clear and the distal 
limit was taken as the appearance of parietal cells. The cardiac mucosal length 
was measured using an ocular micrometer by two independent GI pathologists 
(JJG, MHD) blinded to clinical characteristic of the volunteer. 
9.2.3 Inflammatory Scores 
Biopsies were semi-quantitatively scored for acute and chronic inflammation and 
for reactive atypia, a measure of cell turnover and repair, using scores of 0-3 as 
follows; 0=absent, 1=mild, 2=moderate, 3=severe. Acute inflammation was 
defined by the presence of polymorphs and chronic by a monocytic infiltrate. 
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9.2.4 Acid Data 
To measure intrasphincteric acid position, the mean pH was calculated for each 
of the twelve sensors for each phase of the study. The first pH sensor recording 
a mean pH drop of 1 unit was identified. This was termed the pH transition 
point. We have previously shown that this point represents the abrupt transition 
from oesophageal to gastric pH. The position of this sensor relative to the upper 
border of LOS, the SCJ and the peak LOS pressure was measured. Distances were 
corrected for 1.1cm spacing of pH sensors. 
Acid exposure also was determined at the following points:  
(1) The traditional site 5 cm above the upper border of the LOS 
(2) The sensor 1.1cm proximal to the sensor detecting the pH transition point  
These sites were defined as detecting traditional and short segment reflux 
respectively. Traditional acid reflux was considered present where the pH was 
below 4 at least 4% of the time at the sensor 5cm proximal to the upper border 
LOS and short segment reflux where the pH was less than 4 at least 4% of the 
time in the sensor 1.1cm proximal to the pH transition point.   
9.2.5 Prevalence of the Double Peaked Pressure Profile 
For each phase of the study the manometric recording was split into 60 second 
intervals. For each of these segments the pressure profile of the LES was 
examined using the Manoview analysis software and based on both the colour 
contour plot and the pressure profile. The profile was classified as ‘single’ where 
one pressure peak was identified and ‘double’ where the LOS comprised two 
pressure peaks. A third observation of ‘not analysable’ was allowed where there 
was insufficient stable sphincter tone to enable classification such as occurred 
with the presence of transient lower oesophageal sphincter relaxations or 
frequent swallows. For each group the total time spent in double and single 
pressure profiles was recorded. 
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9.2.6 Detailed Analysis of Lower Oesophageal Sphincter 
For each of the four periods where fluoroscopic screening was available the LOS 
was analysed in detail. Data from six consecutive inspirations and six 
consecutive expirations were selected using a custom-made computer 
programme. The pressure profile was classified as ‘single or double’ where one 
or two peaks were seen respectively. 
The position of the upper border LOS was calculated on inspiration as a decrease 
in pressure to within 2mmHg of intra-gastric pressure moving proximally from 
the sensors within the LOS to the sensors within the oesophagus. The upper 
border LOS was used as a local reference point for the positions of the SCJ and 
pH transition point. Peak LOS pressure was calculated on both inspiration and 
expiration as the peak pressure within the LOS irrespective of pressure profile. 
The inspiratory augmentation pressure was calculated by subtracting the 
expiratory LOS pressure from the inspiratory LOS pressure. 
9.2.7 Fluoroscopy 
The position of the SCJ was derived from the fluoroscopic images for a median of 
6 inspirations and using the manometer and pH sensors as reference and internal 
scale. This was calculated relative to the upper border LOS. 
9.2.8 Statistical Analysis 
All results are presented as median and interquartile range unless otherwise 
stated. The Mann Whitney U Test was used for comparison between groups and 
differences were considered significant at a p value of less than 0.05. 
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9.3 Results 
9.3.1 Group Characteristics 
Of the original study group 15 volunteers (11 male, aged 38-74 years) were found 
to have hiatus hernia. Age range in the control group was 28-73years (p=0.206) 
and 11 were male. Median BMI in the hiatus hernia group was 25.9kg/m2 (Range 
21.0-35.6, IQR 5.8) and waist circumference 91.0cm (Range 77-119, IQR 24). 
Corresponding values for those without hiatus hernia were 28.7 (16.7-34.5, IQR 
7.8) (p=0.650) and 99cm (70-118cm, IQR 23) (p=0.820), respectively. 
Twelve of the 15 hiatus hernias were diagnosed by endoscopy, 10 by MRI and 7 
by both modalities. For those diagnosed by MRI the median length of the hiatus 
hernia was 2.3cm (IQR 0.79) and by endoscopy the median length 3 cm (IQR 0). 
9.3.2 MRI Measures 
The diameter of the diaphragmatic hiatus, measured by MRI was significantly 
larger in the hiatus hernia group. This was true for both fasting [13.3mm (IQR 
5.1) vs. 10.0mm (IQR 2.75), p=0.001] and for after the meal [14.9mm (IQR 6.5) 
vs 9.7mm (IQR 3.45), p=0.006]. 
This widened hiatus was seen irrespective of the method by which the hiatus 
hernia was originally detected. For those diagnosed with hiatus hernia on the 
basis of endoscopy the diameter of the hiatus in fasting was 13.6mm (IQR 5.8) 
compared with 10.6mm (IQR 3.2mm) in those without hiatus hernia on 
endoscopy (p=0.003). For those diagnosed by MRI the diameter of the 
diaphragmatic hiatus was 15.7mm (IQR 5.2) compared with 10.25mm (IQR 3.1) 
for those negative for hiatus hernia by MRI (p<0.001). For those with hiatus 
hernia confirmed on two modalities the diameter of the hiatus was widened 
compared to those with hiatus hernia diagnosed on one modality [17mm (IQR 
3.8) versus 12.4mm (IQR 2.6), p=0.009 for fasting, and 17.4mm (IQR 4.9) versus 
11.1mm (IQR 5.9), p=0.006 after the meal]. 
124 
 
9.3.3 Junctional Mucosal Characteristics 
Three volunteers had Barrett’s oesophagus identified endoscopically and were 
excluded from the analysis of cardiac mucosal length and junctional mucosal 
characteristics. All three had an associated hiatus hernia. Of the remaining 12 in 
the hiatus hernia group 9 had cardiac mucosa that was either ‘measurable’ or 
‘fully measurable’ compared with 13 out of 15 in the control group. 
Cardiac mucosa was significantly longer in the group with hiatus hernia 
compared to controls [3.5mm (IQR 1.0) vs 2.5mm (IQR 1.0), p=0.014]. In only 5 
of the hiatus hernia group was a full span of the cardiac mucosa obtained in a 
single biopsy (fully measurable) whilst 11 out of 15 in the control group had a 
fully measurable cardia (p=0.038). 
Moderate chronic inflammation of the cardiac mucosa did not differ significantly 
between groups [median score for mononuclear infiltrate in hiatus hernia group 
2.0 (IQR 1.0) vs 2.0 (IQR 1.0) in controls, p= 0.248]. Reactive atypia, a marker of 
cell turnover and repair, was also similar between the two groups [median score 
2.0 (IQR 1.0) in hiatus hernia group vs 2.0 (IQR 1.0) in controls, p=0.748]. Acute 
inflammation was not a prominent feature in either group and did not differ 
between groups [median score, based on polymorphonuclear infiltrate, 1.0 (IQR 
2) for hiatus hernia group and 0 (IQR 1.0) for controls, p=0.116]. 
9.3.4 Acid Reflux 
There was no significant excess of reflux symptoms in those with hiatus hernia 
compared to those without (Median reflux scores in hiatus hernia group 7 (IQR 3) 
versus 5 in controls (IQR 3) p=0.065). Acid exposure measured in the traditional 
manner (percentage of time pH was below 4 at 5cm above the LOS) was not a 
feature in either group and did not differ significantly between groups either 
before or after the meal. (Table 9.1) Short segment reflux (percentage of time 
pH was less than 4 at 1.1cm above the pH transition point) was greater in the 
hiatus hernia group versus controls in the supine posture after a meal. (p=0.011, 
Table 9.1) 
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TABLE 9.1: ACID EXPOSURE TIME [MEDIAN % TIME PH<4 (IQR)] IN PH SENSORS LOCATED AT 1.1CM 
PROXIMAL TO THE SCJ AND 5CM ABOVE THE UPPER BORDER LOS IN HEALTHY VOLUNTEERS WITH 
HIATUS HERNIA AND CONTROLS. (FU: FASTING UPRIGHT; FS: FASTING SUPINE, PPU: POST-
PRANDIAL UPRIGHT; PPS: POST-PRANDIAL SUPINE) 
  Hiatus Hernia Controls P value 
Acid Exposure  
5cm above LOS 
FU 0.0 (0.5) 0.0 (0.0) 0.345 
FS 0.0 (0.0) 0.0 (0.0) 0.285 
PPU 1.8 (6.9) 0.2 (1.2) 0.401 
PPS 
 
0.0 (0.0) 0.0 (0.0) 0.686 
Acid Exposure  
1.1cm above pH 
Transition Point 
FU 1.2 (26.9) 0.20 (9.40) 0.424 
FS 0.45 (6.7) 0.10 (13.2) 0.314 
PPU 4.25 (45) 4.0 (17.3) 0.330 
PPS 
 
5.45 (25.4) 0.30 (3.20) 0.011 
 
9.3.5 LOS Pressure and Inspiratory Augmentation Pressure 
There was no significant difference in the hiatus hernia group compared with 
controls in peak LOS pressure either on inspiration or on expiration. However 
inspiratory augmentation pressure was diminished in the hiatus hernia group 
after the meal in the supine posture. (Table 9.2) 
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TABLE 9.2: LOS PRESSURE (LOSP) AND INSPIRATORY AUGMENTATION PRESSURE IN HIATUS HERNIA 
AND CONTROL GROUPS (FU: FASTING UPRIGHT; FS: FASTING SUPINE, PPU: POST-PRANDIAL 
UPRIGHT; PPS: POST-PRANDIAL SUPINE) 
  Hiatus Hernia Controls P Value 
Peak LOSP on 
Inspiration 
(mmHg)(IQR) 
FU 36.9 (20.78) 32.2 (21.41) 0.870 
FS 30.7 (13.21) 35.6 (10.24) 0.345 
PPU 29.4 (12.74) 30.1 (16.48) 0.838 
PPS 27.4 (10.63) 34.2 (9.09) 0.137 
Peak LOSP on 
Expiration 
(mmHg)(IQR) 
FU 27.8 (22.04) 21.6 (14.25) 0.683 
FS 26.0 (16.52) 24.2 (7.10) 0.461 
PPU 22.9 (11.74) 18.2 (7.04) 0.074 
PPS 24.8 (13.92) 24.9 (8.57) 0.775 
Inspiratory 
Augmentation 
Pressure (mmHg) 
FU 6.97 (7.76) 10.4 (11.15) 0.624 
FS 5.12 (7.98) 6.12 (12.2) 0.137 
PPU 6.59 (9.07) 12.18 (14.8) 0.217 
PPS 3.82 (9.08) 8.52 (4.61) 0.037 
 
9.3.6 Prevalence of Double Peak on High Resolution Manometry 
In those with hiatus hernia the double peaked pressure profile was intermittent 
rather than fixed being seen on manometry a total of 36.6% of the time across 
all phases of the study (Table 9.3). Only one volunteer demonstrated a double 
peaked profile persistently throughout the recording. In the control group, 
negative for hiatus hernia by both endoscopy and MRI, the double peaked 
pressure profile was also seen intermittently and for 25.4% of total recorded 
time. Although the double peak was seen in both groups, there was a strong 
trend to increased prevalence of the double peak in those with hiatus hernia 
(p=0.053). The prevalence of the double peak for each group across the phases 
of the study is shown in Table 9.3) 
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TABLE 9.3: PERCENTAGE TIME SPENT IN DOUBLE PEAKED PRESSURE PROFILE FOR HIATUS HERNIA 
AND CONTROL GROUPS. FIGURES ARE SHOWN FOR EACH STUDY PHASE AND FOR THE TOTAL 
RECORDED TIME. (FU: FASTING UPRIGHT; FS: FASTING SUPINE; PPU: POST-PRANDIAL UPRIGHT; 
PPS: POST-PRANDIAL SUPINE) 
 Hiatus Hernia Controls P value 
FU 40.4% 38.6% 0.826 
FS 52% 23.1% 0.077 
PPU 32.9% 22.7% 0.285 
PPS 28.9% 24% 0.431 
Total 36.6% 25.4% 0.054 
 
9.3.7 Intrasphincteric Characteristics of Hiatus Hernia versus Controls 
9.3.7.1 Relative Positions of pH Transition Point, SCJ and Upper Border LOS 
The pH transition point was determined by the position of the most proximal of 
the 12 pH sensors showing a mean pH fall of 1 unit. We have previously shown 
that this sensor represents the abrupt change from oesophageal to gastric pH153 
In those with hiatus hernia the pH transition point was closer to the upper 
border LOS in all phases of the study aside from fasting upright (Figure 9.1). In 
the hiatus hernia group, the SCJ was also more proximally sited within the LOS in 
FU, PPU and PPS with a trend to significance in FS. There were no differences 
between the groups in the relative positions of the pH transition point and SCJ 
except after the meal in the supine posture in which the pH transition point was 
measured 0.31cm proximal to the SCJ in the hiatus hernia group versus 0.55cm 
distal to it in controls. (p=0.033). The upper border LOS was located a similar 
distance from the nares in both groups. 
9.3.7.2 Relative Positions of pH Transition Point, SCJ and LOS Peak Pressures 
 To allow comparison between groups, each having both types of pressure 
profile, the pH transition point was measured relative to either the proximal 
pressure peak of a double profile or the isolated peak of a single profile. In the 
128 
 
hiatus hernia group the pH transition point was proximal to this pressure peak 
after the meal in both upright and supine positions but remained distal 
throughout in controls (Table 9.4). The differences between the hiatus hernia 
subjects and controls were most pronounced in the supine posture after the 
meal and these are illustrated in Figure 9.1. 
TABLE 9.4: DETAILED ANALYSIS OF LOS COMPONENTS IN HIATUS HERNIA VERSUS CONTROLS 
SHOWING POSITIONS OF THE UPPER BORDER LOS, PH TRANSITION POINT, SCJ AND FIRST 
PRESSURE PEAK. (FU: FASTING UPRIGHT; FS: FASTING SUPINE, PPU: POST-PRANDIAL UPRIGHT; 
PPS: POST-PRANDIAL SUPINE)   
  Hiatus Hernia Controls P Value 
Nares to upper border 
LOS (cm)(IQR) 
FU 44.5 (2.0) 44.5 (5.0) P=0.92 
FS 44.5 (3.0) 45.5 (4.0) P=0.138 
PPU 43.0 (3.5) 43.25 (5.63) P=0.783 
PPS 44.0 (3.5) 44.0 (3.0) P=0.365 
Upper border LOS to 
pH Transition Point 
(cm)(IQR) 
FU 2.4 (4.0) 3.15 (1.42) P=0.245 
FS 0.50 (4.2) 2.35 (3.08) P=0.048 
PPU 1.1 (3.0) 2.55 (4.73) P=0.022 
PPS -0.5 (4.2) 2.30 (4.18) P=0.008 
Upper border LOS to 
SCJ (cm)(IQR) 
FU 2.46 (2.33) 2.94 (1.31) P=0.046 
FS 2.13 (1.89) 3.22 (1.69) P=0.055 
PPU 2.21 (2.24) 3.10 (1.26) P=0.033 
PPS 1.23 (2.07) 2.53(1.57) P=0.019 
SCJ to pH Transition 
point (cm)(IQR) 
FU 0.54 (2.13) -0.18 (2.47) P=0.530 
FS 0.22 (3.24) 0.15 (1.90) P=0.638 
PPU -0.56 (2.77) -0.64 (5.44) P=0.249 
PPS -0.31 (3.47) 0.54 (4.28) P=0.033 
Proximal Pressure Peak 
to pH Transition Point 
(cm)(IQR) 
FU 0.40 (3.70) 0.90 (2.53) P=0.217 
FS -1.3 (5.18) 0.20 (3.15) P=0.134 
PPU -0.60 (2.72) 0.55 (4.48) P=0.039 
PPS -2.4 (4.03) 0.7 (4.35) P=0.002 
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FIGURE 9.1: INTRASPHINCTERIC CHARACTERISTICS OF HIATUS HERNIA VERSUS CONTROLS AFTER A 
MEAL IN THE SUPINE POSTURE. 
9.3.8 Intrasphincteric Characteristics of Hiatus hernia Versus Controls When 
Both Have Similar Pressure Profile 
Both the hiatus hernia subjects and controls showed a double peak pressure 
profile for a similar proportion of the recording period. We compared the 
intrasphincteric characteristics of the hiatus hernia versus controls when both 
showed a single peak profile during fluoroscopy and again when both showed 
double peak profile. As this reduced the recording period available for analysis, 
we combined the fasting, postprandial, supine and erect data. 
9.3.8.1 Comparison of the Single Peaked Pressure Profile in Hiatus Hernia and 
Controls 
A total of 32 single pressure profiles were detailed during fluoroscopy for the 
hiatus hernia group and 43 for controls. In the single peaked pressure profile 
there was no difference between the groups in the position of the upper border 
LOS from the nares. However the SCJ and pH transition point were more 
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proximally sited relative to the nares in the group defined as having a hiatus 
hernia in the original study protocol (Table 9.5) 
The pH transition point was closer to the upper border LOS in the hiatus hernia 
group versus controls. Furthermore the pH transition point was sited proximal to 
the peak LOS pressure in those with hiatus hernia but distal to it in controls. 
TABLE 9.5: ANALYSIS OF SINGLE PEAKED PRESSURE PROFILE IN HIATUS HERNIA AND CONTROLS: 
POSITIONS OF SCJ, PH TRANSITION POINT AND PEAK LOS PRESSURE RELATIVE TO NARES AND TO 
UPPER BORDER LOS. RESULTS PRESENTED AS MEDIAN (IQR) 
 Hiatus Hernia Controls P value 
Nares to Upper Border LOS (cm) 44.5 (4.13) 44.5 (3.5) 0.184 
Nares to SCJ (cm)  46.1 (4.76) 47.2 (3.99) 0.010 
Nares to pH Transition Point (cm) 45.6 (7.10) 48.5 (6.33) 0.004 
Upper Border LOS to pH Transition Point 
(cm) 
2.2 (4.28) 2.5 (2.85) 0.011 
Upper Border LOS to SCJ (cm) 1.99 (2.63) 2.34 (1.65) 0.081 
Peak LES Pressure to pH transition point 
(cm) 
 
-0.5 (4.60) 0.8 (2.95) 0.003 
 
9.3.8.2 Comparison of the Double-Peaked Pressure Profile in Hiatus Hernia and 
Controls 
 A total of 28 double peaked pressure profiles were analysable for the hiatus 
hernia group verses 16 in controls. 
In the double peaked pressure profile the distance from the nares to the upper 
border LOS was similar between the groups (Table 9.6). The SCJ and the pH 
transition point were however proximally displaced in those with hiatus hernia 
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with respect to controls when measured relative to the nares. Both the SCJ and 
the pH transition point were also more proximally located with respect to the 
upper border LOS. When the position of the pH transition point was measured 
with respect to the proximal pressure peak of the double peak it was located 
proximal to it in those with hiatus hernia and distally in controls. 
TABLE 9.6 ANALYSIS OF DOUBLE-PEAKED PRESSURE PROFILE IN HIATUS HERNIA AND CONTROLS: 
POSITIONS OF SCJ, PH TRANSITION POINT AND PROXIMAL PRESSURE PEAK RELATIVE TO NARES AND 
UPPER BORDER LOS. RESULTS PRESENTED AS MEDIAN (IQR) 
 Hiatus Hernia Controls P value 
Nares to Upper Border LOS (cm) 43.5 (1.88) 44.5 (4.75) 0.294 
Nares to SCJ (cm) 44.9 (4.25) 46.9 (3.94) 0.003 
Nares to pH Transition Point (cm) 44.4 (3.90) 47.4 (4.80) 0.002 
Upper Border LOS to pH Transition 
Point (cm) 
0.8 (2.55) 2.3 (2.50) 0.003 
Upper Border to SCJ (cm) 1.5 (1.68) 3.2 (2.44) 0.008 
Proximal Pressure Peak to pH 
transition point(cm) 
 
-1.2 (3.10) 0.3 (2.70) 0.012 
 
9.4 Discussion 
The hiatus hernias that were detected in 25% of our healthy volunteers were not 
associated with increased traditional transsphincteric acid reflux or reflux 
symptoms. However, these subjects with hiatus hernia did have proximal 
extension of their cardiac mucosa. In addition, the hiatus hernia subjects had 
short segment acid reflux and their pH transition point located proximal to their 
SCJ following a meal in the supine position. The proximal extension of the 
cardiac mucosa is likely to be due to squamo-columnar metaplasia of the distal 
oesophagus induced by the increased intrasphincteric acid exposure. 
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Of our fifteen healthy volunteers with hiatus hernia, 12 were diagnosed at 
endoscopy, 10 with MRI scan and 7 by both. The variation in findings by these 
two tests performed at different times is in keeping with the intermittent nature 
of hiatus hernia 29, 30. The diameter of the diaphragmatic hiatus assessed by MRI 
was increased in the hiatus hernia subjects consistent with the disorder being 
associated with a weakness of the diaphragmatic crura. This widened hiatus 
detected by MRI was the case irrespective of the method by which the hiatus 
hernia was originally detected although in those confirmed to have a hiatus 
hernia by both modalities the widening was most apparent. This may reflect 
those with a more substantial crural defect spending more time in the hiatus 
hernia state. 
High resolution manometry has been claimed to be useful in diagnosing hiatus 
hernia on the basis of demonstration of a double-peak pressure profile due to 
the separation of the intrinsic and extrinsic sphincter.156 In our subjects with 
hiatus hernia, the double peaked pattern was observed intermittently and for 
less than the 50% of the recording time and this was similar to the subjects who 
were negative for hiatus hernia by both MRI scan and endoscopy. Scheffer et al 
reported that a double-peak was observed 53.2% of the time in patients with 
reflux disease compared to only 14.5% of the time in controls157. The same group 
in a further study reported that a double-peak was present for a similar period in 
reflux patients with a small hiatus hernia and controls but was present for a 
greater proportion of time in reflux patients with a large hiatus hernia 29. The 
similar prevalence of double-peak in our subjects with hiatus hernia versus 
controls is consistent with them having small hiatus hernias. The explanation for 
the double peak present in our healthy controls and also those studied by 
Bredenoord et al is unclear. However, Miller et al 158 described three pressure 
contributions to the LOS in healthy subjects; one from the crural diaphragm, one 
attributable to the intrinsic LOS and a third which the authors hypothesised 
represented the sling and clasp fibres of the proximal stomach i.e. the gastro-
oesophageal flap valve. The third pressure contribution was absent in the 
patients with reflux symptoms. It may be therefore that rather than 
representing an intermittent hiatus hernia, the double peak in our healthy 
volunteers represents the manometric signature of a healthy gastro-oesophageal 
flap valve.  
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There was no evidence of increased acid exposure in our hiatus hernia subjects 
versus controls when measured at the traditional location 5cm above the lower 
oesophageal sphincter. In addition, our subjects with hiatus hernia did not have 
increased reflux symptoms. Hiatus hernia is associated with reflux disease9 and 
the absence of traditional reflux in our healthy volunteers with hiatus hernia 
might be explained by their well-maintained intrinsic LOS pressure. They had 
evidence of impaired extrinsic sphincter function as seen in their widened hiatus 
on MRI and their impaired respiratory augmentation. The lack of reduction of 
peak LOS pressure in our hiatus hernia subjects despite this clear evidence of 
impaired extrinsic sphincter function indicates well maintained intrinsic 
sphincter function and the latter may be protecting them from transsphincteric 
reflux. The hiatus hernias in our present study must represent the majority of 
hiatus hernias in the general population as we detected them in 25% of healthy 
volunteers and the fact that they were not associated with transsphincteric 
reflux may explain the controversies which have existed about the relevance of 
hiatus hernia to reflux disease.159 
Though our healthy volunteers with hiatus hernia did not have traditional 
transsphincteric reflux, they did have evidence of short segment acid reflux 
detected within the sphincter region at 1.1cm proximal to the pH transition 
point but only following the meal and in the supine position. The occurrence 
following a meal may be explained by the increased stress on the lower 
oesophageal sphincter known to occur following a meal 27 and the occurrence 
only in the supine position due to the fact that hiatus hernias tend to reduce 
after a meal when the subject is in the erect position.157  
Our healthy volunteers with hiatus hernia had abnormalities of their mucosa 
within the region of the lower oesophageal sphincter. The length of their 
columnar cardiac mucosa was greater compared to those without hiatus hernia 
and this was after full correction for age and central obesity. In addition, the 
number of volunteers whose mucosa was longer than could be measured by our 
technique was significantly greater in those with versus without hiatus hernia 
indicating that the observed difference may be an underestimate. Three 
volunteers with hiatus hernia had endoscopic evidence of Barrett’s oesophagus 
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and were excluded from analysis. In all subjects, the cardiac mucosa was 
inflamed. 
More detailed analysis of the gastro-oesophageal junction was possible during 
the periods of fluoroscopy when we had accurate information on the relative 
positions of the squamo-columnar junction, pH transition point and sphincter 
manometric landmarks. The distance from the nares to the upper border of the 
LOS was not significantly different but in the hiatus hernia group the squamo-
columnar junction and pH transition point were closer to the nares and also 
closer to the upper border of the LOS. After the meal the pH transition point was 
also proximal to the first pressure peak in the group with hiatus hernia but distal 
throughout in controls. These differences were also apparent when the hiatus 
hernia and controls were compared when showing similar pressure profiles (i.e. 
single or double peak). 
How can we explain the observed proximal displacement of the pH step-up point 
and squamo-columnar junction relative to the upper border of the LOS and nares 
without the proximal displacement of the upper border of the LOS relative to 
the nares? Perhaps this represents the alteration in the relationship between 
extrinsic and intrinsic sphincters in those with a small or intermittent hiatus 
hernia. In the absence of a hiatus hernia where the anatomy at the gastro-
oesophageal junction is preserved the extrinsic sphincter overlaps and reinforces 
the intrinsic sphincter and the pressure inversion point is proximal to the peak 
sphincter pressure. The upper border of the LOS would be detected as a pressure 
increase from oesophageal pressure but the pressure contribution could come 
from the extrinsic sphincter, the intrinsic sphincter or both.  Our observations 
could be consistent with the upper border LOS in normal subjects being formed 
by the extrinsic sphincter with the intrinsic sphincter positioned just distally. 
Thus in our subjects with early hiatus hernia there could be proximal movement 
of the GOJ including the intrinsic sphincter, SCJ and pH transition point within 
and even across the extrinsic sphincter. This would only be detectable from the 
nares once it was persistently proximally displaced with respect to the extrinsic 
sphincter.  Some of the proximal displacement of the SCJ may also be explained 
by the proximal extension of cardia mucosa and proximal displacement of the pH 
transition point by intrasphincteric ingress of gastric acid.  Finally, the lack of 
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proximal displacement might be partly artefactual due to difficulty in detecting 
a small change over a relatively long distance.   
The lengthening of the cardiac mucosa is likely to be due to the observed acid 
ingress within the sphincteric region and consequent columnar metaplasia of the 
distal oesophageal squamous mucosa. Several of the abnormalities observed in 
our healthy volunteers with hiatus hernia are likely to contribute to the 
intrasphincteric reflux. The squamo-columnar junction normally lies within the 
region of the intrinsic sphincter and closure of the latter prevents gastric juice 
from refluxing onto oesophageal squamous mucosa. However, maintaining 
closure of the LOS also depends upon its reinforcement by the extrinsic sphincter 
and in our hiatus hernia subjects there was weakness of the extrinsic sphincter 
and intermittent loss of its superimposition relative to the intrinsic sphincter. 
This impairment of extrinsic sphincter function will predispose to distal opening 
of the intrinsic sphincter and acid ingress. The observation that the pH transition 
point in our hiatus hernia subjects was positioned proximal to the peak pressure 
point within the sphincter is also likely to be important. This will mean that acid 
secreted by the most proximal gastric mucosa lying above this peak pressure 
point will tend to flow proximally on to the most distal squamous mucosa rather 
than distally into the stomach. 
These changes observed in subjects with hiatus hernia are similar to those which 
we observed in subjects without hiatus hernia and associated either with central 
obesity or increased age. Together, they suggest that stress or ageing or damage 
to the supporting structures of the gastro-oesophageal junction allow acid to 
ingress within the sphincteric region encroaching on the most distal oesophageal 
mucosa without increased reflux across the sphincter. 
This dysfunction of the gastroesophageal barrier and associated metaplasia of 
the distal oesophageal mucosa appears to be common in our population. It 
occurs in the 25% of healthy volunteers who have this type of hiatus hernia and 
is also observed in healthy volunteers without hiatus hernia but with central 
obesity or with increasing age. Though the metaplastic change arising at the 
gastro-oesophageal junction might not carry the high risk of adenocarcinoma 
associated with transsphincteric reflux and full Barrett’s oesophagus, the high 
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prevalence of the condition may contribute to the significant number of cancers 
occurring at the cardia and gastro-oesophageal junction in subjects without a 
reflux history. 
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10 Discussion 
This work brings together studies of the pathology and physiology of the gastro-
oesophageal junction in healthy volunteers. The gastro-oesophageal junction is 
disproportionately affected by pathology and recent years have seen a marked 
increase in the incidence of adenocarcinoma at this site.75 Barrett’s oesophagus 
and reflux disease are documented risk factors for adenocarcinoma but many 
cases arise in those without a history of reflux disease or known Barrett’s 
oesophagus suggesting a role for mechanisms other than traditional reflux.35, 60 
To study the gastro-oesophageal junction in detail we employed novel 
techniques including high resolution measurements of pH and manometry. During 
our prolonged recordings the manometry readings appeared unstable. Given the 
accuracy required for detailed manometric assessment of the lower oesophageal 
sphincter this observed error posed a potential problem. Examining this further 
on the benchtop we were able to characterise two components of the error 
identified on the manometry trace; an initial step up in the recorded pressure 
attributable to the temperature change from room temperature to body 
temperature; and an ongoing pressure drift with time. We termed these errors 
thermal effect and baseline drift respectively.135 
Whilst documenting the error is important, arguably more important is 
addressing the error and optimising the accuracy of recordings. In 
communication with the manufacturer we learned of a linear correction process 
already within the capabilities of the current recording system but not well 
recognised or routinely applied. Indeed employing this corrective process at all 
requires both knowledge of the potential error and direct communication with 
the manufacturer. For this process the user must record conditions of body 
temperature and zero applied pressure at the start and end of a study. The 
software then extrapolates between these points assuming a linear drift and re-
zeroes the baseline accordingly. For our studies we incorporated a linear 
correction to address both thermal effect and baseline drift into our custom 
designed software. Testing this process on the benchtop data we found a 
minimal residual error of 0.3mmHg overall independent of study duration.  
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One of the main themes of this work was to study the pathological changes at 
the gastro-oesophageal junction in a healthy population. In particular to explore 
the hypothesis first proposed by Chandrasoma8 that the cardiac mucosa at the 
gastro-oesophageal junction is not an innate but rather an acquired structure 
reflecting squamous to columnar metaplasia. To study the cardia in detail in 
healthy volunteers presented several challenges, not least developing a method 
for accurate length measurement of this mucosa in healthy volunteers. The 
characteristics of the cardia have been previously studied both in resection 
specimens62 and in patients in whom a protocol for mapping biopsies of the 
gastro-oesophageal junction was developed to systematically characterise the 
area.63 We were concerned that discontinuous sampling of the mucosa could 
introduce inconsistencies in length measurement particularly given the 
movement of the gastro-oesophageal junction with respiration and the poor 
resolution of distance measurement on a conventional endoscope. Thus we 
sought to sample the mucosa in its entirety in a single biopsy. To do this we used 
large capacity forceps with a jaw span of 8mm being the largest forceps that 
would fit down a standard biopsy channel of the endoscope. We developed a 
protocol for taking the biopsies to maximise the chances of successfully 
capturing a span of the biopsy in a single sample including intra-procedure 
pathological feedback.  
Despite this there were a proportion of volunteers whose cardia could not be 
fully captured in a single biopsy. In some volunteers this was sampling error but 
in most cases squamous and cardiac mucosae were present and in continuity and 
despite an average biopsy length of 6.5mm the cardia was incompletely 
measured. To minimise the impact of this on the results of our main study 
(Chapter 7) we confined the results relating to cardiac mucosal length and any 
correlations with cardiac mucosal length to those with a fully measurable cardia 
defined by the presence of three mucosal subtypes in continuity. For the study 
examining mucosal characteristics in those found to have hiatus hernia only 5 of 
12 volunteers without Barrett’s oesophagus had a fully measureable cardia 
compared with 11 out of 15 in the control group. For this study we allowed a less 
strict definition of cardiac mucosal length ‘measureable’ rather than fully 
measureable where we were able to quantify the length of cardiac mucosa 
present but not to obtain a full span. This does represent a limitation of our 
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methodology but we considered that any effect of this on our results would be to 
underestimate the impact of a hiatus hernia on cardiac mucosa length and 
therefore there may be an even greater difference between the groups than we 
were able to measure. 
We were able to demonstrate significant lengthening of the cardiac mucosa in 
association with waist circumference and age and we propose that this 
lengthening represents metaplastic transformation of distal squamous mucosa as 
a result of acid damage. This supports the original hypothesis proposed by 
Chandrasoma which has admittedly not garnered universal support. Those who 
argue against the acquired cardia hypothesis have cited its presence in children 
and its universal presence in adults as evidence of an innate rather than an 
acquired structure.68, 160 Many studies in this area have been plagued by 
inconsistencies in definition and we deliberately chose the strict histological 
definition of the cardia to avoid confusion. In our population cardiac mucosa was 
universally present although length varied with the clinical characteristics of the 
volunteer. In no individual did we observe direct transition from squamous to 
oxyntic mucosa or even to oxynto-cardiac mucosa. There are at least two 
possible explanations for this. One is that acid damage to distal squamous 
mucosa is prevalent in our population under study such that by adulthood all 
have some evidence, albeit only mm, of columnar metaplasia. The second may 
be a reflection of our method of sampling. We were not able to sample the 
entire circumference of the squamo-columnar junction in the way that is 
possible with resection specimens and may have missed areas of direct transition 
from squamous to oxyntic mucosa.  
To develop the hypothesis that the cardia is acquired rather than innate we 
studied the inflammatory characteristics of the mucosal subtypes present at the 
gastro-oesophageal junction. We also employed immunohistochemistry to 
compare the cardiac mucosa in our healthy volunteers to a cohort of patients 
with Barrett’s oesophagus. We found that the cardiac mucosa was universally 
chronically inflamed and markedly more so than the adjacent oxyntic mucosa. In 
squamous mucosa the inflammation was most marked distally with reactive 
atypia most pronounced immediately adjacent to cardiac mucosa indicating a 
mucosa under stress. On immunostaining cardiac mucosa resembled non-IM 
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Barrett’s in six of the seven immunohistological markers of differentiation of GI 
epithelium whereas the other mucosal subtypes studies (oxynto-cardiac, oxyntic 
and antral) differed from Barrett’s mucosa with respect to at least three of the 
immunostains.  Long segment Barrett’s oesophagus is typically a patchwork of 
intestinal and non-intestinal columnar metaplasia with a greater proportion of 
the latter distally. Cardiac mucosa is at the most distal end of the oesophagus 
where columnar metaplasia would typically be most similar to non-IM rather 
than IM metaplasia. Taken together, the observations that the cardia mucosa 
lengthens with age and with measures of central obesity and the staining 
demonstrating that cardiac mucosa is histologically indistinguishable from non-IM 
Barrett’s oesophagus indicates that the cardiac mucosa is acquired by acid 
damage to distal squamous mucosa. 
Although Barrett’s oesophagus and gastro-oesophageal reflux disease are well 
documented risk factors for oesophageal adenocarcinoma a significant 
proportion of cases occur in their absence. We have hypothesised and 
demonstrated a mechanism of acid exposure at the gastro-oesophageal junction 
that may reconcile this apparent paradox27, 152, 153. Our volunteers had no known 
reflux disease and were selected from the healthy population. Current or 
previous PPI use excluded participation in the study as did previous attendance 
at primary of secondary care for symptoms of acid reflux. The lack of significant 
acid exposure 5cm above the upper border of the lower oesophageal sphincter 
was confirmed on pHmetry with no subjects demonstrating a pH below 4 more 
than 4% of recorded time at this level. Whilst the recordings were prolonged 
lasting more than 105 minutes in total and including the effect of posture and a 
meal, they do not parallel the clinical approach to diagnosing significant acid 
reflux. Nonetheless, in combination with the lack of symptoms and previous and 
current anti-secretory therapy we have reasonable evidence for lack of 
significant traditional reflux in our study population.  
Although our subjects did not have significant transsphincteric reflux those with 
obesity did demonstrate dysfunction of the gastro-oesophageal barrier allowing 
acid influx within the lower oesophageal sphincter. We termed this mode of acid 
exposure intrasphincteric reflux. In our volunteers with a large waist 
circumference we observed shortening of the lower oesophageal sphincter after 
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the meal attributable to loss of the distal component. Acid was seen to move 
proximally within but not across the lower oesophageal sphincter evident by a 
more proximal positioning of the pH transition point relative to the upper border 
of the sphincter. After the meal the leading edge of this intrasphincteric acid 
was seen to encroach upon or even cross the peak sphincter pressure. We have 
suggested that this acid may then be influenced by a local pressure gradient 
promoting pooling or even retrograde flow of acid rather than distal clearance 
but this is speculation.  
In previous similar work 37 the location of the leading edge of gastric acidity has 
been measured using a pH probe clipped in place to minimise movement 
artefact. We did not employ this approach in our studies instead opting to 
combine the high resolution pH probe to the manometry probe allowing close 
correlation of pH and manometry data. The pH transition point is defined by a 
1u fall in mean pH which we have shown corresponds to a pH of less than 4 for 
38 to 58 % of the time. We have defined short segment reflux at the sensor 
proximal to the pH transition point by the percentage of time the pH was below 
4 and have interpreted acid exposure at these sites as proximal ingress of acid 
within the sphincter. However it is also possible that the pH sensor is recording 
intermittent gastric acidity due to the pH probe dipping into gastric acid with 
movement of the junction such as occurs with respiration and swallows. Whether 
or not this represents reflux, it holds true that this intermittent acid exposure 
occurs more proximally within the sphincter in association with obesity and 
indeed with hiatus hernia. 
Interestingly in the volunteers with a large waist circumference the leading edge 
of gastric acidity was seen to move up in tandem with the squamo-columnar 
junction. How can we explain the observed proximal displacement of the SCJ? 
Perhaps this partly reflects the previously demonstrated lengthening of the 
cardiac mucosa. However since the difference between the groups in the length 
of the cardia is of the order of mm it is unlikely that this is the only explanation. 
Another possibility is that the proximal displacement of the squamo-columnar 
junction represents an early subclinical hiatus hernia in the large WC group with 
proximal movement of the intrinsic sphincter relative to the extrinsic. In support 
of this further work from our group has demonstrated that application of a waist 
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belt to apply external abdominal compression in those with obesity can induce a 
small hiatus hernia125. This would exacerbate any tendency to excess local acid 
exposure. 
Our final study in this series aimed to analyse the impact of hiatus hernia on the 
barrier function of the gastro-oesophageal junction in healthy volunteers. Much 
of the published work on hiatus hernia is in patients with known gastro-
oesophageal reflux disease and its role in the pathophysiology of acid reflux in 
this context is well established. 9, 24 As part of our study protocol we identified a 
subgroup of volunteers with hiatus hernia but without known reflux disease 
which provided us with an opportunity to study the effect of a hiatus hernia in 
this healthy population. There was no significant transsphincteric reflux in the 
group with hiatus hernias despite evidence of GOJ dysfunction. However there 
was short segment reflux and intrasphincteric acid reflux in this group compared 
to those without hiatus hernia.  
Hiatus hernia was diagnosed by MRI or endoscopy with moderate concordance. 
Both endoscopy and radiology have their limitations with previously documented 
sensitivities of 73% for endoscopy and barium swallow.156 There is little direct 
information on the role of MRI in this context but in one study the accuracy of 
dynamic MRI in diagnosing reflux related disorders including hiatus hernia was 
79%.161 In our study population the hiatus hernias detected were small, 2-3cm in 
length. It is increasingly recognised that small hiatus hernias are intermittent 
rather than fixed and in consequence may be missed by diagnostic modalities 
limited to a snapshot in time. In addition endoscopy, performed with air 
insufflation of the stomach, represents non-physiological conditions. This has led 
some to suggest that high resolution manometry, having the advantage of 
continuous and prolonged recording of the pressure profile across the junction, 
may be more sensitive, up to 92% in a recent comparison156. Comparisons are 
marred by the lack of a gold standard and for small hiatal hernias it may also be 
that we are artificially trying to separate a continuum into a dichotomy. 
Nevertheless we recognise that this diagnostic difficulty has the potential to 
impact on our analysis as it does on all similar work.  
143 
 
The prolonged manometry recordings in those with hiatus hernia demonstrated 
that the double peak was observed intermittently and only one volunteer 
demonstrated a fixed double pressure profile for the entire duration of the 
recording. This is consistent with the intermittent nature of early hiatus hernia 
and has been previously described.29, 30 Interestingly despite the absence of 
evidence for hiatus hernia on endoscopy or MRI, the control group also 
demonstrated a double peak on manometry for a similar proportion of recorded 
time.  Whether or not this double peak reflects a hiatus hernia is unclear from 
our data. It is unlikely to be artefact as it was observed intermittently rather 
than persistently. It may represent separation of intrinsic and extrinsic 
sphincters or perhaps there is another pressure contribution to the profile such 
as sling and clasp fibres of the gastro-oesophageal flap valve. 
When we studied the double pressure profiles of the hiatus hernia group 
compared to the control group several differences were apparent. The pH 
transition point and squamo-columnar junction were closer to the nares and to 
the upper border LOS in those with a hiatus hernia with the pH transition point 
traversing the proximal pressure peak in the HH group. It may be therefore that 
the double peak in the control group is actually a reflection of distal positioning 
of the intrinsic sphincter with respect to the extrinsic sphincter rather than 
proximal movement as would be seen with a hiatus hernia. This may also explain 
why we did not see a difference in the distance from the nares to the upper 
border of the LOS between the groups. If we assume that in the control group 
the proximal peak represents the extrinsic sphincter then measuring nares to the 
upper border would be a measurement of nares to extrinsic sphincter. As hiatus 
hernia develops the intrinsic sphincter would first move proximally within the 
hiatus and then across the hiatus so that the intrinsic sphincter was located 
proximal to the extrinsic. In this case the measurement of nares to upper border 
would be a reflection of nares to intrinsic sphincter now a few cm proximally 
displaced but only detectable as a minor difference from the nares.  
Despite a lack of transsphincteric reflux, hiatus hernia in our healthy population 
was associated with increased distal acid exposure. This was measurable as 
excess short segment reflux and proximal positioning of the pH transition point 
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but was also reflected pathologically by lengthening of the cardiac mucosa in 
this group. 
In summary therefore we have presented a series of studies examining the 
pathology and physiology of the gastro-oesophageal junction in healthy 
volunteers without gastro-oesophageal reflux disease. We have demonstrated a 
lengthening of the cardiac mucosa at the gastro-oesophageal junction in 
association with age, central obesity and hiatus hernia. We have further studied 
this mucosa with immunohistochemistry and proven it be histologically 
indistinguishable from Barrett’s oesophagus without intestinal metaplasia. And 
finally we have hypothesised and demonstrated intrasphincteric acid exposure in 
the absence of traditional reflux as a plausible mechanism underlying the 
observed mucosal abnormalities. These observations are likely to be relevant to 
adenocarcinoma of the gastro-oesophageal junction. 
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Appendix 1: Protocol for Endoscopy Study Day  
The volunteer attends fasted from the previous evening. 
Ensure the following specific equipment is available: 
1. Radial jaw 4 forceps without spike 
2. Re-usable clip fixing device and a supply of clips. 
Perform the following steps: 
1. Position the volunteer in the left lateral position as for a standard 
endoscopy. 
2. Check the function of the endoscope. 
3. Ensure that the clip fixer fits through the working channel of the 
endoscope and can be passed out the distal end. 
4. Load the first clip into the clip fixing device 
5. Ensure that expertise is available for immediate handling and orientation 
of the biopsies and for intra-procedure feedback of biopsy adequacy. 
The procedure:  
The volunteer should be offered a choice of sedation or throat spray as for a 
standard diagnostic endoscopy. The following guidance assumes competency in 
endoscopic techniques 
1. Intubate the upper oesophagus under direct vision and perform an 
examination of the oesophagus and stomach. 
2. Take a biopsy from the antrum.  
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3. Visualise the cardia in retroflexion. 
4. Grade the appearance according to Hill’s criteria for the gastro-
oesophageal flap valve. 
5. Photograph the cardia in retroflexion. 
6. Take a biopsy from the gastric body. 
7. Withdraw the endoscope to the level of the gastro-oesophageal junction. 
8. Record the distance from the incisors of the:  
a. Diaphragm 
b. Top of gastric folds 
c. Squamo-columnar junction 
9. Take three biopsies of the gastro-oesophageal junction: 
a. Orientation should be in a cranio-caudal direction across the Z-line. 
b. Each biopsy should include enough squamous mucosa to confirm 
positioning at the squamo-columnar junction but should be 
predominantly cardia. 
10. Junctional biopsies are immediately examined using a magnifier and light 
source to confirm that an adequate biopsy has been obtained. If there is 
doubt as to the adequacy of the biopsies consider a further attempt 
provided the procedure is well tolerated by the volunteer. 
11. Clipping of the gastro-oesophageal junction: 
a. Insert the clip fixing device through the working channel of the 
endoscope. 
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b. Watching the endoscopic view, push the device through until the 
metal is visible. 
c. Ask your assistant to put the ‘clip out’ slowly and watch the 
endoscopic view. The clip should be protruded until the white 
plastic wings can be seen on the screen. Protruding the clip further 
will cause it to fall off. 
d. At this stage ask the assistant to ‘open slowly’. This action will 
bring the plastic wings back until they are flush with the metal 
covering and start to open the clip. 
e. Position the clip at the gastro-oesophageal junction and deploy the 
clip at the Z line under direct vision. 
f. Ask your assistant to load a second clip and repeat the clipping 
procedure (11-15) to deploy a second clip at the squamo-columnar 
junction. 
12. Confirm positioning of the clips and remove the endoscope. 
After the procedure: 
1. Thank the volunteer and confirm the arrangements for the final study 
visit. 
2. Ensure the process for handling and orientating the biopsies is followed. 
3. Enter a report using endoscope and file a copy of this in the volunteers 
study file as well as mailing a copy to the GP. 
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Appendix 2: Protocol for Recording 
Manometry and pH Data 
Manometry Set Up 
1. Switch on DELL computer and Manoscan. 
2. Attach selected HRM probe to manoscan: red connector to red port with 
dots apposed; blue connector to blue port with dots apposed. 
3. Insert catheter into pressure chamber to 42cm depth. Tighten washer. 
4. Open Manoscan Acquisition from Desktop 
5. Select probe screen will display automatically. Using mouse click on 
desired probe to highlight and press select button. Probe number is found 
on…. 
a. EAN0426  
b. EAN0001 
6. Main display screen will appear in contour display mode. At this stage the 
screen should appear blue. 
7. Press start button on menu to right of screen display. This will display a 
Patient Information Screen 
8. Enter the required data indicated by blue highlight or * 
9. Click OK 
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Calibrating the Manometry Probe 
1. Following the instructions in the box to the top right of the screen press 
Next 
2. Calibration display screen will appear. Press start to begin pressure 
calibration. Pressure indicator will climb to 300 mmHg and fall to 0mmHg.  
3. Click OK 
4. Remove the catheter from the pressure chamber and apply manosheath: 
a. Slide manosheath over catheter 
a. Fold at end at dot 
b. Use slider to expel excess air. 
c. Secure sheath in place by wrapping elastic tie three times around 
catheter and attaching onto peg. 
. pH Set-Up 
1) Switch on Viglen computer and open Polygram NET on the desktop 
2) Attach 12 sensor antimony pH probe to polygraph box. 1-6 are the 
proximal sensors and attach to the connector labelled P. 7-12 are the 
distal sensors and attach to the connector labelled D. 
3) Ensure polygraph box is switched on. 
4) On polygram>Home tab>12 pH sensors. This will open studies tab with 12 
sensor pH protocol. 
5) Follow menu on left screen 
6) Study details:  
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a. Enter study ID and additional information as required 
b. Enter patient details by either selecting existing patient from right 
menu or create new patient by selecting patient button (red figure, 
bottom left of screen) 
7) To verify connections: Equipment>12channel pH>Connections. Ensure all 
sensors have green status box 
Calibrating the pH Probe: 
1) Under equipment>12channel pH>Calibration 
2) Go to calibrate group. Select button 2 from bottom left menu. 
3) Immerse all sensors and reference electrode in pH buffer 7.01 (clear) and 
select  
4) Polygram will enter timer based calibration for high level signal. All 
sensor channels should read pH 7 
5) When prompted remove pH probe from buffer 7. Immerse all sensors and 
reference electrode in pH buffer 1.07 (pink) and select  
6) Polygram will enter timer based calibration for low level signal. All sensor 
channels should read pH 1. 
7) A message box will appear with the message calibration successful. Click 
OK 
8) If system fails to calibrate check sensor channels for rogue reading to 
identify culprit sensor. 
Data Capture: 
1) Select Capture from left menu>LES 
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2) Capture screen appears with 12 sensors display. Criss-crossed background 
indicates not in recording mode. 
Combining pH and Manometry Apparatus 
1. Identify sensor 29 on the manometry catheter. (The most distal sensor is 
36) 
2. Identify sensor 7 on the pH catheter. (The most distal sensor is 12) 
3. Align the probes such that sensor 29 and sensor 7 are in alignment. 
4. Cut sleek into the following shapes using sharp scissors: 
 
 
 
5. Use shape f to reinforce the end of the manometry catheter (only 
required where sheath used). Attach to end and double back as shown: 
 
a   b   
d 
f 
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6. Attach the catheters together using shape a ensuring that sensor 29 on 
the manometry aligns with sensor 7 on the pH. Ensure that the sensing 
element of the pH sensor is uncovered and facing outward from the 
manometry catheter. Wind sleek round catheters to attach. 
 
7. Attach shape d to pH catheter and shape e to manometry catheter. Shape 
e slips through the central hole in d and attaches to pH catheter. Shape d 
now attaches to manometry catheter. 
 
 
8. Wind shapes b and c over attachments created as above as reinforcement. 
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9. Finally use sleek to attach catheters together more proximally on the part 
of the apparatus that will remain external. e.g.60cm. 
10. When ready to intubate hold apparatus aloft ensuring no external pressure 
influences on manometry probe and select ALT/Z to zero channels. 
Thermal Calibration Procedure 
1. The water bath designed for in vivo calibration of the manoview 
apparatus must be used. Fill the water bath to 2 centimetres depth with 
water at 37degrees centigrade 
2. Commence recording on pH and manometry systems simultaneously: 
a. On the manoview acquisition display use the mouse to select the 
Start recording button on the bottom left corner of the display. 
Recording will be indicated by the appearance of a red line at top 
of recording and the appearance of stopwatch on top left of 
screen. 
b. On the polygram software use the mouse to depress the green 
record button on the bottom left of the screen. Recording screen 
will appear. Plain background and timer indicate recording 
3. Place the combined apparatus in the water bath ensuring that all the 
manometry sensors are covered. 
4. Use the timer on the manoview acquisition software to time three 
minutes.  
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5. After three minutes remove the combined apparatus from the water bath 
and mark the recording using the wet swallow button on the menu to the 
right of the display. 
The apparatus is ready for intubation. 
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Appendix 3: Protocol for Recording pH and 
Manometry 
Prior to the Arrival of the Volunteer: 
1. Set up the pH and manometry systems as described in the protocol Initial 
Set Up pH and Manometry. The thermal calibration procedure can be 
carried out once the volunteer has arrived and is ready for intubation. 
2. Obtain Phillips BV Pulsera from radiology and ensure availability of 
radiographer. 
The volunteer will attend fasted from the previous evening. Ask the volunteer to 
empty the bladder and to change into scrubs. Women should remove their bra. 
Placement of the Combined apparatus: 
1. Begin with the volunteer fasted and in the upright position. 
2. Start recording on both systems simultaneously. 
3. Perform the thermal calibration procedure described in the Initial set up 
pH and Manometry Protocol. 
4. Use lignocaine spray to selected nostril as a local anaesthetic. 
5. Attach the pH reference electrode to the left upper arm using contact 
gel. 
6. Pass the combined pH/manometry apparatus through the nose and 
carefully advance it until both upper and lower oesophageal sphincters 
are visible on the manometry display. 
7. Record the Insertion Distance on the proforma for study day 4. 
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Recording Protocol: 
1. Allow a period of accommodation of at least 10 minutes. After this period 
talking should be minimised to reduce artefact on the MVS trace. 
2. Carry out recordings in the following sequence: 
Fasted Erect 15 mins 
Supine 15 mins 
Meal  20mins 
Post-Prandial Erect  45 mins 
Supine 30mins 
Fasting Erect: 
1. During the first 15 minutes of recording identify radiographer and clarify 
time of first screening episode. 
2. Estimate timing of meal and arrange pick up of fish and chips from chip 
shop. 
3. The first screening episode is undertaken at the end of the fasting upright 
period. 
4. For each screening episode: 
a. Ensure availability of lead aprons for all present. 
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b. Enter volunteer details on the Phillips workstation if not already 
done by radiographer. 
c. Position C-arm to screen in the area of the GO junction. 
d. Radiographer will perform a check screen. During this episode 
check the following: 
i. The clip should be visible. 
ii. The ends of both catheters are seen 
iii. The exposure is adequate and the lumbar spine and 
diaphragm are in view. 
e. When ready to screen, ask the volunteer to swallow then to 
breathe normally and avoid swallowing for the duration of the 
recording. 
f. Move event marker into field to be screened.  
g. Ask assistant to be ready to activate fluoroscopy event marker on 
polygram software. 
h. Perform the following sequence of events: 
i. Ask the radiographer to “Start screening” 
ii. Count 3,2,1 mark. On “mark” remove the event marker from 
the field of screening and simultaneously use the fluoroscopy 
event marker on the polygram to mark the pH tracing. 
iii. Record the time on the proforma. 
iv. Continue screening for around 30seconds in total 
v. Ask the radiographer to “Stop screening” 
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Fasting Supine: 
1. Reposition volunteer to lie flat on back and continue recording 
2. Note time on proforma 
3. Re-orientate C-arm to screen across GO junction in preparation for next 
screening episode. 
4. Repeat sequence of events as outlined in for each screening episode 
above 
5. Record time on proforma. 
6. Continue recording for 15 minutes 
Meal: 
1. Weigh meal and record weight on proforma 
2. Offer volunteer standardised meal consisting of fish and chips. 
3. Record time on proforma. 
4. Do not interrupt pH and manometry recordings as this will entail 
repeating the entire set up. 
5. Ask volunteer to eat until full over a twenty minute period. 
6. Weigh leftovers and record on proforma. 
Post-Prandial Upright: 
1. Record time on proforma 
2. Continue pH and manometry recordings for 45 minutes in the upright 
position. 
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3. During this time ensure availability of radiographer for screening. 
4. The third screening episode is carried out at the end of this period. 
5. Perform screening as outlined above and record time on proforma. 
Post-Prandial Supine: 
1. Reposition volunteer and record time on proforma. 
2. Perform final screening episode and record time on proforma. 
3. Continue recording for 30 minutes. 
Completing Study and Saving Data: 
1. On completion of the study gently remove the combined apparatus from 
the volunteer. 
2. Hold sensors free from external pressure influence for sixty seconds to 
allow thermal drift calculation. 
3. Stop both recordings simultaneously 
a. On the manoview programme use the mouse to press the Stop 
Recording Button on the bottom left of the screen. The end of the 
red line at the top of the screen confirms end of recording. 
b. On the polygram programme use the mouse to press the Stop 
Recording Button on the bottom left of the screen. The appearance 
of the hatched pattern confirms the end of the recording. 
Saving the Studies: Manoview 
1. Go To File>Close/Save Current.  
2. A message box will appear. Confirm Close/Save Current Study 
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3. Save. File will automatically save into directory: program 
Files>SSI>ManoScan Acquisition>Patients>CSO Fat Study 
Saving the Studies: pH 
1. Go to study details on left menu. 
2. Tick study completed box. 
3. Go back to studies tab and identify the newly created study from list 
displayed. 
4. Right click the required study using the mouse. 
5. On the displayed menu>ASCII export. 
6. A pop up screen appears with Save As. Save with .asc file extension in 
desired directory. For this study files are saved in My 
documents>Elaine>ASCII files pH. 
7. Close polygram. 
Completing the Study 
1. Carefully separate the pH and manometry apparatus using scissors of 
required. 
2. Clean the pH catheter and send for decontamination. 
3. Test  the integrity of the manosheath using the equipment provided.  
4. If the manosheath has a leak (usually suspected by artefact during 
recording) the probe will have to be decontaminated using the TRISTEL 
system. 
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Appendix 4: Protocol for Exporting pH and 
Manometry Data 
Exporting the Manometry Data: 
1. Open ManoScan Acquisition on desktop 
2. Go to file on main menu>review patient file. 
3. Select desired study (.mvs file extension) 
4. Click open 
5. Main display screen will appear with compressed patient data 
6. Compress data to 150000 using the scale on the bottom left of the screen. 
7. Activate smart mouse using the button on the top right of the screen. This 
should change to smart mouse on. 
8. Use the right mouse button with the smart mouse function on to highlight 
all the compressed data 
9. Select file>save selected then save as screen appears. Save as text file 
with .txt file extension. File will automatically save into directory: 
program Files>SSI>ManoScan Acquisition>Patients 
10. To retrieve the saved text file go to Start menu>My computer>C 
drive>Program files>SSI>Manoscan Acquisition>Patients folder. There is a 
shortcut on the desktop entitled patients. 
Exporting the pH Data 
1) The pH data is backed up in ASCII file format in the directory >My 
documents>Elaine>ASCII files pH 
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2) Go to this directory and select created file. 
3) Right click file and on displayed menu >Open with>Notepad. 
4) From notepad screen go to file >save as>. Save with .txt file extension in 
required directory (For this study Desktop>Shortcut to ManpH data>CSO 
Fat Study pH text files 
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Appendix 5: Study Questionnaire 
 
Volunteer Identifier:  
Date:  
 
 
Heartburn is a burning feeling behind the breastbone. How often have you had 
this feeling within the last 2 months?   
 Not at all       
 Less than once a month     
 Between once a month and once a week    
Between once a week and once a day   
Once a day or more      
 
Indigestion is a pain or discomfort in the upper abdomen. How often have you 
has this symptom over the last 2 months  
Not at all       
 Less than once a month     
Between once a month and once a week   
Between once a week and once a day   
Once a day or more      
 
Regurgitation is an acid taste coming up into your mouth from your stomach. 
How often have you had this symptom over the last 2 months? 
Not at all       
 Less than once a month     
Between once a month and once a week  
Between once a week and once a day   
Once a day or more      
 
Nausea is a feeling of sickness without actually being sick. How often have you 
had this symptom within the last 2 months?  
Not at all       
 Less than once a month     
Between once a month and once a week  
Between once a week and once a day   
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Once a day or more      
 
Which, if any, of these symptoms has been the most troublesome to you in the 
last 2 months? 
 Heartburn      
Dyspepsia      
Regurgitation     
Nausea      
None of the above     
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DIETARY INTAKE 
  
Please record your oral intake in the past 24 hour period, starting from wakening 
up yesterday. Include all meals and snacks as well as times of eating 
 
Time Food Taken Portion size* 
 Rice krispies  with semi-skimmed milk, 
White bread toasted with butter and jam 
Banana 
Orange juice 
1 medium bowl 
Two slices 
1 whole 
1 cup 
Before 
Breakfast 
 
 
 
 
Breakfast 
 
 
 
 
 
 
Mid-
morning 
 
 
 
 
Lunch  
 
 
 
Mid-
afternoon 
 
 
 
 
Evening 
meal 
 
 
 
 
Later 
evening 
 
 
 
 
Other 
snacks 
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*See guide for portion sizes. 
 
Weight History 
 
Please enter the following details regarding your weight: 
 
What is your current weight?  
What was your weight one year ago?  
What was your weight five years ago?  
What was your weight aged twenty?  
 
 
MEDICAL HISTORY 
 
Do you have any medical conditions for which you regularly attend your GP or a 
hospital clinic? If so please give details: 
 
 
 
 
Have you previously attended your GP or hospital clinic for any medical 
conditions? If so please give details: 
 
 
 
   
Have you ever been admitted to hospital? If so please give details  
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DRUG HISTORY 
 
Do you take any regular prescribed medications? If so please give details   
 
 
 
 
Have you taken any over the counter medications in the past month? If so please 
give details  
 
 
 
 
 
Do you take any herbal medications or alternative therapies? If so please give 
details 
 
 
 
 
Have you used any remedies for heartburn or indigestion in the past six months?  
No         
Yes     
   -Less than once a month     
-Between once a month and once a week   
-Between once a week and once a day   
-Once a day or more     
 
If so please give the name of the medications you have taken.   
  
 
 
            
Have you ever been treated for helicobacter pylori?  
   Yes       
   No       
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Smoking/Alcohol History 
 
Do you currently smoke? 
 Yes     
 No     
 
What age were you when you started 
smoking? 
 
 
How many cigarettes do you smoke each day? 
 
 
Do you drink alcohol? 
 Yes     
 No     
 
How many units of alcohol do you drink in a week? (A unit is a small glass of 
wine, half a pint of beer or a pub measure of spirits) 
 
 
 
  
 
